Quarterlytics / Chemicals / HeiQ

HeiQ

heiq · LSE
Claim this profile
Ticker heiq
Exchange LSE
Sector
Industry Chemicals
Employees 51-200
← All annual reports
FY2020 Annual Report · HeiQ
Sign in to download
Loading PDF…
Differentiate. 
Innovate.

H

e

i

Q

p

l

c

A

n

n

u

a

l

r

e

p

o

r

t

a

n

d

a

c

c

o

u

n

t

s

2

0

2

0

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

i

H
e
Q
p
c

l

 
 
 
 
 
 
 
 
 
 
 
ADJ UST SPI N E 6M M WH E N SE N D I N G TO PR I NT

Who we are
HeiQ creates innovative 
technologies that add 
functionality, comfort, 
hygiene and sustainability 
to apparel, home textiles, 
technical textiles, medical 
textiles and devices, 
as well as functional 
consumer products.

Our purpose
To improve lives by 
innovating the materials 
people use every day.

Our vision
Heiqed materials 
that improve the  
lives of billions.

Our mission
To pioneer 
differentiating 
materials through  
co-creation.

2020 highlights

Financial

Revenue | US$m

Gross profit margin | US$m

+80.3%

2020 

2019

2018

28.0 

26.2 

+700bpt

50.4 

2020 

55.6 

2019

2018

48.6 

42.8 

EBITDA (Adjusted) | US$m

EPS (Diluted) | US$

+383.7%

+493.0%

2020 

2019

2.9 

2018

2.3 

14.0 

2020 

0.0421 

2019

0.0071 

N/A

Operational
  Broadened business areas and 
product portfolio, entered into  
new high growth markets

  Rapid and deep innovation 

capability gave us a product highly 
relevant to help society during the 
Covid-19 pandemic and deliver 
during an adverse economic 
situation

  Unique go-to-market capability  

and adaptable marketing 
approach to launch product  
with completely new media mix 
(media presence +280% vs. 2019)

  Business of regular products 

unaffected by slowed economic 
activities

r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Contents
  Strategic report

2020 highlights
At a glance
Our DNA
Investment case
Chairwoman’s Statement
Market overview
Business model
Our strategy
Strategy in action
Chief Executive Officer’s Review
Key performance indicators 
Sustainability Report
Section 172 Statement 
Financial Review
Risk management
Principal risks and uncertainties

  Corporate governance

The Board
Chairwoman’s introduction
Corporate Governance Statement
Audit Committee Report
Nomination Committee Report
Remuneration Committee Report
Directors’ Report

  Financial statements

Auditor’s Report
Financial Statements
Notes to the Consolidated Financial 
Statements
Company Financial Statements
Notes to the Company Financial 
Statements
Company Information

.001
.002
.004
.006
.008
.010
.012
.014
.016
.020
.024
.026
.030
.032
.036
.038

.042
.044
.044
.047 
.049
.050
.054

.056
.062
.066

.098
.101

.107

.001

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strategic report
At a glance

HeiQ is a three-in-one company, focused on scientific 
research, specialty materials manufacturing and 
consumer ingredient branding. We further provide  
value-adding services to facilitate our partners in  
bringing innovations to market.

What we do 
From ingredients to  
finished goods, the key 
products and services  
we provide to our  
brand partners can  
be summarized in  
four categories:

.01

Functional ingredients
We are an innovator, creating ingredients based on natural 
components or chemicals which are applied to textiles  
and other products to give the end user an enhanced 
experience. Our ingredients make products more 
functional, more comfortable and more sustainable. 
Functionalities provided by our ingredients include 
enhanced cooling, warming, moisture management,  
odor control, water and oil repellency, insect repellency, 
hygiene, antiviral, antibacterial and antifungal protection 
and microbial management. Our ingredients have been 
used to make cooling sportswear, air purifying curtains, 
antiviral mattresses and water-repellent trench coats, 
among many other applications.

.02

.03

Functional materials
Our functional materials take our unique 
ingredient technologies and processes and 
apply them to textiles, fabrics, membranes, 
filters and more. Our functional materials 
have multiple applications. They can be 
used to make masks and gowns that are 
more resistant to microbes, winter jackets 
that maintain more heat, and in coastlines 
to preserve the maritime life and offset the 
negative environmental impact of oil spills.

Finished goods
We use our functional materials to create 
functional consumer goods and medical 
devices that we market directly to the end 
users. Recent examples include functional 
garments that feature our technology.  
Since 2020, we produce masks, gloves  
and sprays featuring our HeiQ Viroblock 
technology. In collaboration with our brand 
customers, Coats, Sitip, Vagotex and 
NYGUARD (2A SpA), we also created a 
multi-functional travel jacket called Just5.

.04

Support services
We provide expertise in product 
development, testing, regulatory  
affairs and technical support as part  
of our full suite of solutions. We also 
support our brand partners by enabling 
them to communicate the benefits  
of HeiQ technologies to consumers  
through marketing and ingredient  
branding services. 

.002

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Our global brand  
partners include:

Who we work with 
In our 16-year history, we have built long-standing 
relationships with clients all over the world. We 
typically work with brands in fashion, home textiles, 
sportswear and workwear. Recently, we have 
broadened the industries we work with to include 
water treatment, industrial laundry, detergent, paint, 
coating and packaging. To date, we have partnered 
with over 300 major brands and developed together 
with them many of our over 200 technologies. 

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Where we operate 
Including our most recent acquisitions in 2021, we employ over 140 people, based in 11 offices,  
six R&D hubs and seven manufacturing facilities around the world. Over 20 distributors complete  
our global presence. 

  Head Offices
  Innovation centers 
  Manufacturing sites
  Distribution partners

Employees worldwide 

140+
11

Locations worldwide 

.003

 
 
 
 
 
 
 
 
i

H
e
Q
p
c

l

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Strategic report
Our DNA

with our co-founders
Carlo Centonze | CEO
Dr. Murray Height | CSO

HeiQ: Born on a hike 
After a week of hiking in the Swiss Alps, our 
friends began to keep their distance from us 
because we had smelly shirts. So we thought: 

The idea for the company famously came 
during a hike in 2004; how did you meet 
before then? 

We will use science to  
help brands manufacture 
clothes that smell fresh  
all week long!

Murray: After completing my PhD at the 
Massachusetts Institute of Technology (MIT) in 
2003, I accepted a postdoctoral research 
position at ETH Zurich. When I moved to 
Switzerland, a mutual friend introduced me to 
Carlo and we soon became friends through 
running, hiking and sports.

Carlo Centonze
CEO 

Dr. Murray Height
Chief Science  
Officer

HeiQ, pronounced [’haIkju], 
stands for the “hike” on which 
we came up with the HeiQ idea. 
It also stands for high-quality 
materials and for IQ.

.004

 
 
 
 
 
r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Murray: While the Company has grown 
and developed in ways that we did not 
foresee at the beginning, there remain 
features and principles that we have 
had since the start – a focus on novel 
materials as a way to bring value to 
products and a strong curiosity to try 
new and better ways of doing things.

What have been your proudest 
moments from the past 15 years?

Murray: Running our first pilot plant 
with our first employee to produce  
our first kilogram of product was a 
special moment. But being able to 
develop and deploy new technologies  
during times of crisis, like antiviral 
treatments and masks during the 
global pandemic and Oilguard 
nonwoven absorbers during the  
2010 Gulf of Mexico oil disaster,  
are probably my proudest moments.

Carlo: Listing on the LSE was a 
long-desired moment. Agreeing our 
first large acquisition (Chem-Tex 
Laboratories Inc.) in 2017 to double 
the size of HeiQ and increase our 
capabilities, scope and business 
reach. Running a Board of Directors 
of seven industry veterans for over 
100 high-net-worth investors for over 
a decade.

Looking ahead, what are your  
plans for the Company over the  
next 15 years?

Carlo: To further establish a company 
that is second to none, which creates 
tech that improve people’s lives and 
makes our planet more sustainable, 
and deploys its innovation to the 
market in an impactful way.

Murray: To re-double our focus on 
building products and technologies 
that have less environmental impact 
on the planet while delivering 
performance and value for people  
all over the world. To build upon 
HeiQ’s model of innovation co-
creation and boundless research 
network collaboration to achieve 
greater speed and impactful 
innovation.

Why did you decide to start a 
company? What made you think 
you’d be a good team?

Carlo: We were curious whether our 
solutions could solve the problems at 
hand. I believe we make a great team 
because we have complementary 
capabilities. Murray has an amazing 
ability to access science, tech and its 
market viability, and my skills lie in 
assessing the market opportunity and 
delivering a go-to-market strategy.

Murray: We were both at a stage in  
our lives where we thought we could 
apply ourselves to building a company, 
with the sense that no matter what 
happened we could learn a lot by 
creating a new enterprise together.

What was your original vision for 
the Company?

Murray: The initial vision was to be a 
producer of antimicrobial ingredients 
for use in textiles, coatings and 
medical implants. The thinking was  
to produce unique materials through 
scale-up of the patented flame spray 
pyrolysis manufacturing process and 
then sell the materials to the supply 
chain of a wide range of final products.

Carlo: We wanted to be the material 
innovation company that everyone 
knows. Recognized by brands and 
consumers for ingredients that provide 
unrivaled functionality, performance, 
quality and sustainability. Just like 
Gore-Tex, Bluetooth or Intel Inside.

How has the Company’s progress 
compared with your expectations?

Carlo: In some ways progress has 
been slower than we’d have liked.  
We have often had more arrows in  
our quiver than we’ve been able to 
shoot. One thing we are really proud 
of is to have successfully bridged the 
academic and commercial worlds, 
bringing research and innovation 
ideas from academia and finding 
market space for them.

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Key milestones in our history

2020
IPO
We achieved a long-time 
ambition to go public by listing  
on the LSE’s Main Market in 
December 2020 via a reverse 
takeover of SPAC Auctus  
Growth Plc.

2019
Global expansion
Our global footprint grew with 
the establishment of HeiQ 
Portugal, HeiQ Shanghai and 
HeiQ Taiwan, as well as a 
dozen new distributors.

2017
Acquisition of Chem-Tex 
Laboratories and Series C 
The acquisition of Chem-Tex 
Laboratories Inc., USA doubled the 
size of the Company and enabled 
us to enter the world of mass 
manufacturing. We raised CHF  
4 million from Kemin Industries 
(USA) and ten more investors.

2010
Series B
We raised CHF 11.1 million 
from Credit Suisse, Zürcher 
Kantonalbank, OneLife and 30 
more investors, to build up HeiQ 
Australia and create additional 
technology platforms. 

2008
First recurring customers, acquisition 
of Tex-A-Tec and Series A
We gained our first recurring 
customer, Odlo, in January 2008 and 
raised CHF 6.4 million from Zürcher 
Kantonalbank and 20 more investors 
to conduct our first M&A of Tex-A-Tec 
in an up-round closed ten days after 
Lehman Brothers went bust.

2005
Company founded
Six months after the hike which 
inspired the idea, the Company 
was founded on March 21, 2005.

.005

 
 
 
 
 
 
 
 
Strategic report
Investment case

Innovator 
Differentiator.

HeiQ has built a reputation as a high intellectual 
capital company, with world-leading innovation,  
a global R&D and sales network, strong ESG  
credentials and an established  
presence in multiple high  
growth markets.

Strong  
financials
We are a cash-generative and 
high margin business, with a 
healthy balance sheet, diversified 
revenue and a track record of 
delivering financial growth. The 
£20 million raised in conjunction 
with the Company’s reverse 
takeover in December 2020 has 
further strengthened our 
financial position, creating a 
meaningful cash balance to fund 
our growth initiatives.

£20m 

raised at our IPO has 
further strengthened  
our financial position

Intellectual  
property
We have substantial IP, 
technology and regulatory 
permits which create strong 
barriers to entry for competitors. 
Our unique technologies, 
products, process methods  
and materials are protected  
by nine patent families with 
three more pending and over 
180 trademarks. In addition  
to the directly owned patent 

portfolio, HeiQ also engages  
in patent licenses with 
technology partners and 
industry peers.

Substantial IP,  
technology and  
regulatory permits 
create strong 
barriers to entry

Strong brand equity  
enabling royalty and  
licensing revenue model

.006

 HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Experienced  
management
Our founders – CEO Carlo 
Centonze and Chief Science 
Officer Dr. Murray Height – 
have an impressive track 
record of creating innovations 
and successfully marketing 
them, generating value for 
every stakeholder. They are 
leading a fast-growing team, 
supported by diverse and 
knowledgeable global 

leadership, an experienced 
Board of Directors, and an 
Innovation Advisory Board  
with research experts in  
many different fields.

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

World-leading  
antimicrobial range
In the wake of the Covid-19 
pandemic, there is significant 
global demand for our 
world-leading antimicrobial 
technology platform, HeiQ 
Viroblock. As a textile 
technology, it is already being 
used by 150 brands and 
applied on at least one billion 
textile and medical products; 
we also market products with 
this technology directly to 

consumers. Antimicrobial 
technology is expected to 
become a mainstream 
requirement in response to  
the pandemic. Further to 
antimicrobials, HeiQ has 
branched out to develop 
greener, non-biocidal microbial 
management technologies 
such as probiotics and 
synbiotics.

Strong innovation
HeiQ aims to achieve market 
differentiation through rapid and 
deep innovations. We have six  
key technology platforms. To date, 
we have developed over 200 
technologies, many in partnership 
with major brands. New products 
(innovations launched in 2020) 
make up over 40% of revenue as of 
2020. We also have a healthy R&D 
pipeline containing over 40 projects, 
including one with the potential to 
become a blockbuster in the 
medium term.

HeiQ’s key technology 
platforms:
  Flame Spray Pyrolysis (FSP)
  Short Polymer Fibers (SPF) 
   Chemical and physical  
vapor deposition (CVD) 

   Synthesis and 
polymerization 

   Textile finish formulation, 
dispersions, emulsions 
  Probiotics and synbiotics 

High growth  
markets
We are well established and 
expanding across multiple 
significant growth markets, 
including the US$24 billion 
textile chemicals market, the 
US$10 billion antimicrobial 
textiles market, the US$29 
billion industrial filtration market 
and we are newly entering the 
US$50 billion probiotic market.

probiotic market

$50bn 
$24bn 

textile chemicals market

.007

  
 
 
 
 
 
 
 
i

H
e
Q
p
c

l

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Strategic report
Chairwoman’s Statement

IPO enhances 
our advantage.

Esther Dale-Kolb
Chairwoman 

Having known HeiQ and its 
founders for the last decade,  
I am delighted to be writing my 
first statement as Chairwoman 
of HeiQ plc, and the first as a 
constituent of the Main Market 
of the London Stock Exchange.

HeiQ wants to expand to better serve 
our customers and partners and to 
create more value for our stakeholders. 
After going public on the London Stock 
Exchange in December 2020, the 
Company raised £20 million (gross)  
to fuel our future growth and we are 
well placed to continue delivering on 
this mission. 

Overview
I am pleased to report on a year which 
has seen HeiQ make significant 
progress towards our long-term 
objectives and deliver record results. 
HeiQ has long been a cash-generative 
and high margin business, with a 
healthy balance sheet, diversified 
revenue and a track record of delivering 
financial growth. In 2020, we took this 
further by generating revenues of 
US$50.4 million, almost doubling the 
previous year’s figure.

.008

 
 
 
 
 
r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

The ability to rapidly adapt to a changing 
environment in a smart way and with 
innovative ideas is clearly one of HeiQ’s 
core strengths. This has enabled us to 
become well established and a rapidly 
expanding company across multiple 
significant growth markets, including the 
US$24 billion textile chemicals market 
and the US$10 billion antimicrobial 
textiles market. During the last year, the 
market for sanitation and disinfection 
has grown enormously due to the 
Covid-19 pandemic. We seized the 
opportunity to contribute to combating 
the pandemic and expand our product 
assortment by launching HeiQ Viroblock 
and by establishing ourselves in the 
medical devices market, producing 
personal protective equipment (PPE) 
like antiviral face masks that are more 
protective than conventional ones. Both 
the outstanding success of HeiQ 
Viroblock and entering the PPE market 
have contributed strongly to our revenue 
growth. At the end of the year, HeiQ 
acquired a controlling stake in the 
Spanish medical device production 
plant MasFabEs in order to in-source 
medical device manufacturing 
knowhow for future R&D in the key 
strategic field of PPE. 

It is noteworthy that this all took place 
whilst sustaining a healthy level of sales 
activities with the regular products. 
Despite the global economic headwinds 
that affected many of our industry peers 
severely, we were able to grow our 
revenue with the regular product range. 
New products and application ideas  
are continuously being developed by  
the HeiQ innovation hubs, in close 
cooperation with customers, as well as 
with over 20 universities around the 
world. As demonstrated by HeiQ 
Viroblock, HeiQ rapidly researches new 
solutions for partners, quickly delivers 
scale-up manufacturing from its sites 
across the world and helps partners 
market the product to end consumers 
– from lab to consumer in months.  
The continuous flow of our innovation 
pipeline is ingrained, and 2021 has 
commenced with a healthy, promising 
innovation pipeline.

After such a boost in growth and going 
public, other tasks like the refinement of 
our strategy, Company structure and 
corporate processes and systems are 
being enhanced to cope with the 
increased demands of the business, as 
well as from a governance perspective. 
These are in the process of being 
diligently implemented. We also decided 
to repay most current bank loans in 

December 2020 whilst retaining 
significant credit line facilities with  
the banks.

Dividend
In order to take advantage of the 
momentum created in 2020 and 
invest into the growth opportunities, 
the Board has decided not to pay a 
dividend from 2020 retained earnings. 

Board 
At the time of re-admission to trading 
on the London Stock Exchange, all 
Board Members of the former  
Auctus Growth Plc resigned and the 
new HeiQ plc Board was appointed.  
Of the five new directors, three were 
Board members of the former parent 
company of the Group (HeiQ Materials 
AG): Ben Bergo (NED), Carlo Centonze 
(Executive Director and Group CEO) 
and me (NED). In addition, Karen 
Brade (NED) and Xaver Hangartner 
(Executive Director and Group CFO) 
joined the Board. With a Board of five 
directors (of which three are non-
executive), we believe we have a 
balanced, diversified and experienced 
team to lead the whole Group on 
behalf of the shareholders in an 
efficient and effective way. I have 
been impressed with the approach 
and achievements of the Board since 
we became a public company and 
look forward to working with this team 
and building the Group.

The Board meets frequently to 
challenge and support the dynamic 
management team. Audit, 
Remuneration and Nomination 
Committees have also been in place 
since Re-admission.

Governance
Upon admission to the London Stock 
Exchange’s Main Market, HeiQ has 
chosen to adopt the QCA Corporate 
Governance Code (the ‘Code’) on a 
comply or explain basis. The Code is 
constructed around ten broad 
principles and how we have complied 
with each of these can be found in our 
Corporate Governance report 
contained within the Annual Report to 
be posted to shareholders shortly.

Outlook
The £20 million of new capital raised 
(before expenses) in December 2020 
will support our ambitious expansion 
strategy to diversify beyond textiles to 
become a leader in materials 
innovation. HeiQ is investing in 
additional personnel, geographic 

expansion, strategic alliances, 
regulatory registrations, product 
development, technology platforms 
and M&A activities. We are in 
discussion with a number of targets 
which fit and complement our 
offerings for our partners and 
customers. 

Since the start of the pandemic last 
year, we have all become much more 
aware of pathogens on the surfaces 
we touch and the health risks 
associated. This is driving increased 
market demand for material 
innovations that enable better 
microbial management on surfaces, 
such as packaging and other printed 
surfaces, as highlighted by some 
recent notable contract wins. We 
acquired 51% of Chrisal NV, a Belgium 
based company which offers expertise 
in probiotics/synbiotics in March 
2021. This is a new technology 
platform for HeiQ and provides us with 
access to the US$50 billion global 
probiotic market.

We will also invest to develop existing 
and new technologies, and to better 
monetize them and expand into new 
markets. Although this will increase 
our cost base in the short term, it is 
expected to contribute to a healthy 
and profitable growth in the mid and 
long term. 

I am extremely proud to chair and to 
be part of HeiQ. Its employees 
continually surprise me. Despite not 
having a lot of personal contact due to 
the workforce being spread all over 
the world under travel restrictions and 
home office requirements, they are 
nevertheless fulfilling their tasks with 
enthusiasm, team spirit and a big 
sense of responsibility.

On behalf of the Board, I would like to 
thank the whole HeiQ team which has 
performed in the most extraordinary 
way to achieve the impressive overall 
2020 result. We have set ourselves 
ambitious goals for 2021 in an 
uncertain environment and I am 
confident that, through our dedication 
and effort, we will achieve them.

Esther Dale-Kolb 
Chairwoman

.009

 
 
 
 
 
 
 
 
 
Strategic report
Market overview

Solutions for future 
unmet needs.

Our technology and solutions are created in response to 
megatrends and market needs. We identify, or even foresee,  
a problem and develop a science-based solution to solve it. 

Anticipating future needs brought by global megatrends
Challenges facing the industries we operate in give us the opportunity to contribute and serve. A number of global, 
long-term trends are having a major impact on the planet. These sustainability challenges are driving change in both 
manufacturing processes and product development in the markets where we operate.

.01

.02

.03

Growing, urbanizing and  
migrating global population
Technological advancements and 
economic prosperity have enabled 
improvements in medicine, sanitation, 
food production and living conditions, 
resulting in lower mortality rates and  
a rapidly growing global population.

This growth has led to more people 
flooding into towns and cities in 
pursuit of increased quality of life, with 
cities and urban areas now home to 
over half of the world’s population. 
This influx places huge strain on 
infrastructure such as transportation, 
sewage, housing and utilities in a 
limited space.

Population growth and urbanization 
result in increased air pollution, 
meaning a greater requirement for low 
emissions solutions and appropriate 
filtration to mitigate these risks.  
A denser populace also poses greater 
threats of disease and future 
pandemics due to more people living  
in close quarters, putting substantial 
emphasis on surface and air hygiene.

Climate change and 
environmental degradation
The negative implications of earth’s 
rising temperatures, increased CO2 
levels and biodiversity loss are 
profound. The scientific community 
has clearly stated the urgent need to 
keep global warming below a 1.5˚C 
increase to preserve stable living 
conditions. Despite this, emissions 
continue to rise, species are lost and 
forests are felled. 

The detrimental effects of climate 
change include rising sea levels, 
extreme weather events and habitat 
loss, and will inevitably lead to 
resource scarcity and social and 
political unrest. Often the poorest in 
society are most severely impacted  
by these environmental changes, 
meaning the developed world has a 
heightened responsibility to address 
its production and consumption 
habits and the wider implications of 
these habits on poorer communities.

.010

Scarcity of and global  
competition for resources
Humanity uses approximately 1.6 
planets’ worth of resources to support 
its current activities and if drastic 
measures aren’t taken, this will 
increase to two planets’ worth by 
20301. In short, we need to halve  
our current activity levels to ensure  
we are able to live within our planetary 
boundaries. 

We are already seeing the 
interconnected problems arising from  
the resource demands of a growing 
population coupled with the impacts of 
climate change on the availability of 
resources. These two unstoppable forces 
mean competition for limited resources 
is fierce and management and mitigation 
are vital to maintain a fair and balanced 
society and avoid conflict. 

The manufacturing of products that 
use recycled materials and that are 
recyclable at the end of their usable 
life will preserve the raw material 
value throughout its lifecycle. Focusing 
on sustainable solutions for 
production practices will support the 
preservation of natural capital. 
Political intervention and global 
collaboration are essential to ensure 
sustainable development and the 
creation of closed-loop economies 
and fair access to natural resources.

1. Source – www.footprintnetwork.org/

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

The market opportunity for HeiQ
Acting as a translator and connector 
between academic research and 
market need, we work with our global 
network of more than 20 academic 
partners and over 300 brands to 
understand how these megatrends 
are necessitating material and 
product innovation in terms of both 
process and output. 

Our partners, direct customers and 
wider consumers are looking for  
two things from HeiQ: materials and 
products that allow them to minimize 
the negative impacts during 
manufacture and throughout the 
product’s usable life, and modern 
functionality and performance of  
our products, which provide long-
term sustainable benefits and even 
combat some of the effects of 
outlined trends. For instance, in 
2019 we created HeiQ Fresh AIR,  
a technology that adds the ability  
to purify indoor air to home textiles.

The pandemic has led people to 
realize how much exposure to 
pathogens they have in their daily 
lives and to be much more aware of 
the surfaces they come into contact 
with. This will drive increased market 
demand for microbial management 
products, including coatings for 
packaging, paints and products that 
help maintain surface hygiene.

The markets we operate in
As an innovator in materials, there is 
scope for our technology to be used 
across many markets. We continue  
to consolidate our strong position in 
the textile industry and build up our 
medical device offer. New markets  
we will increasingly move into include, 
for instance, probiotics, through the 
acquisition of Chrisal NV in 2021,  
and technical filtration, batteries and 
electronics with our advanced R&D 
project in regard to a highly porous 
graphene membrane technology. The 
magnitude of the markets we operate 
in are as follows:

Antimicrobial textiles market

+$10bn

in 2019 | CAGR 9.8%
(Global Market Insights)

Textile chemicals market

+$24bn

in 2019 | CAGR 4.5%
(Grandview Research)

Industrial filtration market

+$29bn

in 2020 | CAGR 6.9%
(MarketsandMarketsTM)

Probiotic market

+$50bn

in 2019 | CAGR 6.9%
(Grandview Research)

How we are responding  
to opportunities
Whether driven by a scientific 
development or a new consumer 
desire brought to us by a brand 
partner, we have the unique ability 
to respond to opportunities with  
rapid and deep innovation and 
turnkey solutions.

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Sustainable manufacturing
We are responding to the need for 
more sustainable and efficient 
production by:

  Embracing circularity
  Improving process efficiency
  Increasing material efficiency
  Replacing dangerous goods with 

non-dangerous goods

  Replacing conventional ingredients 

with natural, bio-based and recycled 
alternatives

  Extending the useful lifetime of 

products by higher quality and less 
maintenance

Innovative and functional products
We are creating materials and products 
that:

  Allow for efficient production and 
help to reduce the environmental 
footprint of the manufacturing 
process

  Promote safety and wellbeing 

(microbial management, filtration, 
water treatment, thermo regulation)

  Are sustainable (recycled, 

recyclable, non-dangerous, durable)
  Help to reduce the footprint during 

the usable life of the products 
(clothes that require less washing, 
sheets that can be cleaned 
effectively with mild detergent and 
cold water, clothes that dry  
faster, etc.)

Please refer to the Sustainability Report on page 26  
for more examples of how our innovations help our 
customers to create more sustainable products.

.011

 
 
 
 
 
 
 
 
i

H
e
Q
p
c

l

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Strategic report
Business model

When partnering with a brand or manufacturer, we distinguish 
ourselves from competitors by offering end-to-end turnkey solutions, 
with experience and capabilities across the value-chain and project 
lifecycle. When manufacturing finished goods that we directly market, 
we combine our experience and capabilities to ensure excellent 
product quality and effective communication to the consumers.

What we do
There are three key elements to our partner offering. 
We are unrivaled in our overall blend of products and 
services, and also bring a unique range of strengths  
to each stage of the process.

.01

Scientific 
research

Our research is motivated by the problems 
our market partners bring to us. We solve 
problems following a three-step process. 
Step 1: Define the problem and its single 
components.
Step 2: Create a hypothesis and proof of 
concept with our research partner network 
for each component.
Step 3: Develop and assemble market- 
ready products with our internal 
development tech support and consumer 
validation teams.

The HeiQ difference
Internally, 15% of our employees 
are highly skilled scientists and 
work in the area of research and 
development; externally, we have 
an extensive network of academic 
research partners. Through our 
co-creation approach, we share 
and diversify the risk of exploratory 
research projects with our 
partners, and we have experience 
navigating multiple global 
government funding processes.

.02

Specialty materials 
and ingredients 
manufacturing

After research and a successful proof of 
concept, projects move into a phase where 
the initial recipe or prototype is developed, 
refined and optimized to ensure it is 
scalable. The production protocol is 
documented and deployed to our 
production sites. Our manufacturing 
capacity also allows us to pursue large 
manufacturing projects in our industry.

The HeiQ difference
Our knowledge, facilities and 
IP enable us to manufacture 
ingredients, materials, consumer 
goods and medical devices in 
industrial volumes and bring 
to market at speed but with 
validation and quality control. 
We operate in markets that have 
medium to high barriers to entry, 
including increasingly complex 
regulatory, registration and 
compliance requirements.

.03

Consumer 
marketing 
and ingredient 
branding

For an innovation to be successful and 
benefit as many people as possible, it is 
crucial that we get the marketing and the 
message right and communicate through 
multi-media content. We work with our 
partners to develop marketing narratives 
and communication strategies together.  
We join launch events, make press releases 
and promote products. Often we also 
participate in training our customer’s sales 
organization how to sell and capture the 
added value of the innovation. By helping 
our ingredient brand customers maximize 
the price premium and lowering their barrier 
to innovate, we foster innovation spirits in 
the industries in which we operate.

The HeiQ difference
We have a team of marketing 
and branding professionals 
with experience across a range 
of markets. We have strong 
knowledge and experience 
of consumer behavior and 
understand how to create 
branding materials that translate 
complex technical scientific 
knowledge into plain consumer 
language. We produce multi-
media content and have  
expertise in all channels.

.012

 
 
 
 
 
r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

How we generate  
revenue
Our primary source of revenue is 
the production and the sales of 
functional ingredients, materials 
and finished goods. Other 
sources of revenues include 
research and development 
services as well as laboratory 
work. Because of the highly 
differentiating nature of the 
products, we generally adopt  
a value-based pricing strategy.

After we develop a production 
protocol, we manufacture the 
functional ingredients, materials 
or products ourselves or 
selectively license the IP to other 
manufacturers for a licensee or 
franchisee fee.

Some research projects are 
financed through grant funding 
or directly by customers,  
either in the form of a research 
partnership, or by their 
purchases of existing 
(off-the-shelf) technology. 

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

The value we create

Partners and customers
Our brand partners and direct 
customers benefit from access  
to our differentiating technology.  
Our performance-enhancing 
materials improve their products. 
We provide end-to-end support and 
all the services required to bring 
innovations to market.

Consumers
Products featuring our technology 
offer tangible benefits for the  
end user, including innovative 
functionality, comfort, hygiene and 
sustainability features.

Employees
Our employees have the chance to 
work and develop in a meritocratic 
and diverse environment, being 
challenged and supported to help 
the Company deliver on its purpose 
and make a difference for a  
better world.

Investors
HeiQ is in a robust financial position 
with a healthy balance sheet and 
diversified revenue. We have been 
cash generative for many years, and 
our investors benefit from the 
ongoing growth of our business and 
our willingness to create disruptive 
innovation.

Suppliers
We develop strong and trusted 
partnerships with our suppliers.  
Our growth and momentum  
will lead to increased spending  
on raw materials in innovative  
product applications. 

Society
By helping many brands and 
consumers to reduce their impact 
on the environment, we are 
indirectly improving the lives  
of billions more. Through our 
engagement with university 
research partnerships, we play  
a role in fostering the education  
of new generations of scientists  
and engineers.

.013

 
 
 
 
 
 
 
 
Strategic report
Our strategy

Our growth strategy is built around five pillars, which will 
help us achieve our vision of delivering materials that 
improve the lives of billions.

Strategic pillar

Why we focus

Progress in 2020

.01

Growth  
markets

Textiles
In the textile industry, low margins are a major 
barrier to take risks (innovate) and make change 
(new ways of doing things more sustainably).  
Our unique approach of innovation and 
differentiation is the key to overcoming this 
barrier and achieving above-average margins.

Medical devices
Innovation in medical devices is slow because 
of a bureaucratic culture and long approval 
processes as well as large, entrenched players. 
However, the pandemic has demonstrated an 
urgent need to have better, more protective 
and safer medical devices.

Surface hygiene 
Increasing awareness of pathogens on surfaces 
and demand for sustainable solutions to 
maintain surface hygiene.

Other materials
Any material can become better, more functional 
and more sustainable.

Textiles 

  Increased sales from US$28 million in 2019 to 
US$42 million in 2020
  Doubled the number of customers

Medical devices 

  Entered the medical device and consumer goods 
market, created direct-to-consumer sales channel
  Achieved US$8 million sales

Surface hygiene 

  Ventured into this new market with our antimicrobial 
ingredients

.02

Innovation

Innovation is the process of creating value by 
doing things differently. Innovation is the only 
way to become more sustainable.

  The innovation pipeline featured over 40 projects 
in 2020
  Launch of HeiQ Viroblock NPJ03 antiviral textile 
treatment
  Helped the fight against the pandemic with our antiviral 
textile technology, upgrading protection to one billion  
face masks

.03

Differentiation

Our innovations benefit consumers and the 
planet. However, the value we create needs  
to be understood by consumers, so that our 
customers are able to up-charge consumers for 
the added value and therefore are willing to pay 
us for our innovations. This is why we help our 
customers to differentiate towards consumers 
by explaining the value of our innovations and 
making them tangible.

  Successfully positioned HeiQ as the innovation leader 
for textiles and materials, gaining brand equity for HeiQ 
for future product launches and royalty business
  Successful launch of HeiQ Viroblock brand
  Started our direct-to-customer business (webshop) and 
consumer goods business
  HeiQ Smart Temp grew over 16% year-on-year thanks 
to years of cultivating this into the leading “cooling 
technology” brand

.014

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Strategic pillar

Why we focus

Progress in 2020

.04

People and
sustainability

Innovation needs high intellectual capacity and 
human capital, and we are only as good as our 
people. Sustainability is not only ingrained in our 
DNA and drives us as a Group, but is also key to 
the long-term success of any corporation.

.05

Digital

Digital improvements can lead to process 
efficiency, greater innovation and an enhanced 
customer experience.

  Strengthened our human capital by expanding the 
workforce in the office and lab in China and lab and 
quality control center in Taiwan
  Established a team and a new office and lab in Portugal
  Acquired a team and facility for medical device 
manufacturing in Spain
  Applied our in-depth knowledge in textiles and created a 
mask that is rated by consumers as “most comfortable”, 
to lessen discomfort and enhance protection to the 
users during the pandemic
  Refer to the Sustainability Report (page 26) for some 
examples of how we are helping our customers become 
more sustainable as well

  Launched direct-to-consumer webshop for protective 
equipment and medical devices
  Initiated the adaptation of several digital tools to 
enhance administration and collaboration across a 
multinational, decentralized organization to facilitate 
efficiency for prolonged home office or remote working

.015

 
 
 
 
 
 
 
 
Strategic report
Strategy in action

Rapid 
innovation.

  deep 

.016

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Case study 

Creating the most 
comfortable mask  
in Switzerland

As the pandemic unfolded in early 2020,  
our teams quickly identified the added value  
of our textile technology for this crisis.

We realized masks would be a necessary part of 
life for the coming years, and that we had multiple 
technologies that could be brought together to create 
a highly effective and comfortable mask.

Major discomfort of face masks comes from the 
trapping of water vapor between the face and  
the mask. HeiQ rapidly lined up a supply chain to 
manufacture masks designed with multiple 
technologies: cooling and moisture wicking on the 
innermost layer, antiviral in the filter layer, odor control 
and water repellence on the outer layer. The team 
also quickly set up a direct-to-consumer channel to 
market these masks. To date, the HeiQ community 
mask is widely praised as  
“the most comfortable mask in Switzerland”.

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

+1 billion

face masks and an enormous amount 
of other textile and non-textile products 
have been treated with HeiQ Viroblock.

We thought it would take a while until 
a cure or a vaccine became globally 
available to solve this problem. While the 
pharmaceutical industry is doing its job, 
we as a leader in textile innovation should 
do our part too. We launched an antiviral 
textile technology to mitigate or stall the 
problem from getting worse too quickly.

Hoi Kwan Lam
Group Chief Marketing Officer

.017

 
 
 
 
 
 
 
 
Strategic report
Strategy in action

We are  
“glocal”. 

.018

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Case study 

Providing local 
support in Portugal, 
Shanghai and  
Taiwan

HeiQ is proud to be a lean, global organization, 
and our worldwide footprint proved to be 
beneficial when international travel was halted 
during 2020.

Nothing is more reassuring to customers at the time 
of a global crisis than having a local contact person 
to communicate with. Our new offices in Portugal, 
Shanghai and Taiwan, all set up in 2019, were able to 
provide local support to customers in the region, with 
local staff also present at the customers’ facilities. 
Technology also enabled our technical staff, locked 
down outside of the manufacturing countries, to 
supervise product applications and trials.

Since their establishment, these three offices have 
continued to grow. Today, HeiQ Portugal runs an 
innovation laboratory and an administration, sales 
and logistics office, HeiQ Shanghai operates an 
administration, sales and logistics office, and a 
testing laboratory where customer products are 
validated and local product development projects 
take place. HeiQ Taiwan now has a sales office,  
a local warehouse and a laboratory and carries  
out the production of one of HeiQ’s product lines.

Number of employees  
in Shanghai and Taiwan

23

Number of employees worldwide

140+

We set up HeiQ Shanghai and Taiwan 
offices in 2019 with the goal to provide 
customers in the Greater China region with 
best support. When the Covid-19 pandemic 
hit, countries were locked down and airline 
fleet all grounded, it became obvious that 
we had made the right decision. We are 
continuing to build a strong team here.

Celine Huang 
CEO Greater China

.019

 
 
 
 
 
 
 
 
 
i

H
e
Q
p
c

l

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Strategic report
Chief Executive Officer’s Review

Improving
the lives
of billions.

Carlo Centonze
CEO 

Sixteen years ago we started a 
venture, an unquenchable 
adventure named HeiQ. 
Conceived on a hike and born 
through Schlieren’s first flame 
spray pyrolysis reactor, HeiQ 
today gives chase to the sun.

From New Zealand to Colorado, today 
over 140 HeiQans work closely and 
around the clock to innovate and 
differentiate in order to improve the 
lives of billions of people.

2020 has been a transformative and 
momentous year for HeiQ, 
characterized by fast growth. After 
having successfully built an agile 
business model that allows for rapid 
deep innovation, in March 2020  
as the World Health Organization 
(WHO) declared the pandemic, HeiQ 
stepped up to deliver an innovative 
antiviral technology for the benefit  
of the society.

.020

 
 
 
 
 
r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Over the years, we have developed 
over 200 high-performance textile 
technologies, many in partnership 
with major brands. Until recently, 
these have had a strong “lifestyle” 
focus – a T-shirt that cools you, a 
curtain that purifies the air in your 
home, or the lightest but warmest 
jacket for those climbing Mount 
Everest are just a few of hundreds of 
examples of our innovations. Our 
strategy has successfully positioned 
HeiQ as a global, cash-generative and 
IP-backed leader in the US$24 billion 
textile chemicals market.

We are known for creating some of 
the most effective, durable and 
high-performance technologies in the 
market. Our research network with 
over 20 universities, our seven 
manufacturing plants and our 
marketing and ingredient branding 
prowess allow us to be trusted by 
over 300 brands, including several 
Fortune 500 companies, as their 
innovation arm. Our skills and 
reputation have enabled sales of  
our core lifestyle range, HeiQ Smart 
Temp, which has seen a +16% 
year-on-year growth despite 
pandemic economic headwinds.

Our business is evolving at a time of a 
global emergency and we have shown 
our agility in rapidly shapeshifting and 
redeploying our innovation and 
production resources to deliver a 
best-in-class and Swiss Technology 
Award-winning technology, HeiQ 
Viroblock, to market, which has been 
hugely satisfying during the period. 
HeiQ is now known for another leading 
innovation: we turn textiles and other 
surfaces antiviral. The global health 
crisis became a tipping point for 
antimicrobial textiles. And over the past 
12 months, we have been part of the 
creation of the antiviral textile market, 
which enlarges the US$10 billion 
antimicrobial fabrics market (9.8% 
CAGR) and positioned ourselves as 
technology leaders in this space. In 
doing so, we have demonstrated the 
rapid growth and value creation that 
we can deliver for our shareholders 
through fast, disruptive and eco-
conscious innovation.

I am very proud of the can-do 
mentality, spirit and dedication shown 
by the entire HeiQ team in 2020. Our 
culture and teamwork allowed us to 
make a significant contribution to the 
fight against Covid-19, and it has been 
very rewarding for us all to know that 
our technology is protecting people 

around the world, allowing businesses 
to keep operating and retain jobs. 

Another proud moment of 2020 was 
our listing on the Main Market of the 
London Stock Exchange. Going public 
has been a long-standing vision of the 
Founders and Board, and we have 
been preparing for it for several years. 
We were very pleased with the support 
for our listing, and the funds raised will 
enable HeiQ to build on the significant 
momentum achieved in 2020.

Operational and financial 
performance 
2020 saw the Group achieve its best 
ever results in both financial terms and 
operational output. We manufactured 
an unprecedented quantity of products 
and, as a result, we almost doubled 
our revenue and delivered a strong 
EBITDA figure. In a year of home 
working, we managed to establish new 
teams and facilities and on-board new 
talents in all our locations.

Our excellent performance was driven 
by the tremendous success of HeiQ 
Viroblock, our world-leading 
antimicrobial technology. We quickly 
allocated our innovation resources to 
satisfy the pressing demand for this 
antiviral technology, and dedicated 
much of our manufacturing capacity 
to ramp up production. The team 
quickly built a solid business around 
antiviral medical devices, including 
creating a new direct-to-consumer 
business, which has strengthened 
brand awareness of HeiQ and will 
continue to do so going forward. 

Since its launch, HeiQ Viroblock has 
been embraced by existing clients and 
attracted many new partners due to 
its ability to provide brands with a 
unique point of differentiation, which 
protects their customers when they 
need it most. Consequently, we have 
doubled our customer base.

Thanks partly to our IP-licensing and 
royalty model, which sees HeiQ 
Viroblock production licensed to third 
parties, we have been able to deploy 
this innovation very quickly to achieve 
a wide distribution of ingredient-
branded products and increased 
consumer awareness of HeiQ. HeiQ 
Viroblock has already been used by 
over 150 brands and deployed in over 
a billion face masks worldwide. We 
continue to build relationships with 
the medical industry by delivering 
much needed PPE in the form of 
surgical face masks and gowns. 

150Number of brands using  

HeiQ Viroblock worldwide

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

.021

 
 
 
 
 
 
 
 
As a cash-generative, high margin 
company expanding across multiple 
significant growth markets, we have 
built a strong platform for future 
growth. While 2021 will remain a year 
of regional disruption and limitations 
for many businesses, for HeiQ it is a 
capability building and investment 
year that will see us enter new 
industries, launch new innovations 
and establish new revenue streams. 
This is an exciting time for HeiQ and  
I look forward to keeping the market 
abreast of our progress. 

I wish all our stakeholders a healthy 
and prosperous year.

Carlo Centonze
CEO

Strategic report
Chief Executive Officer’s Review continued

Our recent HeiQ Viroblock contract 
wins with leading industrial laundry, 
paint and packaging coating 
manufacturers attest to our vision to 
grow beyond textiles, as do the 
completed acquisitions in the medical 
device and industrial biotech arenas. 
Through our acquisition of a majority 
stake in Belgian industrial biotech 
company Chrisal NV, we now have 
access to the US$50 billion probiotic 
market. In the synbiotic and probiotic 
market our focus is on hospital 
hygiene and microbial management. 
Our strong pipeline of brand partners 
underpins our confidence that market 
demand for microbial management 
technologies will continue to be very 
strong going forward. We will work 
tirelessly to maintain our leading 
position, while entering new lucrative 
markets such as durable antimicrobial 
surface protection, synbiotic 
healthcare and homecare cleaning as 
well as synbiotic cosmetic ingredients. 

Looking ahead, our focus lies in the 
innovation of more sustainable 
materials as well as increasing market 
penetration of our core technologies. 
HeiQ GrapheneX, our highly porous 
graphene membrane research 
project, remains an exciting potential 
value trigger and we look forward to 
building the pilot commercialization 
plant. We expect it to be the stepping 
stone for us to enter the US$29 billion 
technical filtrations and membranes 
market from a position of strength.

To ensure that we remain at the top  
of our game, we will be expanding our 
research, building our capabilities  
and diversifying our tech platforms 
into new markets and industries,  
both organically and through strategic 
M&A. HeiQ innovates systemically  
and our technology and solutions are 
created in response to megatrends 
and market needs. We identify, or 
even foresee, a problem and develop 
a science-based solution to solve it.  
It is solving the problems that 
customers bring to us with 
sustainable functional ingredients  
and materials that will guide the 
specific areas we target. 

Despite the resource requirements of 
our rapidly expanding antimicrobial 
business, our fundamental 
innovations and sales have not been 
impacted. Many of our established 
products continued to grow in 2020, 
with demand following the growth rate 
of previous years despite dire 
conditions in the textile industry. 

Delivering for stakeholders
The commitment and resilience of our 
team enabled us to scale up HeiQ 
Viroblock and protect many families 
across the globe. With brand partners 
we also made several mask donations 
to big and small hospitals and 
organizations such as the NHS (UK) or 
the Blue Cross in Como (Italy). 

We are thankful for the ongoing trust 
and support of our customers. We 
believe that our unique approach to 
co-creation ensures that we can build 
strong and long-lasting relationships 
with our brand partners, and these 
have been beneficial for both sides 
during a challenging year. 

Many of our manufacturing partners, 
suppliers and customers in textiles 
have been and still are severely 
affected by the pandemic, and we 
have engaged and supported them 
wherever possible.

Current trading and outlook
2020 was a tipping point for HeiQ and 
we continue to see strong demand for 
our technologies. Despite the global 
supply chain still being in distress, we 
are gearing up to sustain the 
momentum throughout 2021 and we 
will invest the capital in talents, 
capabilities and infrastructure to 
facilitate this. I am pleased that, 
despite Texas freezes, California 
shortages, Suez blockages and 
regional lockdowns, our first quarter 
performance is in line with our 
expectations for our antimicrobials 
and comfort technologies. Our just 
launched enhanced fluorine free 
water repellent performance range 
will have to prove its mettle in a year 
of unprecedented opportunity where, 
due to the ban of perfluorinated 
chemicals, market shares will be 
reallocated. Our medical devices 
manufacturing facility acquired in 
December 2020 will build its success 
on innovations that we are launching 
this May and beyond. 

.022

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

In early 2020, we rapidly revalidated 
our antiviral textile technology, 
fine-tuned it and scaled up 
production. On March 16, 2020, two 
hours after the Swiss Government 
announced a state of emergency and 
mobilized the army, HeiQ Viroblock 
was relaunched with the mission to 
mitigate the transmission and help 
stop the state of affairs from rapidly 
deteriorating. The global response to 
HeiQ Viroblock has been way beyond 
our wildest expectations, and thanks 
to an agile team, we mobilized a 
global task force to prioritize and work 
relentlessly to serve this urgent need.

Nine months later, before any jabs of 
vaccine were administered, over one 
billion face masks and an enormous 
number of other textile and non-textile 
products have been treated with  
HeiQ Viroblock.

.023

Case study 

Joining the  
fight against  
Covid-19

At the end of 2019, as we 
recognized the signs of a 
potential pandemic, we made 
the decision to play an active 
role in stemming the spread  
of the virus while the world 
waited for a vaccine or cure.

We identified the opportunity to 
relaunch an innovation we had 
developed for the Ebola crisis almost 
a decade ago. In 2013, HeiQ 
Viroblock masks were created with 
the vision of providing a mask that not 
only protected the wearer by filtering 
virus particles, but deactivated the 
virus particles as well. The textile 
finishing formulation was ultimately 
shelved as the crisis did not  
turn into a global pandemic and the 
demand for an antiviral textile 
technology receded.

 
 
 
 
 
 
 
 
Strategic report
Key performance indicators

We use a number of key performance indicators (KPIs) 
to measure our performance over time. We select 
KPIs that demonstrate the financial and operational 
performance underpinning our strategic drivers.

.01

Finance

2
0
2
0
p
e
r
f
o
r
m
a
n
c
e

W
h
y
w
e
m
e
a
s
u
r
e

2
0
2
0
p
e
r
f
o
r
m
a
n
c
e

W
h
y
w
e
m
e
a
s
u
r
e

Revenue growth | US$m

 +80.3%

2020 

2019

2018

28.0 

26.2 

50.4 

Gross profit margin | US$m

 +700bpt

2020 

2019

2018

55.6 

48.6 

42.8 

Sales growth is one of the most basic  
barometers of success for any business.

This KPI gives insight into our operational  
profitability. 

.02

Innovation

Number of new projects that made  
it into R&D process

Number of launched  
innovations

5

2020 

2019

2018

5 

3 

3 

Innovations that made it to the market are ready  
to give return on the R&D investments.

12

2020 

2019

2018

12 

10 

7 

We never run out of creative ideas and there are 
countless opportunities to innovate. HeiQ’s ability to 
qualify the ideas through “proof of concept” and 
market potential evaluation before bringing them into 
our R&D pipeline is key to ensure we have the market 
in mind before investing excessively into a project.

.024

HeiQ plcAnnual report and accounts 2020 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

.03

Differentiation

2
0
2
0
p
e
r
f
o
r
m
a
n
c
e

W
h
y
w
e
m
e
a
s
u
r
e

Total number of media mentions

Royalties (number of enacted contracts)

7’610

2020 

2019 2’000 

2018 2’179 

7’610 

As a B2B, B2C and B2B2C ingredient brand, HeiQ 
is building its brand awareness across different 
target audience groups. Media mentions are 
“earned” media, which shows our ability to gain 
face time with the audience without having to 
invest heavily in media-buying. 

8

2020 

2019  1 

2018  1 

8 

A brand’s worth is indicated by the premium  
the buyers are willing to pay. 

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

.025

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strategic report
Sustainability Report

In our DNA 
 purpose.

HeiQ’s triple bottom line

.01

Prosperity

To run a profitable business, creating 
value for all stakeholders, with respect 
for all partners in the value chain such 
as suppliers, industrial customers and 
consumers. Purpose-driven companies 
tend to outperform the market. People 
who identify with our purpose will also 
support our business.

.02

People

To improve the lives of billions by 
innovating the materials they use in 
their daily lives; to develop our own 
people, foster diversity, communicate 
our code of conduct transparently, to 
measure employee engagement; to 
empower our employees to make 
decisions and trust them with 
responsibilities; to provide them with 
an environment where they are 
encouraged to trial-and-error and 
learn from failure. 

The safety and happiness of our people, 
of our customers and the health and 
safety of the consumers are always at 
our heart.

.03

Planet

HeiQ research is focused on 
functionality and sustainability. We 
strive to reduce the ecological impact 
of our industrial activity and inspire, 
convince and enable our partners in 
the value chain to do the same.

Sustainability is deeply rooted 
in the DNA of the Company and 
anchored in its purpose. 

  to achieve this by creating 

state-of-the-art, eco-friendly and 
sustainable technologies.

We pursue sustainability initiatives 
that simultaneously create business 
value and address societal concerns. 
We strive to act in the interests of all 
stakeholders, including employees 
and communities.

Sustainability at HeiQ
As global problems worsen, business 
must take responsibility and show 
leadership. At HeiQ, sustainability 
comes from within, as a key mission 
of founders Carlo Centonze and 
Murray Height. Their purpose when 
they created the Company in 2005 is 
still alive today: 

  to run a profitable business;
  to improve the lives of people by 
innovating the materials they use 
in their daily lives; and 

This triple bottom line goes beyond 
the acknowledgement that we have  
a corporate social responsibility; it is 
integrated into the core strategies  
of the Group. The acquisition of the 
industrial biotech company Chrisal NV, 
Belgium in 2021 proves that 
sustainability is already present in our 
investment logic as the extra 
technology platform that is acquired 
through this acquisition, probiotics, 
has the potential to become a more 
sustainable alternative to 
conventional antimicrobial 
technologies. We look at global 
sustainability problems as 
opportunities to drive innovation, 
collaboration and co-creation.

HeiQ is the second company I’ve founded. 
The first one, myclimate, is a market-leading 
NGO in carbon offsetting. I am a firm 
believer that by using innovation technology 
one can make a profitable business by 
reducing the ecological footprint of everyone 
that uses a service or buys products.
Carlo Centonze
CEO

.026

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Social
Covid-19
When society faces major problems, 
like the current pandemic, HeiQ does 
what it can to help. In view of the 
severe shortage of medical personal 
protective equipment (PPE) in many 
countries, we mobilized our global 
team and network to help source 
these essentials to help hospitals,  
first responders, essential services, 
governments and businesses; our 
people worked day and night to deliver 
a technology that makes a huge 
difference in the prevention of the 
transmission of the disease. 

By the end of 2020, before 
any Covid-19 vaccine has 
been officially given, our 
antiviral technology, HeiQ 
Viroblock, has been used  
on at least one billion  
face masks.

Musa Raibin
VP South Asia Brandforce

Developing our strategy
Sustainability is a process of 
continuous improvement, of getting 
better every day and securing this 
progress. 

We are laying the foundations to build 
our sustainability strategy. We are 
consulting with our stakeholders to 
define materiality, to learn from 
industry and best practice and to 
establish a sustainability community 
inside and outside the Company. 

Preparations are being made to 
deploy sustainability in all its aspects 
and to report these efforts following 
the guidelines of the Global Reporting 
Initiative (GRI) going forward. The 
transparent communication of these 
ongoing efforts to our stakeholders 
(investors, employees, customers, 
industries, governments, NGOs, 
regulators, communities and wider 
society) is an essential element in  
this process.

More than anything we are putting our 
brains to work on disruptive 
technologies, capable of dramatically 
reducing the ecological footprint 
humanity is having on our planet. 

Culture and values
The success of our business is 
grounded in our culture – the way we 
think, behave and act towards each 
other and our key stakeholders.  
Our culture is reflected in our values, 
which ensure everyone understands 
and is aligned with the kind of 
business we strive to be and how  
we want to operate.
  Sustainability
  Entrepreneurship
  Empowerment
  Ownership
  Dedication 
  Trust
  Respect
  Teamwork
  Continuous Improvement
  Excellence

Environmental
We are an environmentally conscious 
organization. We aim to ensure that, 
moving forward, we can grow 
sustainably and maximize the 
sustainability impacts and 
opportunities not just of our products, 
but also in how we operate. This is 
done in multiple ways: 

  We develop bio-based products 

that replace synthetics.

  We promote upcycled, recycled and 
recyclable products (for example, 
Nylstar zero microplastic pollution 
fabric). An increased production 
volume of sustainable, renewable 
fibers and the development of 
recycled/recyclable fibers, suited 
for circularity, will solve the acute 
textile resource depletion problem.

  We enable a better efficiency in 

industrial processes. Do more with 
less energy, less water and fewer 
raw materials.

  We maximize the use of green, 

renewable energy.

  We replace bad or less safe 

ingredients with safer ingredients.
  We operate close to the markets to 

reduce shipping.

  We improve product durability and 

lifetime.

  We provide solutions that reduce 

leaching and pollution.

  We develop products that reduce 
the need of maintenance or the 
washing frequency.

  We encourage the consumer 

to buy fewer, and better quality 
products, making multi-purpose 
and multifunctional garments the 
preferred choice over fast fashion.

Streamlined Energy and Carbon 
Reporting (SECR)
The SECR disclosure is omitted in this 
report because it is not practical for 
our organization to obtain all the 
required energy and carbon 
information on 2020. SECR 
disclosures became mandatory for 
the Group only upon Re-admission to 
the LSE stock market on December 7 
2020 as the Group did not include 
any legal entity based in the United 
Kingdom before that date. In the 
2021 annual report, we will disclose 
the Group boundaries and report our 
2021 energy usage and carbon 
emissions as requested by the SECR.

Throughout 2021 greenhouse gas 
emissions will be calculated using  
the industry standard conversion 
factor of each country where we 
operate. A HeiQ energy efficiency  
task force will analyze this first set of 
data and elaborate energy efficiency 
measures for the Group. These 
measures will be communicated in 
the 2021 annual report.

.027

 
 
 
 
 
 
 
 
Strategic report
Sustainability Report continued

.028

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Our people
Although sustainability starts at the 
top, it involves all employees. We 
believe talent gravitates towards 
companies that make a difference, 
and the awareness that our Company 
is doing the right thing connects with 
our personal ethics and morality and 
is a strong motivator. 

We currently employ over 140 people 
in 14 countries and are committed to 
a policy of equal opportunities in the 
recruitment, engagement, 
performance management and 
retention of employees.

Diversity
The diversity of our teams is a 
business requirement for the 
Company. We are committed to 
advancing collaboration, diversity, 
equity and inclusion because these 
differences enable us to create 
better solutions as we change the 
world of materials. We are proud  
to have more than 40% female 
leadership in the Company.  
Our employees represent over  
20 different nationalities. 

Overall gender split 

65%

Male
Female

35%

Learning and development
We believe that the development of 
talent is important to achieve the 
long-term strategic goals of the 
business. We cultivate an open and 
outspoken culture where employees 
receive constant feedback on their 
performance and are encouraged to 
speak about their career aspirations 
and plans, so that their job is 
constantly adjusted to allow them to 
create the best value to the Company. 
We offer traineeship and internship 
opportunities for career starters.

Wellbeing
HeiQ hires people with enthusiasm 
and the right work ethic. We believe 
with modern technology, most jobs 
can be performed well regardless of 
location and working hours. Even long 
before the pandemic, our employees 
have been allowed to work flexible 

hours and had the freedom to work 
from the office or home for them to 
maintain the best work-life balance 
while choosing the best way to 
maximize their productivity. Therefore, 
lockdowns and social distancing 
measures have not affected HeiQ as 
much as a lot of other companies.

Having said that, during the pandemic 
we hosted regular online socializing 
activities, such as virtual coffee breaks 
and quarantine-style “happy-hour”, at 
different times of the day to engage 
employees in different time zones and 
provide them the opportunity to chat 
outside of work interactions.

Working with our partners
Sustainability is not done alone, but in 
collaboration. We aim to build strong, 
mutually beneficial relationships with 
our brand partners, and through 
co-creation, we innovate for brands and 
help them become more sustainable.

Here are some examples of how we 
have made our partners more 
sustainable:

  In 2020, we “Viroblocked” more 
than one billion face masks, 
mostly through our brand partners’ 
products.

  We launched the world’s first air 
purifying curtain with the largest 
home furnishing retailer in 2019.

  Our founding customer, 

Odlo, asked us to develop 
an antimicrobial odor control 
treatment for its synthetic base 
layers. Twelve years later, it 
adopted a newer generation of 
the treatment that is even more 
sustainable. The durability of our 
first-generation innovation to date 
is still market leading – it lasts 
100 washes – which also means 
it extends the usable life of the 
products.

  Berger in India has teamed up with 
us to make a paint which reduces 
the risk of contamination and 
transmission of virus from surfaces.
  Burton adopts several innovations 
by HeiQ to enhance the comfort 
and sustainability in its products. 
This includes HeiQ Eco Dry, a PFC-
free water repellent, and HeiQ Fresh 
FFL, a bio-based, antimicrobial-free 
odor control solution.

  Gap Old Navy uses HeiQ Fresh FFL, 
our silver-free, antimicrobial-free 
odor control solution, which is fully 
bio-based.

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

  The Meryl® Skinlife Force zero-

pollution textile of Nylstar is recycled 
and infinitely recyclable and it 
prevents the release of microplastics 
in the air and in the water through 
stronger molecular cohesion and 
natural elasticity of the yarn.
  Patagonia worked with HeiQ 

to convert several critical, high 
volume raw materials to PFC-free 
durable water repellency early 
in Patagonia’s transition from 
conventional treatments.

  The North Face uses HeiQ XReflex, 

a radiant barrier technology, in 
certain of its styles that helps with 
insulation saving.

  Zara, part of the Inditex Group, 
used HeiQ XReflex in a jacket as 
part of its new Join Life sustainable 
collection.

Upon Re-admission in 2020, the 
Board formed a Nomination 
Committee, comprising Esther 
Dale-Kolb (Chairwoman), Benjamin 
Bergo and Karen Brade. The Board 
intends to constitute an 
Environmental, Occupation, Health 
and Safety Committee comprising 
Carlo Centonze (Chair), Karen Brade 
and Esther Dale-Kolb.

+41% 

female leadership  
in the Company

.029

 
 
 
 
 
 
 
 
 
 
 
Strategic report
Section 172 Statement

Stakeholder 
engagement.

Section 172 Statement 

The Directors of the Company, as 
those of all UK companies, must act 
in accordance with a set of general 
duties. These duties are detailed in 
section 172 of the UK Companies Act 
2006, which is summarized as follows:

“A director of a company must act in 
the way they consider, in good faith, 
would be most likely to promote the 
success of the company for the 
benefit of the shareholders as a  
whole and, in doing so have regard 
(amongst other matters) to:

  the likely consequences of any decisions  

in the long term; 

  the interests of the company’s employees; 

  the need to foster the company’s business 
relationships with suppliers, customers  
and others; 

  the impact of the company’s operations  
on the community and environment; 

  the desirability of the company maintaining 
a reputation for high standards of business 
conduct; and 

  the need to act fairly as between members  

of the company.”

.030

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Business conduct
As more fully explained in the 
Corporate Governance section on 
page 45, values and culture are an 
integral part of our strategy and the 
Board strives to promote a culture 
based on high business conduct 
standards.

Acting fairly between members  
of the Company
Having assessed all necessary factors, 
and as supported by the processes 
described above, the Directors 
consider the best approach to 
delivering on the Company’s strategy. 
This is done after assessing the impact 
on all stakeholders and is performed  
in such a manner so as to act fairly as 
between the Company’s members.

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

The following paragraphs summarize 
how the Directors fulfill their duties:

Shareholders
HeiQ seeks to develop a broad 
investor base with those who share 
our values and are supportive of our 
strategy and mission. Engagement 
with shareholders is a key element to 
this objective and is achieved through 
various ways: besides engaging 
through the Company’s AGM and 
through publication of full and half- 
year financial results, members of the 
executive team, supported by the 
Company’s broker and Investor 
Relations advisors, will engage with 
investors directly, mainly through 
regulatory news, press releases and 
other publications, as well as 
presentations and investor talks. 
Investors and other stakeholders can 
also access information about the 
Company on our website. 

Employees
The Group’s staff are employed in 
various countries, mainly outside the 
United Kingdom. The Group maintains 
a decentralized leadership structure so 
that all staff are guided and supported 
closely in a way which allows them to 
grow and achieve their potential. The 
Group has a meritocratic culture, 
employs staff of different ethnicities 
and has a high female ratio in its 
management (41%). A global monthly 
newsletter ensures that all employees 
are aware of the important recent 
developments of the Group, including 
those of the headquarters as well as 
each local office. The Group has an 
informal culture and its employees are 
engaged in social activities organized 
by the headquarters or each local 
office. Such activities include team 
sports, group outings, yearly meetings 
and team-building activities, after-work 
drinks, an annual dinner and, 
particularly popular during the 
Covid-19 pandemic, virtual socializing 
events. As an innovation company, the 
Group encourages creativity and 
innovation ideas. With a centralized 
email address, every employee can 
submit their product innovation ideas 
for the R&D team to review and, if 
qualified, add to the R&D pipeline.

Customers
We can only be successful if our 
customers’ needs are satisfied. 
Understanding our customers and 
even their customers and what 
matters to them is therefore of 
paramount importance to us. We 
listen and talk to them using all of  
the tools at our disposal. We collect 
product innovation ideas and learn 
about our customers’ innovation 
needs through “innovation seminars.” 
We serve our customers directly or,  
in certain regions, via our qualified 
agents and distributors. We run 
consumer polling to identify trends 
and evaluate product or marketing 
ideas. Our customers generally 
appreciate that we share our learning 
and consumer insights with them,  
as these help them make better 
informed business decisions. 

Suppliers
We have long-standing, close 
relationships with our suppliers and are 
in regular contact with them. Fostering 
good business relationships with key 
stakeholders including suppliers is 
important to the Company’s success 
and we are committed to acting ethically 
and with integrity in all business 
dealings and relationships. 

Community and environment 
We are proud to employ people in the 
communities in which we operate.  
We have product standards, policies 
and guidance covering the products 
we make to help ensure that they  
are manufactured safely, legally and 
to the required quality standards. 
Besides legally required standards, 
most HeiQ products are also certified 
for voluntary quality standards such 
as ZDHC (Zero Discharge for 
Hazardous Chemicals), bluesign®  
and OEKO-TEX®. 

.031

 
 
 
 
 
 
 
 
i

H
e
Q
p
c

l

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Strategic report
Financial Review

Significant 
progress on 
our goals.

Xaver Hangartner
CFO 

2020 was a game changing 
year for HeiQ. After a very 
strong start into the year with 
strong sales in the first months, 
HeiQ had been challenged from 
early spring when Covid-19 
pandemic arrived in the  
western hemisphere.

Although our own sites did not cease 
operations at any point, we faced 
shutdowns of customer plants around 
March/April directly impacting existing 
product sales.

Thanks to the anticipation and our 
proven ability to innovate and launch 
a new product very quickly, we were 
able to bring HeiQ Viroblock, a 
treatment for textiles and other 
chemicals with an antiviral effect, to 
the market in only three months. 
Therefore, we could not only hedge 
our endangered business, but 
significantly grow our sales and 
become a brand known to a broader 
audience beyond the textile industry.

.032

 
 
 
 
 
Results for the year

Revenue
Cost of sales

Gross profit

Gross profit margin
Other operating income
Selling and general administrative expenses
Other operating expenses

Operating profit

Deemed cost of listing
Transaction costs
Other income
Other costs
Finance income
Finance costs
Share of (losses)/profits of associates

Income before taxation
Taxation

Income after taxation

Earnings per share (cents) – basic

Earnings per share (cents) – diluted

Adjusted EBITDA

EBITDA margin (adjusted)

The steep growth in business required 
additional financing for working capital 
which was secured by extending 
short-term credit lines from banks.

Based on the strong momentum 
created by the significant growth (sales 
increased by +80.3% 2020 vs. 2019) 
and the again-proven capability to 
innovate and differentiate coupled with 
the huge attention from an audience 
outside our traditional industry, the 
Board of HeiQ Materials AG decided to 
execute the long-ambitioned listing. 
The listing was achieved through a 
reverse takeover of the SPAC (Special 
Purpose Acquisition Company) Auctus 
Growth Plc and the readmission of the 
renamed, enlarged group HeiQ plc to 
the Standard Segment of the Main 
Market at London Stock Exchange on 
December 7, 2020. In the course of 
the listing, HeiQ raised in total £60 
million, comprising a £20 million new 
capital raise as well as £40 million in 
secondary transactions to realize value 
for certain selling shareholders at a 
valuation of £1.12 per HeiQ plc share. 
Since the listing on December 7, 2020 
the share price increased by 61.6% to 
£1.81 as of December 31, 2020.

r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

Note

8
9

8
9

5
5

22
22
7

10

11

11

 50’401 
 (22’402)

 27’999 

55.6%
 4’744 
 (16’117)
 (5’127)

 11’499 

 (1’402)
 (1’871)
 – 
 (69)
 68 
 (1’184)
 (15)

 7’026 
 (2’112)

 4’914 

4.41

4.21

13’970

27.7%

Growth

80.3%

106.3%

27’954
(14’382)

13’572

48.6%
1’585
(12’048)
(1’687)

1’422

708.6%

–
–
24
–
8
(428)
3

1’029
(314)

715

0.71

0.71

2’888

10.3%

582.8%

587.3%

521.1%

493.0%

383.7%

Revenues
Revenue increased in 2020 by 
US$22.4 million to US$50.4 million, 
an increase of +80.3% compared to 
2019. This performance was driven 
on the one hand by new business 
generated from the launch of HeiQ 
Viroblock in March 2020 and the 
forward integration into functional 
materials, medical and personal 
protection devices like face mask and 
other finished goods. On the other 
hand, an existing product range 
comprised of innovative technologies 
and traditional ingredients provided 
us with a balanced revenue. The 
antimicrobial product family HeiQ Pure 
as well as the dynamic cooling range 
HeiQ Smart Temp product family both 
had their best year, more than 
offsetting the slowing down of 
auxiliary product sales, giving us an 
overall increase in revenue of the 
existing product range brought to the 
year under review from 2019 despite 
the challenge posted by the economic 
situation. This was an outstanding 
achievement considering the textile 
industry suffered significantly during 
the pandemic with many stores  
closed for a prolonged period in 
various markets. 

Another highlight in 2020 is the fact that 
HeiQ was able to increase the number of 
licensing/royalties contracts significantly, 
although revenue contribution in 2020 
was not yet material. This demonstrates 
the strengthening of our brand and the 
trust of the industry in our products. We 
believe that licensing and royalty-pricing 
models can become a significant 
contributor to both top and bottom line in 
the future though.

Gross profit
Our gross profit increased from 
US$13.6 million in 2019 to US$28.0 
million in 2020 – an increase of 
106.3%. This is reflected in an 
increased gross profit margin of 55.6% 
(2019: 48.6%). In general, we were 
able to maintain contribution margins 
of individual products at similar levels 
compared to 2019. As such the 
increase in gross profit margin is 
mainly derived from the favorable 
development of the product mix sold. 
The successful launch of HeiQ 
Viroblock added a new, high margin 
product to our range. Additionally, the 
other key driver of the sales growth 
(HeiQ Smart Temp and HeiQ Pure 
product families) typically achieved 
above-average contribution margins. 

.033

 
 
 
 
 
 
 
 
Adjusted EBITDA
The significant growth in sales 
coupled with increased gross profit 
margins and decreasing SG&A ratio  
is reflected in the Adjusted EBITDA 
which increased by 384% from 
US$2.9 million in 2019 to  
US$14.0 million in 2020.

HeiQ adjusts EBITDA for share options 
and rights granted to Directors and 
employees.

Finance costs
Finance costs mainly include foreign 
exchange rate impacts on non-operating 
assets of in total US$0.7 million. Actual 
interest paid on borrowings amount to 
US$0.1 million.

Income after tax
Income after taxation amounted to 
US$4.9 million, an increase of +587% 
compared to 2019 (US$0.7 million). 
Diluted earnings per share  
increased from US$0.0071 (2019)  
to US$0.0421 per share – an 
increase of +493%.

Strategic report
Financial Review continued

Cost of goods sold also include a 
major part of our logistic and 
warehousing costs. These costs 
significantly increased in 2020 
compared to 2019. Faced with 
lockdowns around the globe and air 
traffic that dramatically decreased, 
transportation costs have in general 
considerably increased, and we had 
to rely more often than usual on air 
shipment to maintain a timely service 
for our customers. In view of 
increased uncertainty relating to 
transportation systems and the low 
forecast visibility due to moving 
demand, we strategically increased 
our stock of key raw materials and 
products, which led to increased 
warehousing costs.

Selling and general administration 
expenses (SG&A)
SG&A increased by US$4.1 million  
to US$16.1 million (2019 US$12.0 
million) driven by the growth of the 
business. SG&A represent 32.0%  
of sales in 2020 vs. 43.1% in 2019. 
The increase in the nominal  
amount represents the growth of  
our organization (average monthly 
employees: +11 respectively or 
+12.8%) and, based on the very 
successful business performance, 
higher accruals for variable 
compensation components and 
commissions. The rapid growth  
also required higher expenses for 
marketing and professional fees, 
including consulting in regard to 
regulatory matters. Other increased 
cost items like insurance costs and 
audit costs were mainly driven by  
the fact that we became a listed 
company in 2020.

Other income and expenses 
The other operating income and 
expenses are mostly related to foreign 
exchange impacts on operating  
assets and liabilities. The net foreign 
exchange expenses amounts to 
US$1.1 million compared to overall 
net other operating expenses of 
US$0.4 million.

Costs related to the reverse 
takeover of Auctus Growth Plc 
by HeiQ Materials AG
  Deemed cost of listing: The 

deemed cost of listing represents 
the difference between the 
notional consideration paid by 
HeiQ plc for HeiQ Materials AG of 
(US$28.1 million) and the HeiQ 
plc net assets acquired of £20.4 
million (US$26.7 million). It has 
been charged to the Consolidated 
Statement of Comprehensive 
Income as a deemed cost of 
listing amounting to £1.1 million 
(equivalent to US$1.4 million) 
with a corresponding entry to the 
merger reserve.
The notional consideration paid 
represents the fair value of 
the notional number of equity 
instruments that the legal 
subsidiary would have had to have 
issued to the legal parent to give 
the owners of the legal parent the 
same percentage ownership in 
the combined entity which was 
15.2% of the market value of the 
shares after issues (£141 million 
or US$184 million).

  Transaction costs: Costs directly 
attributable to the transaction 
amounted to US$1.9 million and 
are charged to the statement of 
comprehensive income directly.

Adjusted EBITDA

US$’000

Operating profit
Depreciation
Amortization
Share options and rights granted to Directors  
and employees

Adjusted EBITDA

2020

11’499
1’144
110

1’217

13’970

2019

1’422
1’116
149

201

2’888

.034

HeiQ plcAnnual report and accounts 2020 
r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Statement of financial position
Assets
Non-current assets increased by 
US$2.7 million (+23.3%) from 
US$11.6 million to US$14.3 million in 
2020. The increase is driven by the 
acquisition of HeiQ Medica in 
December 2020, adding Machinery 
and Equipment of in total US$1.2 
million. Further additions of US$0.6 
million represent capitalizations 
related to internally developed 
intangible assets. Deferred tax assets 
also saw a significant increase by 
US$0.4 million owing to tax losses 
assessed to be recoverable in the 
years to come. 

Current assets increased by US$38.8 
million and amount to US$55.1 
million as of December 31, 2020 
(2019: US$16.3 million). The main 
increase relates to cash and cash 
equivalents as the Group raised £20 
million (gross amount) of new capital 
in December 2020. 

Inventories increase significantly as 
well and amount to US$13.3 million 
as of December 2020 (2019: US$3.2 
million). The increase in inventory 
reflects the overall growth of the 
business as well as the fact that the 
Group increased its minimum stock 
for key materials in order to guarantee 
supply to customers globally despite 
the challenging circumstances owed 
to the Covid-19 pandemic.

Liabilities
Non-current liabilities increased from 
US$5.4 million (2019) to US$8.0 
million as of December 2020 as the 
newly acquired participation in HeiQ 
Medica has a long-term loan received 
from banks (US$1.4 million). Other 
than the loan acquired with HeiQ 
Medica, no long-term bank loans are 
outstanding as of December 2020. 
There was also a US$0.6 million in 
deferred tax liabilities which arose 
from temporary differences in the 
reporting for tax purposes. Other 
non-current liabilities have increased 
due to higher defined benefit 
obligations as per IAS 19 for the Swiss 
pension plan (US$ +1.4 million) and 
reduced deferred consideration 
liabilities related to the Chem-Tex 
acquisition (US$–0.7 million).

Current liabilities increased by US$2.9 
million. The increased business in 
2020 brought a US$3.9 million 
increase in trade and other payables 
as well as a US$1.5 million rise in tax 
liabilities offsetting the US$2.3 million 
repayment of borrowings.

Cash flow
Cash generated from operating 
activities amounts to US$1.1 million 
(2019: US$3.0 million) after 
increasing the working capital by 
US$10.5 million related to the strong 
growth of business. 

The cash from investing activities of 
US$24.2 million reflects the reverse 
takeover of HeiQ plc (formerly Auctus 
Growth Plc) and therefore includes the 
raised capital of £20 million (gross).

Financing activities of US$3.5 million 
mainly related to US$2.7 million 
repayments of borrowings.

Mergers & acquisitions
On December 11, 2020, HeiQ closed 
the acquisition of a controlling-stake in 
MasFabEs – renamed HeiQ Medica 
upon closing. HeiQ Medica operates a 
surgical mask production site in Spain 
enabling HeiQ to further growth into 
the medical device business and bring 
new innovations in this field to market 
quickly. HeiQ Medica was established 
in Coin, Spain on May 18, 2020 
building up a production site  
and achieving medical industry 
certifications in October 2020. 
Commercial activities only started just 
before the year end. HeiQ Medica is 
fully consolidated into HeiQ Group as of 
date of acquisition. Based on the fact 
that the acquisition was only closed 
shortly before year end, it had no 
material impact on the consolidated 
comprehensive income of HeiQ Group.

In March 2021, the Group executed 
the acquisition of a controlling stake  
of 51% in Chrisal NV, Belgium to 
strengthen its position in the strategic 
field of probiotics and hygiene 
technologies.

Xaver Hangartner
CFO

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

.035

 
 
 
 
 
 
 
 
 
Strategic report
Risk management

Integral to
our business.

Corporate risk management is 
an integral part of running a 
company, particularly a public 
company. A company’s ability 
to manage risk can also greatly 
impact its sustainability.

We strive to work in the interests of 
all stakeholders. As a comprehensive 
risk management strategy is an 
essential part of a truly sustainable 
business, HeiQ has adopted a 
systematic method of identifying, 
analyzing, evaluating, treating, 
monitoring and communicating risks 
in a way that will enable us to 
minimize losses and maximize 
opportunities.

Risk management will not be able to 
eliminate risks entirely, but it will 
enable us to identify, prioritize and 
manage risks and opportunities in a 
way that a possible impact can be 
absorbed by the organization. The 
heat map appears on the leadership 
team’s agenda quarterly, and a risk 
report will also be reviewed and 
discussed in Board meetings at least 
twice a year.

As risks can arise from many 
different angles, they need to be 
identified top down and bottom up. 
Having said that, while it is necessary 
to have a formal risk management 
system in place throughout the 
organization, managing risk is also 
the responsibility of each employee.

Risk management does not only 
focus on preventing erosion of value 
and addressing and minimizing risk 
to an acceptable level, but it can be a 
tool to set strategies and identify 
business opportunities to create and 
maintain value. HeiQ has 
demonstrated this in the past year 
clearly. With our diverse range of 
products and specialized knowledge 
in material science, we were able to 
quickly identify one innovation that 
could be of high demand for the 
situation. We were able to validate 
and launch the innovation quickly, 
and adjust our operations as the 
pandemic unfolded. By responding to 
the new global situation, we were 
able to build new businesses around 
it very quickly.

.01

Identify
the potential risks

Risk  
management  
framework

.05

Monitor
the results on an 
ongoing basis

.02

Measure
the risk regarding 
probability of occurring

.04

Manage
the identified risks

.03

Examine
solutions

.036

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

.01

.02

.05

Monitor results 
Since the organization, the 
environment and potential risks  
are constantly changing, risk 
management is a continuous process 
which needs to be monitored 
regularly. A formalized process 
ensures a more complete picture of 
the organization which enables more 
informed decision-making. 

Identification of risks 
We use five main risk categories 
under which our key risks are listed, 
as follows:

  Environmental and hazard risks

Natural disasters like fires, 
earthquakes, flooding as well as 
accidents and injuries 

Measure the risk 
The risks must be identified and 
assessed individually and should be 
measured against the likelihood of 
them occurring and the foreseeable 
impact if they do occur. See our  
heat map for our analysis of our 
principal risks.

  Operational risks

Loss of personnel (talent, key 
people), supply chain 
interruptions, IT infrastructure or 
systems breakdown, cyber-
attacks, management errors

  Financial risks

Economic recession, currency 
risk, fraud, liquidity, lack of growth 
in revenue, tax

  Strategic risks

Increased competition, regulatory 
changes and governmental 
restrictions regarding products 
and production. Brand and 
corporate reputation, theft of 
intellectual property

  Legal risks

Compliance of our products and 
claims, compliance with capital 
market rules

.03

Examine solutions 
What are the various solutions to 
manage the risks and what is   
considered to be the optimal balance 
between cost and effectiveness? 
Organizations usually have the option 
to accept, avoid, control or transfer  
a risk.

.04

Manage the risk – decision 
regarding solution and its 
implementation 
Once the solutions are listed and 
prioritized, resources and personnel 
including senior management, 
possibly with external expertise, have 
to be allocated. A process should be 
established to implement the solution 
and actively manage the risk.

Risk heat map 
This risk heat map demonstrates how 
we consider the likelihood and impact 
of our principal risks. It provides a 
reliable basis for comparison and 
classification of risks and allows 
management to focus on the potential 
risks which need the most urgent 
attention, while not losing sight of all 
the other types of risk.

1    Delivery of growth strategy/
growth rates not sustainable
2    IP protection and first-mover 

advantage

3    Increase in competition
4    Innovation pipeline
5    Regulatory risks
6   Supply chain issues
7   Product liability
8   Geographical risks
9   Reputational risk/brand equity
10   Personnel
11   Currency risks

h
g
H

i

9 

1 

4 

t
c
a
p
m

I

i

m
u
d
e
M

6

7

10 

2

3 

5 

11

w
o
L

8

Low

Medium

Likelihood

High

.037

 
 
 
 
 
 
 
 
 
 
Strategic report
Principal risks and uncertainties

Principal Risk

Description and Impact

Controls/Mitigation

.01

Delivery of growth 
strategy/growth 
rates not  
sustainable

If the Group does not successfully 
implement its growth strategy for a high 
margin business, this could have a material 
adverse effect on its business, financial 
condition and operating results.

.02

IP protection 
and first-mover 
advantage

Any failure to substantiate or successfully 
assert HeiQ’s intellectual property rights 
could make it less competitive and may have 
a material adverse effect on net revenue. 
HeiQ may face challenges to its intellectual 
property rights from third parties. If HeiQ is 
unable to successfully defend against 
allegations of infringement, it may face 
various sanctions, including injunctions, 
monetary sanctions, product recalls and 
alterations to its products and/or packaging, 
which could result in significant expense and 
negative publicity.

.03

Increase in 
competition

As competing products come to market in 
direct competition to HeiQ’s products, 
particularly from large global companies, this 
may result in a reduction in sales and 
therefore in revenues and associated profit 
margins. HeiQ faces substantial competition 
throughout its business from international 
and domestic companies.

.04

Innovation 
pipeline

Bringing innovations to market at high speed 
and high pace is key to the Group’s growth 
strategy and market positioning. Failure to 
launch innovations at a high pace might 
have a material adverse impact on the 
Group’s growth and operating results. 

Clear strategy communication 
and alignment throughout the 
organization with an Executive 
Board (Lead Circle) sponsoring 
each of the defined strategic 
initiatives.

Leadership culture based on 
objectives and key results  
(OKR) that all are aligned with 
the strategy.

HeiQ’s business relies on 
protecting its brands and claims 
to a combination of intellectual 
property rights, unique market 
positioning, trade secrets and 
freedom to operate strategies 
and not only on intellectual 
property rights alone.

It is key to the Group’s 
intellectual property protection 
strategy to constantly innovate 
and further develop its existing 
product portfolio to maintain a 
first-mover advantage.

HeiQ’s innovations typically open 
up new markets and thus the 
Group enjoys a first-mover 
advantage before competitors 
start to follow. 

HeiQ, with its three-in-one 
approach (innovation, production 
and marketing), positions itself 
as a partner to brands over the 
entire lifecycle of a technology 
which provides a lock-in effect.

HeiQ has a broad source for 
innovation ideas and a clear, 
lean process for assessing and 
developing these ideas into 
product offerings. 

The Innovation Advisory Board 
prioritizes innovation projects 
based on technical feasibility 
and market potential; the 
Group’s network of research 
partners allows it to access 
knowledge needed for each 
individual project.

Trend

Stable

Stable

Stable to increase

Stable

.038

HeiQ plcAnnual report and accounts 2020 
 
 
r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

Principal Risk

Description and Impact

Controls/Mitigation

Trend

Increase

Increase

HeiQ follows closely 
developments in the regulatory 
environment and actively 
manages its product portfolio 
and innovation pipeline based on 
regulatory trends. 

It is an integral part of HeiQ’s 
strategy to innovate and replace 
today’s solution on the market 
with “greener”, future-proof 
technologies. 

HeiQ engages actively in 
regulatory discussions in 
industries where it operates.

HeiQ sources raw and packaging 
materials and finished goods 
from a wide variety of 
international chemical and 
packaging companies and 
co-producers.

HeiQ sources key (raw) materials 
whenever possible from at least 
two different suppliers. 

HeiQ periodically assesses 
potential for backward 
integration for materials which 
allow either a cost advantage or 
strategic advantage including 
supply security. 

.05

Regulatory 
risks

.06

Supply chain 
issues

The manufacturing and marketing of 
chemicals and medical devices are subject 
to medical, biocidal, chemical and 
environmental regulations and permits. Such 
regulations change constantly and require 
HeiQ to invest in its regulatory portfolio in 
order to maintain access to the markets and 
licenses to operate. Failure to do so may 
result in restricted market access or prevent 
HeiQ from manufacturing its products in the 
relevant plants. 

Regulators in different jurisdictions might 
restrict use of certain ingredients that  
are included in HeiQ products and disallow 
marketing of respective products in 
different markets.

HeiQ faces the risk of interruptions to its 
supply chain and disruptions in its 
production facilities, which could materially 
and adversely affect the results of 
operations. Significant disruptions to HeiQ’s 
suppliers’ or HeiQ’s own operations, such as 
those resulting from natural catastrophes, 
outbreaks of diseases, acts of war or 
terrorism may affect HeiQ’s ability to source 
raw materials and negatively impact its 
costs. The failure of suppliers to fulfill their 
contractual obligations in a timely manner 
may result in delays or disruptions to HeiQ’s 
business. Replacing suppliers may require a 
new supplier to be qualified under industry, 
governmental or HeiQ’s own internal 
standards, which may take time. In addition, 
a number of HeiQ’s facilities are critical to its 
business. Major or prolonged disruption at 
those facilities, whether due to accidents, 
sabotage, strikes, closure by government 
agencies or otherwise, could materially  
and adversely affect operations. Moreover, 
manufacturing sites are subject to 
supervision by regulatory agencies, on both 
an ongoing and ad hoc basis. If the Group  
is unable to obtain or produce sufficient 
quantities of a particular product, at 
specifically approved facilities, whether due to 
disruption to, or failure of, manufacturing 
processes, or otherwise, it may fail to meet 
customer demand on a timely basis, which 
could undermine sales and result in customer 
dissatisfaction and damage to reputation.

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

.039

 
 
 
 
 
 
 
 
Strategic report
Principal risks and uncertainties continued

Principal Risk

Description and Impact

Controls/Mitigation

Trend

Stable

HeiQ operates with defined 
quality control procedures 
integrated in production to 
ensure that products sold are 
within specifications defined and 
agreed with customers. 

.07

Product 
liability

.08

Geographical 
risks

As a product manufacturer, HeiQ is  
subject, from time to time, to certain legal 
proceedings and claims arising out of  
its products, including as a result of 
unanticipated side effects or issues that 
become evident only after products are 
widely introduced into the marketplace. 
HeiQ may be required in the future to pay 
compensation for losses or injuries that are 
allegedly caused by its products. Product 
liability claims may arise, among other 
things, from claims that products are 
defective, contain contaminants, provide 
inadequate warnings or instructions, or 
cause personal injury to persons or damage 
to property. Product liability claims, if 
resolved unfavorably, or if settled, could 
result in injunctions and/or may require 
HeiQ to pay substantial damages and 
related costs, including punitive damages, 
as well as result in the imposition of civil 
and criminal sanctions. If one of HeiQ’s 
products is found to be generally defective, 
HeiQ could be required to recall the 
product, and/or may be required to alter 
trademarks, labels or packaging, which 
could result in adverse publicity, significant 
expenses, potential disruptions in the 
supply chain and loss of revenue.

HeiQ operates in a variety of countries which 
have different laws, taxes and different levels 
of maturity together with a range of 
competitors and customer expectations. 
HeiQ’s business and results of operations 
are affected by changes in both global 
economic conditions and the individual 
markets in which it operates.

Terrorist acts, civil unrest and other  
similar disturbances, as well as natural 
catastrophes, can impact economic 
conditions and consumer confidence, 
degrade infrastructure, disrupt supply 
chains and otherwise result in business 
interruption. A variety of factors may 
adversely affect results of operations and 
financial conditions during periods of 
economic uncertainty or instability, social  
or labor unrest or political upheaval in the 
markets in which it operates.

.040

Stable

HeiQ’s strategy includes building 
up a global footprint for 
innovation and manufacturing  
as well as sales and distribution 
channels. This includes own 
presences as well as cooperation 
with, for example, distributors. 
This ensures that the Group is 
able to serve one market through 
different channels both from 
inside and outside the respective 
geographical area.

HeiQ is building up local 
presence in key markets  
to ensure the local market  
and regulatory framework 
(including laws, taxes, etc.)  
is well understood and 
addressed properly.

HeiQ plcAnnual report and accounts 2020r
e
p
o
r
t

S
t
r
a
t
e
g
i
c

C
o
r
p
o
r
a
t
e

g
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a

i

l

i

H
e
Q
p
c

l

s
t
a
t
e
m
e
n
t
s

A
n
n
u
a

l

r
e
p
o
r
t
a
n
d
a
c
c
o
u
n
t
s
2
0
2
0

Principal Risk

Description and Impact

Controls/Mitigation

Trend

.09

Reputational risk/
brand equity

.10

Personnel

.11

Currency
risks

Substantial harm to HeiQ’s reputation may 
materially adversely affect its business. 
Various factors may adversely impact HeiQ’s 
reputation, including product quality 
inconsistencies. Product defects may occur 
due to human error or equipment failure, 
among other things, which may be outside of 
the direct control of HeiQ. Reputational risks 
may also arise with respect to the methods 
and practices of third parties that are part of 
HeiQ’s supply chain, including labor 
standards, health, safety and environmental 
standards, and raw material sourcing. HeiQ 
may also be the victim of product tampering.

Moreover, third parties have sold or may sell 
products that are counterfeit or unauthorized 
versions of HeiQ’s products or inferior 
“lookalike” products that resemble HeiQ’s. 
Consumers may confuse HeiQ’s genuine 
products with such unauthorized products, 
which may adversely affect HeiQ’s 
reputation.

HeiQ’s business depends, in part, on the 
ability of executive officers and senior 
management to provide uninterrupted 
leadership and direction for its business, 
and, in particular, on the ability to recruit, 
train and maintain qualified personnel for 
product research and development. This 
need is all the more acute in the context  
of a growing business and in the strategic 
internal reorganizations and resource 
planning programs to promote and manage 
such growth. 

HeiQ’s ability to attract and retain key 
management and other personnel is 
dependent on a number of factors, 
including prevailing market conditions, 
attractiveness of competitors as potential 
employers, working conditions and culture 
and the ability to offer attractive 
compensation packages.

HeiQ Group operates mainly in CHF, EUR, 
CNY, TWD and US$ and reports in US$. 
Consequently, changes in the GBP, CHF, 
EUR, CNY, TWD and US$ exchange rates will 
impact on the earnings of the Company. The 
exchange rates are affected by numerous 
factors beyond the control of the Group, 
including international markets, interest 
rates, inflation and the general economic 
outlook and, as such, the Group may not be 
able to adequately manage these risks in 
some circumstances.

Increase

HeiQ has a clear strategy and 
policy in regard to 
communication, both in terms of 
product marketing as well as on 
a corporate level.

HeiQ actively manages claims 
that are allowed in different 
jurisdictions for different 
products which is also reflected 
in trademark license agreements 
with our customers.

HeiQ actively follows and 
manages communication both 
off and online to ensure potential 
issues can be addressed in a 
timely and appropriate way.

HeiQ has a structured hiring 
process to ensure the cultural fit 
of new hires.

Stable

HeiQ offers key senior 
management and talent 
participation via its share option 
plan to align incentives of 
individual employee to that of 
the Group.

HeiQ supports employees’ growth 
based on professional and 
personal development.

HeiQ fosters an inclusive, 
meritocratic work atmosphere 
where employees can contribute 
and participate and offers 
flexible work models allowing 
alignment of work with private 
and family life.

The Group, as far as possible, 
aligns operational cash inflows 
and outflows in the respective 
currencies to achieve a natural 
hedge.

Remaining short or long 
positions are monitored centrally 
and subject to hedging where 
appropriate.

Increase

The Strategic Report was approved by the Board of 
Directors and signed on its behalf by:

Carlo Centonze
Director
April 23, 2021

.041

 
 
 
 
 
 
 
 
Corporate governance
The Board

Esther Dale-Kolb
Chairwoman 
Non-executive Director 

Carlo Centonze
Co-founder and CEO 
Executive Director

Committees

Committees

Xaver Hangartner
CFO 
Executive Director

Committees

Xaver started his career in finance 
in 2005 after obtaining a 
bachelor’s degree in Business 
Administration from the University 
of St. Gallen (HSG). At the 
beginning of his professional 
career, he worked with EY 
Switzerland as an auditor for 
industrial clients and graduated as 
a Swiss Certified Public Accountant 
in 2009. He later worked in various 
finance positions and led the 
global finance and accounting 
team of a listed Korean specialty 
chemical producer before  
joining HeiQ in 2018 as Head  
of Controlling. He was appointed 
Group Chief Financial Officer in 
October 2019.

Carlo studied Environmental 
Sciences and Forest Engineering 
(MSc) at the Swiss Federal 
Institute of Technology, ETH Zurich. 
He earned his Executive MBA at 
the University of St. Gallen (HSG). 
After his service as an army pilot, 
he started his professional career 
as co-founder of the ETH spin-off, 
myclimate, a non-profit 
organization and prominent 
provider of carbon offsetting 
measures. Since 2004, Carlo has 
served HeiQ as co-founder and 
CEO, developing the firm from a 
two-employee company to an over 
140-employee company. He also 
serves as chairman of ECSA 
Group, a 108-year-old Swiss 
chemical and energy distributor 
with an annual consolidated 
turnover of over US$300 million 
and is a member of the executive 
board of Science Industries, the 
Swiss association of the 
pharmaceutical, biotech and 
chemical industries.

Esther was Chief Executive Officer 
of Dr. W. Kolb Holding AG (Kolb),  
a Swiss specialty chemicals 
company. From 1991 until 2007 
Esther was CEO of the Kolb Group, 
with over 200 employees, 
producing in Holland and 
Switzerland as an internationally 
operating specialty chemicals 
company. Esther managed the 
change from a pioneer-driven 
family company to a process- 
orientated modern business with 
cooperative management style, 
contributing to substantial growth 
in production capacity, revenue 
and EBIT. She then successfully 
concluded the trade sale of the 
Kolb Group to Kuala Lumpur 
Kepong Berhad, KLK Malaysia  
and remained on the board for a 
further 18 months. Before leading 
Kolb, Esther worked as a product 
manager in paper chemicals and 
started her career as a laboratory 
technician at Dow Chemical. She 
completed her apprenticeship at 
the Swiss Federal Institute of 
Technology, ETH Zurich, and 
received her Bachelor of Science 
degree at King’s College London. 
Esther was active as a member  
of the board of the Swisscross 
Foundation, a Swiss charitable 
foundation. Esther is the 
Chairwoman of HeiQ.

.042

HeiQ plcAnnual report and accounts 2020Benjamin Bergo
Non-executive Director 

Karen Brade
Non-executive Director 

Committees

Committees

Ben brings a wealth of experience 
in high growth technology 
operations and venture capital.  
He currently serves as President 
and CEO of Visus Therapeutics, 
Inc., an ophthalmic drug 
development company. He also 
serves as a non-executive director 
at Lumos Diagnostics Holdings Pty 
Ltd, a leading full-service provider 
of point-of-care diagnostic 
solutions. Ben previously served as 
a non-executive director of Planet 
Innovation Holdings Limited, a 
healthtech innovation and 
commercialization company, and 
led investments into life sciences 
transactions at a seed stage 
venture fund between 2007 and 
2011. Prior to this, Ben held 
management roles at Vision 
BioSystems, until the sale of Vision 
Systems Limited to Danaher 
Corporation in 2006.

Karen has extensive experience of 
project finance, private equity and 
asset management. She started her 
career at Citibank working on 
multinational project finance 
transactions. Karen worked at CDC 
(Commonwealth Development 
Corporation), the UK Government’s 
development finance institution, 
where she held positions in equity 
and debt investing, portfolio 
management, fund raising and 
investor development. Karen has 
been an advisor to hedge funds, 
family offices and private equity 
houses. She currently serves as chair 
of Aberdeen Japan Investment Trust 
plc; chair of Keystone Positive Change 
Investment Trust plc; non-executive 
director and chair of audit at 
Augmentum Fintech plc and is an 
external panel member of the Albion 
Capital VCT investment committee.

Overall gender split 

65%

Male
Female

35%

Board structure 

40%

Executive
Non-executive

60%

Key: Committee membership 

  Audit Committee
  Nomination Committee 
  Remuneration Committee

.043

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020 
 
 
 
 
 
Corporate governance
Corporate Governance Statement

Delivering growth
Strategy and business model
Principle one of the Code requires 
that companies establish a strategy 
and business model which promotes 
the long-term value for shareholders. 
Our strategy, and the key challenges 
we face in executing the strategy, are 
set out in the Strategic Report on 
pages 14 to 15. HeiQ’s leadership 
team meets regularly and focuses on 
the delivery of the Group’s strategic 
plan which is set by the Board. The 
Chief Executive Officer reports to the 
Board on progress, and the Board 
supports and challenges the 
leadership team. Employees are kept 
informed of strategy and progress 
through regular employee briefings 
and newsletters. 

Shareholder relations
Under principle two of the Code, we 
are required to seek to understand 
and meet the needs and expectations 
of our shareholders. In order to 
achieve this, we plan to make our 
Executive Directors available to 
shareholders through regular 
meetings throughout the year along 
with investor roadshows around the 
time of our financial results 
announcements. 

Stakeholder engagement
Principle three of the Code requires us 
to take into account wider stakeholder 
and social responsibilities and their 
implications for long-term success. We 
consider our key stakeholders, in 
addition to our shareholders, to be our 
employees, our partners, our 
customers, our suppliers, our bankers 
and our lenders, the local 
communities in which we operate and 
the environment. More information on 
our engagement with our key 
stakeholders can be found in our 
s172 Statement on pages 30 to 31  
of this report.

Risk management
Principle four of the Code requires the 
Company to embed effective risk 
management, considering both 
opportunities and threats, throughout 
the organization. The Company’s 
significant risks and uncertainties are 
set out on pages 38 to 41 of this 
report together with a summary of 
how risk management is executed 
within the Group.

Esther Dale-Kolb
Chairwoman

Chair’s Introduction

Dear Shareholder

I have pleasure in introducing 
HeiQ’s Corporate Governance 
Report, our first since the Re-
admission of the Company’s 
securities on the London Stock 
Exchange in December 2020 
(“Re-admission”). As we stated at 
that time, the Board is committed to 
the principles underpinning good 
corporate governance. We aim to 
apply these in a manner which is 
most suited to the Company, and 
best addresses the Board’s 
accountability to shareholders and 
other stakeholders. The Company, 
therefore, voluntarily observes the 
requirements of the QCA Corporate 
Governance Code (the “Code”) as 
the Board feels that this Code is 
more appropriate for the Company’s 
size and stage of development than 
the more prescriptive UK Corporate 
Governance Code. 

During the period under review the 
Company has complied with the QCA 
Corporate Governance Code with  
the exception of, inter alia, the 
expectation that each member of  
the Remuneration Committee be 
independent and each independent 
non-executive director be re-elected 
on an annual basis. The Company  
will keep these matters and its 
governance framework under review 
as it continues to grow and develop.

In this report, we have set out how we 
have applied the ten principles of the 
Code in the year ended December 31, 
2020.

Esther Dale-Kolb
Chairwoman

.044

HeiQ plcAnnual report and accounts 2020Maintaining a dynamic 
management framework
The Board
Principle five of the Code calls for the 
maintenance of the Board as a 
well-functioning, balanced team led  
by the Chair. 

The Board is led by Esther Dale-Kolb, 
who is the non-executive Chairwoman. 
The Board also includes two non-
executive Directors who both have 
extensive experience with international 
and/or UK listed companies, and two 
Executive Directors. All Directors, 
including the Chairwoman, hold shares 
in the Company. The two Executive 
Directors and the Chairwoman are  
not considered independent, while the  
two non-executive Directors are 
considered independent. 

There are three Board Committees: 
the Audit Committee, the 
Remuneration Committee and the 
Nomination Committee. A fourth 
Committee – the Environmental, 
Occupation, Health and Safety 
Committee (EOHSC) – is intended to 
be established in the course of 2021. 
More information on the Audit, 
Nomination and Remuneration 
Committees can be found on pages 
47 to 53. 

There has been one Board meeting 
since the Re-admission until December 
31, 2020 and all Directors attended. 

Directors are expected to attend all 
Board meetings and the meetings  
of the Committees on which they sit. 
They are also required to devote 
sufficient time to the Company to 
enable them to fulfill their duties  
as Directors. The time commitment 
expected of the non-executive 
Directors is set out in their letters  
of appointment. 

The Board’s skills and capabilities
Principle six of the Code requires that 
the Company ensures that, between 
them, the Directors have the 
necessary up-to-date experience, 
skills and capabilities. The Board 
comprises five individuals with a mix 
of skills and experience that is most 
appropriate for the Company at this 
stage in its development. More 
information on the background and 
skills of the individual Directors can 
be found on pages 42 to 43. The 
Board’s gender balance is good, being 
two female and three male Directors. 

The Board’s training and development 
needs will be met by implementing 
appropriate periodical training during 
the course of 2021. The Company 
Secretary tables a report at each Board 
meeting which covers any significant 
developments in corporate governance.

The Board provides strategic 
leadership and sets the culture and 
practices that should be followed 
throughout the business. The Board 
maintains a schedule of matters 
reserved for its decision and these 
include:

Management structure and 
appointments:
  senior management 

responsibilities;

  Board and other senior 

management appointments or 
removals;

  Board and senior management 

succession, training, development 
and appraisal;

  appointment or removal of the 

Company Secretary;

  appointment or removal of the 

internal auditor;

  remuneration, contracts, 

grants of options and incentive 
arrangements for senior 
management;

  delegation of the Board’s powers;
  agreeing to membership and terms 
of reference of Board Committees 
and task forces;

  establishment of managerial 
authority limits for smaller 
transactions; and

  matters referred to the Board by 

the Board Committees.

Strategic/policy considerations:
  business strategy;
  diversification/retrenchment 

policy;

  specific risk management policies 
including insurance, hedging, 
borrowing limits and corporate 
security;

  agreement of codes of ethics and 

business practices;

  receipt and review of regular 
reports on internal controls;

  annual assessment of significant 
risks and effectiveness of internal 
controls;

  calling of shareholders’ meetings; 

and

  avoidance of wrongful or 

fraudulent trading.

Board performance and evaluation
The seventh Code principle requires 
the Board to evaluate its performance 
based on clear and relevant 
objectives, seeking continuous 
improvement. The Directors feel that  
it is too early to have conducted a 
Board evaluation but have committed 
to running an internal evaluation in 
the latter part of 2021.

Succession planning will be 
addressed by the Nomination 
Committee which will make 
recommendations to the Board.

Corporate culture
Principle eight of the Code requires 
that the Company promotes a 
corporate culture that is based on 
ethical values and behaviors. At HeiQ, 
we strive to ensure that our business 
success is in accordance with the best 
environmental, ethical and social 
standards. We aim to provide diligent 
product stewardship and deliver value 
to all our stakeholders. We have an 
entrepreneurial culture where 
disciplined execution is key. We expect 
all our employees to work hard and 
with determination and in return we 
care for our people who respect each 
other. We pride ourselves on being 
customer-focused thinkers who act 
with integrity, honesty and trust. 
Sustainability is our guiding star in all 
our actions, processes and products.

The Board will monitor and promote a 
healthy corporate culture by 
conducting an annual employee survey 
with the aim to capture strategic 
alignment, the level of satisfaction, as 
well as suggested improvements.

Governance structure
Principle nine of the Code requires the 
Company to maintain governance 
structures and processes that are fit 
for purpose and support decision- 
making by the Board. The Board 
meets at least four times a year and 
the Audit and Remuneration 
Committees meet at least two and 
one times a year respectively. The 
Nomination Committee meets at least 
once a year and more if circumstances 
require it.

.045

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Corporate governance
Corporate Governance Statement continued

The Board has approved terms of 
reference for each of the Board 
Committees to which certain 
responsibilities are delegated. The 
chair of each Committee reports to 
the Board on the activities of that 
Committee. Further information on 
the Committees can be found on 
pages 47 to 53 of this report.

The Chair is responsible for the 
leadership of the Board, ensuring its 
effectiveness on all aspects of its role 
and the setting of its agenda. She 
ensures the Directors receive 
accurate, timely and clear information 
and she is responsible for ensuring 
the Board’s effective communication 
with shareholders. In leading Board 
meetings, the chair facilitates the 
effective contribution of non-executive 
Directors and ensures constructive 
relations between Executive and 
non-executive Directors.

The Chief Executive Officer is 
responsible for the leadership and 
management of the Company, and 
the implementation of objectives and 
strategies agreed by the Board. 

Build trust
Stakeholder communication
Principle ten of the Code requires  
the Company to communicate  
how the Company is governed and is 
performing by maintaining a dialogue 
with shareholders and other relevant 
stakeholders.

During the period under review we 
have had over 30 interactions with 
shareholders, have conducted several 
audits by regulatory counterparts and 
interacted with our 10,000 consumer 
strong customer base. Further 
information on our engagement with 
shareholders can be found on page 
31 of this report.

Transactions:
  acquisitions and disposals of 

subsidiaries or other assets over 
10% of net assets/profits;
investment and other capital 
projects over a similar level;

  substantial commitments 

including:
–  pension funding;
–  material contracts in excess of 

one year’s duration; and

–  giving securities over significant 

Group assets (including 
mortgages and charges over 
the Group’s property);
  contracts not in the ordinary 

course of business;

  actions or transactions where 

there may be doubt over property;

  approval of certain 

announcements, prospectuses, 
circulars and similar documents;
  disclosure of Directors’ interests; 

and
transactions with Directors or other 
related parties.

Finance:
  raising new capital and 

confirmation of major financing 
facilities;
treasury policies including 
foreign currency and interest rate 
exposure;

  discussion of any proposed 
qualification to the accounts;
  final approval of annual and 

interim reports and accounts and 
accounting policies;

  appointment/proposal of auditors;
  material charitable donations;
  approval and recommendation of 

dividends; and

  approval before each year starts of 
operating budgets for the year and 
periodic review during the year.

Liaison with investees:

liaison with investees regarding the 
Group’s financial commitments; 
and
liaison with investees regarding the 
Group’s working and net revenue 
interests.

General:
  governance of Company pension 
schemes and appointment of 
Company nominees as trustee; 
and

  allotment, calls or forfeiture of 

shares.

.046

HeiQ plcAnnual report and accounts 2020 
 
 
 
 
 
Corporate governance
Audit Committee Report

In the period between Re-admission 
on December 7, 2020 and December 
31, 2020, the Committee has met 
once, with both its members in 
attendance.

Karen Brade
Chair

On behalf of the Committee,  
I am pleased to present the Audit 
Committee Report for the year 
ended December 31, 2020.

There are two members of the Audit 
Committee. I chair the Committee 
and the other member is Benjamin 
Bergo. Our biographies setting out 
our skills and qualifications can  
be found on page 43 of this report. 
We are both non-executive 
Directors. It is intended that the 
Audit Committee meets at least 
twice a year and the Committee is 
responsible for ensuring that the 
Group’s financial performance is 
properly monitored, controlled and 
reported. I report to the Board after 
each Committee meeting and I will 
attend each Annual General 
Meeting of the Company. 

Duties of the Audit Committee
Internal control and risk assessment 
The Committee assists the Board in 
discharging its duty to ensure that the 
financial statements presented by the 
Company to its shareholders conform 
with all legal requirements and that 
the Company and its subsidiaries’ 
financial reporting and internal control 
policies and procedures for the 
identification, assessment and 
reporting of risks are adequate,  
by keeping such matters under  
review and making appropriate 
recommendations to the Board. The 
Committee also considers the major 
findings of internal investigations and 
responses of service providers and 
reviews its own performance, 
constitution and terms of reference.

External audit 
The Committee considers and makes 
recommendations to the Board 
regarding the appointment and 
reappointment of the Company’s 
external auditor, as well as any 
questions relating to their resignation or 
removal. The Committee oversees the 
relationship with the external auditor, 
including, but not limited to, the 
approval of their remuneration and 
terms of engagement, whether in 
relation to audit or non-audit services, 
and annually assesses the auditor’s 
independence, objectivity, qualifications, 
expertise, resources and effectiveness. 
The Audit Committee meets the external 
auditor at least twice a year and reviews 
the findings of the audit.

Financial statements 
The Committee monitors the integrity 
of the financial statements of the 
Company, including the annual and 
interim reports, preliminary results 
announcements and any other formal 
announcement relating to its financial 
performance. It reviews any significant 
financial reporting issues and 
judgments, and challenges, where 
necessary, the Company’s financial 
statements before submission to the 
Board. The Committee keeps under 
review the consistency of accounting 
policies and practices on a year-to-
year basis, and across the Company. 

The Company has implemented 
control procedures designed to 
ensure complete and accurate 
accounting for financial transactions 
and to limit the exposure to loss of 
assets and fraud. Measures taken 
include segregation of duties and 
reviews by management.

.047

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Corporate governance
Audit Committee Report continued

Anti-bribery
The Company has an anti-bribery and 
anti-corruption policy which sets out 
its zero-tolerance position and 
provides information and guidance to 
employees on how to recognize and 
deal with bribery and corruption 
issues. As the Committee has been 
established only upon Re-admission 
on December 7, 2020, no review of 
the policy and its effectiveness has 
taken place yet.

Assessment of the effectiveness of 
the Committee 
The Committee members feel that it  
is too early to have conducted a 
Committee evaluation but intends to 
take part in the Board and Committee 
internal evaluations planned for the 
latter part of 2021.

Karen Brade
Chair
April 23, 2021

Reporting responsibilities 
The Committee meets formally with 
the Board at least once a year to 
discuss matters such as the annual 
report and the relationship with the 
external auditor and also makes 
whatever recommendations to the 
Board it deems appropriate.

Internal audit and review of 
third-party service providers 
At present, the Company does not 
have an internal audit function. The 
decision of whether or not to set up an 
internal audit function will be made  
by the Board, on the recommendation 
of the Audit Committee, based on  
the growth of the Company, the scale, 
diversity and complexity of the 
Company’s activities and the number 
of employees, as well as cost and 
benefit considerations.

Work of the Audit Committee
For the period since establishment of 
the Committee on December 7, 2020 
the Audit Committee discharged its 
responsibilities by considering the 
following matters:

Significant issues in relation to the 
financial statements
When considering the financial 
statements, the Committee 
considered among others the issues 
set out in the table below.

External auditor
The Committee considered the 
independence and effectiveness of the 
external auditor. The annual report 
2020 is the first year Crowe U.K. LLP 
has been auditing and Ian Weeks has 
been the audit partner for the same 
period. The Committee was satisfied 
with the service provided by Crowe U.K. 
LLP and recommended that the Board 
should propose their reappointment at 
the forthcoming Annual General 
Meeting. When assessing the 
independence of the external auditor 
the Committee took into account the 
fees paid to Crowe U.K. LLP for 
non-audit services. The auditor has  
not provided any non-audit services  
to the Company since readmission  
on December 7, 2020.

Whistleblowing
The Company has a whistleblowing 
policy in place which sets out the 
formal process by which an employee 
of the Group may, in confidence, raise 
concerns about possible improprieties 
in financial reporting or other matters. 
As the Committee has been 
established only upon Re-admission 
on December 7, 2020, no review of 
the policy and its effectiveness has 
taken place yet.

Issue

How this was addressed

Annual Report  
and Accounts

The Committee was required to provide advice to the Board on whether the Annual Report and Accounts, taken  
as a whole, provide a fair, balanced and understandable assessment of the Company’s financial position and 
future prospects and provide all information necessary to a shareholder to assess the Group’s performance, 
business model and strategy.

The assessment was assisted by an internal verification of the factual content by management and a 
comprehensive review by the senior management team and the external auditors. 

Following its review, the Committee was of the opinion that the Annual Report and Accounts 2020 were 
representative of the year and present a fair, balanced and understandable overview, providing the necessary 
information for shareholders to assess the Group’s position and performance, business model and strategy. 

Financial  
Reporting

The Committee reviewed whether suitable accounting policies had been adopted, and whether management  
had made the appropriate estimates and judgments. In addition, support and assessment were sought from  
the external auditor. To do so, the Committee received presentations from the CFO and also received reports  
from the external auditor covering the key risk areas addressed during the year end audit, and the auditors’  
view of key judgments made by management.

Specific issues addressed by the Committee for the period ended December 31, 2020 included revenue 
recognition for take of pay contracts and provisions for expected credit losses.

Based upon the business assurance process and discussions with management and the external auditor,  
the Committee was satisfied that the accounting disclosures and assumptions were reasonable and appropriate 
for a business of the Group’s size and complexity, that the external auditor had fulfilled its responsibilities in 
scrutinising the financial statements for any material misstatements and that the disclosures were satisfactory.

.048

HeiQ plcAnnual report and accounts 2020Corporate governance
Nomination Committee Report

Esther Dale-Kolb
Chair

On behalf of the Committee, I am 
pleased to present the Nomination 
Committee Report for the year 
ended December 31, 2020.

There are three members of the 
Nomination Committee. I chair the 
Committee and the other members 
are Karen Brade and Benjamin 
Bergo. We are all non-executive 
Directors. The Committee meets at 
least annually, close to the end of 
each financial year, and at such 
other times as the Nomination 
Committee requires.

In the period between Re-admission 
on December 7, 2020 and 
December 31, 2020, the Committee 
has not held any meetings.

Duties of the Nomination 
Committee
Regular reviews 
The Committee reviews regularly, 
and at least annually, the time 
required from a non-executive 
Director and whether each 
non-executive Director is spending 
enough time to fulfill his or her 
duties. The Committee reviews the 
structure, size, composition, skills, 
knowledge and experience of the 
Board and the leadership needs of 
the Group to ensure that the Group 
continues to compete effectively in 
its marketplace. The Committee 
undertakes to consider its own 
performance, constitution and 
terms of reference and makes 
recommendations to the Board 
about any matters arising. 

Board appointments
The Committee is responsible for 
identifying and nominating, for the 
approval of the Board, candidates 
taken from a wide range of 
backgrounds to fill Board vacancies as 
and when they arise for any reason, 
including retirement by rotation. It 
evaluates, before making an 
appointment, the balance of skills, 
knowledge and experience on the 
Board and, in the light of this 
evaluation, prepares a description of 
the role and capabilities required for 
particular appointments. The 
Committee is required to give full 
consideration to succession planning 
in the course of its work, taking into 
account the challenges and 
opportunities facing the Group and 
the skills and expertise that will be 
needed on the Board in the future. 
The Committee ensures that, on 
appointment to the Board, non-
executive Directors receive a contract 
setting out clearly what is expected of 
them in terms of time commitments, 
Committee service and involvement 
outside of Board meetings. 

Recommendations to the Board 
The Committee undertakes to make 
recommendations to the Board about 
plans for an orderly succession of the 
Chairman and non-executive Directors 
and a formal, rigorous and 
transparent procedure to be used by 
them. The Committee also considers 
and recommends, if appropriate, the 
reappointment of any non-executive 
Director at the conclusion of their 
specified term of office or under the 
retirement by rotation provisions in 
the Company’s Articles of Association. 
The Committee considers and makes 
recommendations on the 
membership of the Audit Committee, 
the Nomination Committee and the 
Remuneration Committee in 
consultation with the Chairmen/ 
Chairwomen of those Committees.  
The Committee may also, at any time, 
recommend to the Board the 
appointment of additional non-
executive Directors and any Executive 
Directors (if such are considered  
to be appropriate).

Assessment of the effectiveness 
of the Committee 
The Committee members feel that it is 
too early to have conducted a 
Committee evaluation but intends to 
take part in the Board and Committee 
internal evaluations planned for the 
latter part of 2021.

Esther M. Dale-Kolb
Chair
April 23, 2020

.049

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Corporate governance
Remuneration Committee Report

Chair’s statement 
The Directors are pleased to present 
their annual report on remuneration 
for 2020. The aim of the 
Remuneration Committee is to set 
clear objectives for each individual 
Executive Director and executive 
management team member relating 
to the Company’s KPIs plus individual 
and strategic targets taking into 
account where an individual has 
particular influence and 
responsibility. As the Remuneration 
Committee was only established 
upon Re-admission on December 7, 
2020, targets for Executive Directors 
and management had not been 
defined by the Remuneration 
Committee itself. All five Directors  
of the Company, both executive and 
non-executive, are shareholders of 
the Group. During the year, the two 
Executive Directors were granted 
share options upon Re-admission  
to trading of the enlarged Group.

Directors’ remuneration policy 
The Company’s policy is to maintain 
levels of remuneration sufficient to 
attract, motivate and retain senior 
executives of the highest caliber  
who can deliver growth in shareholder 
value. Executive Directors’ 
remuneration currently consists of 
basic salary, benefits (including 
pensions allowance), performance-
related bonus and participation in  
a share option plan. 

The Company continues to seek to 
strike an appropriate balance between 
fixed and performance-related rewards, 
reinforcing a clear link between pay 
and performance. The performance 
targets for staff, senior executives  
and the Executive Directors continue  
to be aligned to the key drivers of the 
business strategy, thereby creating a 
strong alignment of interest between 
staff, Executive Directors and 
shareholders. The Remuneration 
Committee will continue to review the 
Company’s remuneration policy and 
make amendments, as and when 
necessary, to ensure it remains  
fit for purpose and continues to drive 
high levels of executive performance 
and remains both affordable and 
competitive in the market.

The policy is subject to shareholder 
approval through the votes cast at the 
upcoming AGM to be held on  
June 25, 2021.

Benjamin Bergo
Chair

Benjamin Bergo
Chair

Overview
The Remuneration Committee was 
established upon Re-admission of 
trading of the enlarged Group as of 
December 7, 2020. The Committee 
comprises two non-executive 
Directors, Benjamin Bergo (Chair) 
and Esther Dale-Kolb, and one 
Executive Director, Carlo Centonze.

In the remaining period to 
December 31, 2020, no meetings 
of the Remuneration Committee 
were held. Going forward, the 
Remuneration Committee will meet 
at least annually, and the 
Committee Chair shall attend each 
Annual General Meeting of the 
Company. No one shall be present 
during the discussion of, or vote on, 
matters regarding her/his own 
position. The Chairwoman of the 
Board shall not chair the Committee 
meeting when it is dealing with the 
appointment of her successor.

Summary of the Committee’s 
responsibilities
The Committee’s responsibilities 
include the following:
  Regular reviews – to regularly 
review: the time required from 
a non-executive Director and 
whether each non-executive 
Director is spending enough 
time fulfilling his or her duties; 

comparable Company data to 
ensure that the Board is being 
adequately remunerated and 
to a level which will allow the 
Company to attract new Directors, 
the Remuneration Committee’s 
own performance, constitution 
and terms of reference and 
remuneration to ensure it is 
aligned to the implementation of 
the Company strategy and effective 
risk management, taking into 
account the views of shareholders 
and consultants as required. 
  Recommendations to the Board 
– to make recommendations 
about matters arising from the 
Remuneration Committee’s regular 
reviews and the annual review of 
fees paid to the Board and any 
changes to the current levels of 
remuneration.

  Option Scheme awards – to make 
all decisions relating to awards to 
be made to Executive Directors 
under the Option Scheme.
  Other matters – to make a 

statement in the annual report, 
to keep up to date and fully 
informed about strategic issues 
and commercial changes affecting 
the Company and the market in 
which it operates and to ensure an 
annual review of the Board and its 
operations is undertaken.

.050

HeiQ plcAnnual report and accounts 2020Policy table
Base salary

Purpose and link  
to strategy

To provide fixed remuneration to:
  help recruit and retain key individuals; and

reflect the individual’s experience, role, rank and 
contribution within the Company.

Operation

The Remuneration Committee takes into account a 
number of factors when setting salaries, including:

Salaries are reviewed, but not necessarily increased,
annually with any increase usually taking effect in Q1.

the scope and complexity of the role;
the skills and experience of the individual;

  salary levels for similar roles within the industry;
  pay elsewhere in the Company.

Performance 
conditions

None

Maximum 
opportunity

The current base salaries of the Directors can be 
found in the Directors’ Remuneration section.

Other benefits

Purpose and link  
to strategy

To provide a basic benefits package, in order to help 
recruit and retain key individuals.

Operation

The Group may provide Directors and management 
as well as employees with accident insurance, 
pension insurance and similar benefits in line with 
legal requirements in the jurisdiction of employment 
of the respective employee. 

Performance 
conditions

None

Maximum 
opportunity

Maximum opportunity will be the expense of providing 
the benefit. 

Annual bonus

Purpose and link  
to strategy

Operation

Performance 
conditions

To incentivize and reward the achievement of annual 
financial, operational and individual objectives which 
are key to the delivery of the Company’s short-term 
strategy.

Executive Directors and staff are eligible to participate 
in a discretionary bonus plan.
  Maximum bonus levels and the proportion payable 

for on-target performance are considered in 
the light of market bonus levels for similar roles 
among the industry sector. 

  From 2021 objectives will be set annually to 

ensure that they remain targeted and focused on 
the delivery of the Company’s short-term goals, 
which will usually be based on the annual budget.
  The Remuneration Committee sets targets which 
require appropriate levels of performance, taking 
into account internal and external expectations of 
performance.

At least 60% of the award will be assessed against 
Company metrics including operational, financial and 
non-financial performance. The remainder of the 
award will be based on performance against 
individual objectives.

Maximum 
opportunity

The maximum potential bonus entitlement for 
Executive Directors under the plan is up to 100% of 
base salary.

The Board retains discretion to make higher 
increases in certain circumstances, for example, 
following an increase in the scope and/or 
responsibility of the role or the development of the 
individual in the role or by benchmarking.

As soon as practicable after the year end, the 
Remuneration Committee meets to review 
performance against objectives and determines 
payout levels.

A sliding scale of between 0% and 100% of the 
maximum award is paid dependent on the level of 
performance.

.051

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020 
 
 
Corporate governance
Remuneration Committee Report continued

Share Option Plan

Purpose and link  
to strategy

Operation

Performance 
conditions

  To incentivize and reward the creation of long-term 

shareholder value.

  To align the interests of the eligible employees with 

those of shareholders.

  To help recruit and retain key individuals.

Under the terms of the share option plan (the “Share 
Option Plan”), the Remuneration Committee may 
issue options over shares up to 10% of the issued 
share capital of the Company from time to time. 
Executive Directors and employees are eligible  
for awards.

Vesting of the awards is dependent on financial, 
operational and/or share price measures, as set by 
the Remuneration Committee, which are aligned with 
the long-term strategic objectives of the Company. 

The exercise of options may be subject to the 
satisfaction of such performance conditions, if any,  
as may be specified and subsequently varied and/or 
waived by the Remuneration Committee.

The relevant performance conditions will be set  
by the Remuneration Committee on the award  
of each grant.

Annual report on Directors’ remuneration (audited)
All current Directors have taken office upon Re-admission of the enlarged Group for trading on December 7, 2020. The 
Executive Directors are employed under a service agreement, which is capable of termination by either party giving 12 
months’ notice in writing. The non-executive Directors are employed under service agreements with notice periods of 
three months. The non-executive Directors are required to retire and seek re-election by the shareholders at the next 
AGM, which is expected to take place on June 25, 2021, and at any subsequent AGM as required by the Articles or as the 
Board resolves. The Articles require all Directors to retire and seek re-election at the second AGM or general meeting (as 
the case may be) at which he or she was previously appointed.

The Executive Directors have – in addition to the Director’s service agreement – entered into employment contracts with 
HeiQ Materials AG with aligned terms in regard to notification periods. The disclosed emoluments include the total 
compensation under both agreements. 

Directors’ emoluments for the year were as follows:

Currency 
of 
payment

Carlo 
Centonze

Xaver 
Hangartner

Esther 
Dale-Kolb

Karen Brade

Benjamin 
Bergo

CHF
GBP

CHF
GBP

CHF
GBP

CHF
GBP

CHF
GBP

Salary/Fee

Pension benefits

Cash bonus payments

Total

2020

2019

2020

2019

2020

2019

2020

2019

208’800.00
2’397.26

208’800.00
–

16’070.00
–

16’328.00
–

17’400.00
–

162’400.00
2’397.26

141’850.00
–

7’928.00
–

6’955.00
–

27’066.70
–

–
4’794.52

–
12’739.73

–
2’739.73

–
– 

–
– 

–
– 

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–
–

242’270.00 225’128.00

2’397.26

197’394.70 148’805.00

2’397.26

–
4’794.52

–
12’739.73

–
2’739.73

–
–

–
–

–
–

.052

HeiQ plcAnnual report and accounts 2020Before the reverse takeover of Auctus Growth Plc and the respective Re-admission to trading of the enlarged Group, the 
HeiQ Materials AG compensation structure for Board of Directors members and key employees included share-based 
payments with HeiQ Materials AG shares. Since Re-admission however, this share-based compensation is no longer in 
place. The number of shares and the value accounted for in the financial statements of the enlarged Group are as follows:

Share-based payment (HeiQ Materials AG shares)

Carlo Centonze

Xaver Hangartner

Esther Dale-Kolb

Karen Brade

Benjamin Bergo

Year

2020
2019

2020
2019

2020
2019

2020
2019

2020
2019

Number of shares  
allocated

3’600
1’000

2’000
600

250
–

–
–

500
250

Value included in  
the financial  
statements (CHF)

234’000.00
65’000.00

130’000.00
39’000.00

16’250.00
–

–
–

32’500.00
16’250.00

The Directors’ interests for disclosure purposes are as follows (audited):

Numbers of shares 
held as of 
Re-admission 
December 7, 2020

Number of options 
granted as of 
Re-admission 
December 7, 2020

Total beneficial 
interest as of 
December 7, 2020

Shares purchased/
sold on market 
December  
7 – 31, 2020

Total beneficial 
interest as of 
December 31, 2020

% shares and 
options held of total 
shares in issue as at 
December 31, 2020

Carlo Centonze1
Xaver Hangartner
Esther Dale-Kolb
Karen Brade
Benjamin Bergo

14’523’362
493’746
902’986
–
284’853

1’120’000
1’120’000
–
–
–

15’643’362
1’613’746
902’986
–
284’853

–
–
–
7’976
–

15’643’362
1’613’746
902’986
7’976
284’853

12.43%
1.28%
0.72%
0.01%
0.23%

1. Including shares owned by close relatives and controlled entities.

Share options issued in 2020 are subject to the following conditions:

Exercise price

Employment period

Performance conditions

£1.23 per option share

Three years

  65% of the options are conditional upon sales growth targets
  35% of the options are conditional upon annual operating 

margin targets

Changes of conditions compared to prior year/since grant date 

None

Share options awarded to Executive Directors in the year are as follows:

Carlo Centonze
Xaver Hangartner

No share options have been awarded to non-executive Directors.

2020

1’120’000
1’120’000

2019

–
–

Payments to past Directors (audited)
Ross Ainger, former director of Auctus Growth Plc until December 7, 2020, was paid a director’s fee of £20’000 for his 
services during 2020. In addition, consultancy fees amounting to £40’000 relating to work undertaken on the reverse 
takeover of HeiQ Materials AG were paid by Auctus Growth Plc to RFA Consulting Limited, a company of which Ross Ainger 
is a director. 

Payments for loss of office (audited) 
No payments were made to Directors for loss of office in the year.

.053

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Corporate governance
Directors’ Report

The Directors’ Report for the year ended December 31, 2020 comprises pages 
54 to 55 of this report, together with the sections of the annual report 
incorporated by reference.

Directors
The names and biographical details of the current Directors are shown on 
pages 42 to 43 of this report.

Changes during the year/period under review are as follows:

Name

Date of appointment

Date of resignation

Benjamin Bergo
Karen Brade
Carlo Centonze
Esther Dale-Kolb
Xaver Hangartner
Ross Ainger
Michael Burne
Charles Cannon-Brookes
Nathan Steinberg

December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
December 7, 2020
January 10, 2020

December 7, 2020
December 7, 2020
January 10, 2020
December 7, 2020

Particulars of the Directors’ 
emoluments and their beneficial and 
non-beneficial interests in the shares 
of the Company are shown on pages 
52 to 53.

Political donations
The Company made no political 
donations and incurred no political 
expenditure during the year/period 
under review.

Dividend
The Directors have declared that no 
dividend would be paid in year 2021. 

Post balance sheet events
In March 2021 the Company acquired 
51% of Belgian industrial biotech 
company Chrisal NV, which is active in 
the research, development and 
manufacturing of products with 
probiotics and symbiotic ingredients.

Substantial interests
Information provided to the Company 
pursuant to the Financial Conduct 
Authority’s (FCA) Disclosure Guidance 
and Transparency Rules (DTRs) is 
published on a Regulatory Information 
Service and on the Company’s 
website. As at April 23, 2021, the 
following information has been 
received, in accordance with DTR 5, 
from holders of notifiable interests in 
the Company’s issued share capital. 

Powers of the Directors
The Directors manage the business 
under the powers set out in the 
Company’s Articles of Association. 
These powers include the ability to 
issue or buy back shares. 

Shareholders’ authority to empower 
the Directors to buy back up to 10%  
of the Company’s issued share capital 
will be sought at the Annual General 
Meeting. The Company’s Articles of 
Association can only be amended, or 
new Articles adopted, by a resolution 
passed by shareholders in a general 
meeting by at least three-quarters of 
the votes cast.

Directors’ indemnity provisions
Throughout the year/period under 
review the Company has maintained 
directors’ and officers’ liability 
insurance cover in respect of the acts 
or omissions of its Directors and 
continues to do so. Details of the 
policy are provided to new Directors 
on appointment. In common with 
other companies, the Group has 
made qualifying third-party indemnity 
provisions for the benefit of its 
Directors against liabilities incurred  
in the execution of their duties.

.054

HeiQ plcAnnual report and accounts 2020Notifiable interest

Amati Global Investors Limited
Carlo Centonze
Dr. Murray Height
Premier Miton Group plc
Bombyx Growth Fund SC
FIL Limited
Cortegrande AG1
Darren Morcombe
Mike Smith

Voting rights

11,607,000
8,667,909
8,018,063
6,827,500
6,407,120
5,357,000
5,186,237
5,019,486
4,268,628

% of capital 
disclosed

9.14%
6.83%
6.31%
5.38%
5.05%
4.22%
4.08%
3.95%
3.36%

Nature of holding

Ordinary shares
Ordinary shares
Ordinary shares
Ordinary shares
Ordinary shares
Ordinary shares
Ordinary shares
Ordinary shares
Ordinary shares

1. A company wholly owned by Carlo Centonze and of which he is the sole director.

Other information relevant to this Directors’ Report can be found on the 
following pages of this report:

Topic

Share capital
Future developments
Research and development
Financial instruments
Employee share option schemes
Restrictions on voting rights
Branches outside the UK
Environmental matters

Annual General Meeting
The Company’s Annual General 
Meeting will be held at Ruetistrasse 
12, 8952 Schlieren (Zurich) 
Switzerland, with a satellite meeting 
place at the offices of Charles Russell 
Speechlys LLP, 5 Fleet Place, London 
EC4M 7RD on Friday 25 June 2021 at 
11.00 a.m. Swiss time/10.00 a.m. 
London time. The AGM is being held 
at the Company’s offices in Zurich to 
ensure that the Executive Directors 
and the Chair are able to attend the 
AGM in person, given the current 
ever-changing travel restrictions 
imposed by governments and the 
potential that further restrictions may 
come into force before the date of  
the Meeting. 

Disclosure of information  
to the auditors
The Directors, who were in office on 
the date of the approval of this report, 
confirm that, so far as they are aware, 
there is no relevant audit information 
of which the Company’s auditor is 
unaware and that they have taken all 
reasonable steps to make themselves 
aware of any relevant audit 
information and to establish that the 
Company’s auditor is aware of that 
information.

Page(s)

87
22
12
93
87
105
107
26

Statement of Directors’ 
responsibilities in respect of  
the annual report and financial 
statements
The Directors are responsible for 
preparing the annual report and the 
Consolidated Financial Statements in 
accordance with applicable law and 
regulations. 

The Directors of the Company are 
responsible for preparing the financial 
information in accordance with 
International Financial Reporting 
Standards (IFRSs).

The Directors must not approve the 
financial statements unless they are 
satisfied that they give a true and fair 
view of the state of affairs of the 
Group and of the profit or loss of the 
Group for that period. In preparing 
these financial statements, the 
Directors are required to: 
  select suitable accounting policies 
and then apply them consistently; 

  make judgments and estimates 

that are reasonable and prudent; 

  state whether they have been 
prepared in accordance with 
IFRSs; and 

  prepare the financial statements 

on the going concern basis unless 
it is inappropriate to presume 
that the Company will continue in 
business.

The Directors are responsible for 
keeping adequate accounting records 
that are sufficient to show and explain 
the Company’s transactions and 
disclose with reasonable accuracy  
at any time the financial position of 
the Company. They have general 
responsibility for taking such steps  
as are reasonably open to them to 
safeguard the assets of the Company 
and to prevent and detect fraud and 
other irregularities. 

The Directors are responsible for the 
maintenance and integrity of the 
corporate and financial information 
included on the Company’s website. 
Legislation in the UK governing the 
preparation and dissemination of 
financial statements may differ from 
legislation in other jurisdictions.

Directors’ responsibilities  
pursuant to DTR4
The Directors confirm to the best of 
their knowledge:

the financial statements have been 
prepared in accordance with IFRSs 
and Article 4 of the IAS regulation 
and give a true and fair view of the 
assets, liabilities, financial position 
and profit or loss of the Group; and
the management report includes a 
fair review of the development and 
performance of the business and 
the financial position of the Group, 
together with a description of the 
principal risks and uncertainties 
that they face.

Ross Ainger
Company Secretary
April 23, 2020

.055

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020 
 
Financial statements
Independent Auditor’s Report to the Members of HeiQ plc

Opinion
We have audited the financial statements of HeiQ plc 
(the “Parent Company”) and its subsidiaries (together 
the “Group”) for the period ended December 31, 2020 
which comprise:
•  the Consolidated Statement of Comprehensive 
Income for the year ended December 31, 2020;
•  the Consolidated and Company Statements of 
Financial Position as at December 31, 2020;

•  the Consolidated and Company Statements of Cash 

Flows for the year then ended

•  the Consolidated Statement and Company 

Statements of Changes in Equity for the year then 
ended; and 

•  the notes to the financial statements, including a 

summary of significant accounting policies. 

The financial reporting framework that has been 
applied in their preparation is applicable law and 
International Financial Reporting Standards (IFRSs) as 
adopted by the European Union.

In our opinion the financial statements:
•  give a true and fair view of the state of affairs of the 
Group and of the Parent Company as at December 
31, 2020 and of the Group’s profit for the year then 
ended;

•  have been properly prepared in accordance with 
International Financial Reporting Standards in 
conformity with the requirements of the Companies 
Act 2006 and international financial reporting 
standards adopted pursuant to Regulation (EC) 
No.1606/2002 as it applies to the European Union;

•  have been prepared in accordance with the 

requirements of the Companies Act 2006 and, as 
regards the Group financial statements, Article 4 of 
the IAS Regulation.

Basis for opinion
We conducted our audit in accordance with 
International Standards on Auditing (UK) (ISAs (UK)) 
and applicable law. Our responsibilities under those 
standards are further described in the Auditor’s 
responsibilities for the audit of the financial statements 
section of our report. We are independent of the Group 
and the Parent Company in accordance with the ethical 
requirements that are relevant to our audit of the 
financial statements in the UK, including the FRC’s 
Ethical Standard, and we have fulfilled our other ethical 
responsibilities in accordance with these requirements. 

We believe that the audit evidence we have obtained  
is sufficient and appropriate to provide a basis for  
our opinion.

Conclusions relating to going concern 
In auditing the financial statements, we have concluded 
that the Directors’ use of the going concern basis of 
accounting in the preparation of the financial 
statements is appropriate. 

Based on the work we have performed, we have not 
identified any material uncertainties relating to events  
or conditions that, individually or collectively, may cast 
significant doubt on the Group and Parent Company’s 
ability to continue as a going concern for 12 months from 
the date the Annual Report and accounts are signed.

Overview of our audit approach
Materiality 
In planning and performing our audit we applied the 
concept of materiality. An item is considered material  
if it could reasonably be expected to change the 
economic decisions of a user of the financial 
statements. We apply the concept of materiality both  
in planning and performing our audit to evaluate the 
results arising from undertaking our planned testing 
procedures and the impact of any unadjusted 
misstatements arising therefrom. Importantly, 
misstatements below the assessed level of materiality 
will not necessarily be evaluated as immaterial as we 
also take account of the nature of identified 
misstatements, and the particular circumstances of 
their occurrence, when evaluating their effect on the 
financial statements as a whole.

Materiality for the Group was set at US$445’000 and 
was based upon approximately 5% of profit before tax. 
We applied this benchmark as we believe it represents 
the key measure by which the Group’s performance is 
evaluated. Materiality for the Parent Company financial 
statements was set at US$400’000, determined with 
reference to a benchmark of Parent Company total 
assets. It represents 2% of total assets, a key metric 
given the investment held in its subsidiary. 

We use a different level of materiality (“performance 
materiality”) to determine the extent of our testing for 
the audit of the financial statements. Performance 
materiality is set based on the financial statement 
materiality as adjusted for the judgments made as to 
the entity risk and our evaluation of the specific risk of 
each audit area having regard to the internal control 
environment. On the basis of our risk assessment of 
the Group’s overall control environment, our judgment 
was that Group performance materiality was 75% of 
our planning materiality, namely US$333’750 (2019: 
not reported). Parent Company performance materiality 
was set at US$300’000 (2019: not reported). Where 
considered appropriate, performance materiality may 
be reduced to a lower level, such as for related party 
transactions and Directors’ remuneration. 

.056

HeiQ plcAnnual report and accounts 2020Based on this understanding we assessed those 
aspects of the Group and Parent Company’s 
transactions and balances which were most likely to 
give rise to a material misstatement and were most 
susceptible to irregularities including fraud or error. 
Specifically, we identified what we considered to be key 
audit matters and planned our audit approach 
accordingly.

Key audit matters
Key audit matters are those matters that, in our 
professional judgment, were of most significance in our 
audit of the financial statements of the current period 
and include the most significant assessed risks of 
material misstatement (whether or not due to fraud) 
that we identified. These matters included those which 
had the greatest effect on: the overall audit strategy; 
the allocation of resources in the audit; and directing 
the efforts of the engagement team. These matters 
were addressed in the context of our audit of the 
financial statements as a whole, and in forming our 
opinion thereon, and we do not provide a separate 
opinion on these matters. 

We agreed with the Audit Committee to report to it all 
identified errors in excess of US$20’000 (2019: not 
reported). Errors below that threshold would also be 
reported to it if, in our opinion as auditor, disclosure 
was required on qualitative grounds.

Where comparative materiality figures are referred to, 
these were set by the previous auditor.

Overview of the scope of our audit
Our audit approach was developed by obtaining an 
understanding of the Group structure, the activities of 
each entity, the jurisdiction and regulatory environment 
in which each entity operates. 

Through this understanding we identified the following 
key audit components:
•  HeiQ plc, the Parent Company;
•  HeiQ Materials AG, a Swiss corporation based in 
Zurich that manufactures and develops specialist 
textiles and acts as holding company for the rest of 
the Group; and,

•  HeiQ ChemTex Inc, a US corporation specializing  
in carpet research and development, production  
and trading.

These components account for 96% of income 
receivable and 98% of net assets as represented 
within the Group financial statements. 

A full scope audit for Group purposes was applied to all 
Group entities and was performed by the audit 
engagement team. Due to Covid-19 related travel 
restrictions we were unable to conduct physical site 
visits from the UK. We accessed supporting 
documentation via document sharing platforms and 
arranged for local members of the Crowe Global 
International network to attend physical stock counts.

We gained an understanding of:
•  the nature of the activities;
•  the nature, scale, complexity and level of judgment 
of the transactions and balances of the Group; and

•  the overall control environment and the level of 
oversight of the Board in respect of outsourced 
activities.

.057

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Independent Auditor’s Report to the Members of HeiQ plc continued

The key audit matters we identified and how the scope of our audit responded to these is set out below.  
The following table is limited to key audit matters and is not a complete list of all risks identified by our audit.

Key audit matter

How the scope of our audit addressed the key audit matter

Revenue recognition 
The Group has a number of sources of 
income. Its main income is derived by the 
sale of functional chemicals and 
functional consumer goods. Revenue for 
the sale of goods is generally recognized 
on despatch, but as some ‘take or pay’ 
arrangements exist, judgment is required 
in determining accrued income.

The Group also has service income 
including product development 
agreements which cover multiple periods. 
Judgment is required to determine stage 
of completion under these agreements.

Carrying value of intangible assets may 
be overstated
The Group has both internally generated 
development assets and acquired 
intangible assets arising on the 
acquisition of some of its subsidiaries. 

Judgment is required in determining 
whether a need for an impairment 
provision arises. 

Inventory existence and valuation
The Group has material levels of 
inventory in multiple locations. A risk 
exists that profit is manipulated by 
overstating inventory either by 
overstating physical quantities or by 
overvaluing individual inventory items. 

.058

We gained an understanding of:
•  the principal terms and conditions relating to each income stream; 

and 

•  the controls and review procedures applied by the Group to 

identify the right to and recognition of income. 

Based on that understanding we:
•  evaluated and tested the operation of the key controls; 
•  performed analytical review procedures to determine whether 
movements are consistent with our knowledge of the business 
and results for the year. Investigated reasons for any deviations 
from expectation corroborating explanations provided; 

•  reviewed the basis for recognising accrued income focusing on 
non-standard arrangements including ‘take or pay’, product 
development and grant income; and

•  agreed a sample of transactions to supporting documentation. 

We have no adverse findings to report from our testing of revenue.

We reviewed the Board’s assessment of the carrying value of the 
intangible assets. We split our work between intangibles arising from 
acquisitions and those that were internally generated.

For internally generated development expenditure we:
•  evaluated and tested the operation of the key controls 
implemented to assess the development projects; 

•  discussed with key operational staff and scientists the technical 

feasibility of the projects on a sample basis; and

•  obtained current and budgeted profitability of a sample of the 

products under development to assess their commercial viability.

For acquired intangible assets we:
•  evaluated and tested the operation of the key controls 

implemented to identify potential impairments;

•  obtained the Board’s impairment review calculation and confirmed 

its arithmetical accuracy; and

•  challenged the basis for key assumptions and agreed them to 

supporting evidence.

We have no adverse findings to report from our testing of intangible 
assets.

We gained an understanding of: 
•  the nature and location of the Group’s inventory holdings;
•  the basis of valuation of inventory; and
•  the controls applied by the Group to ensure that inventory is 

accurately recorded in the accounting records.

Based on that understanding we:
•  evaluated and tested the operation of the key controls; 
•  obtained and agreed year-end inventory reconciliations to the 

accounting records;

•  performed in-person inventory sample counts in the Swiss entity 
and remote sample counts for the US and Spanish entities via 
video link to confirm existence;

•  obtained direct confirmation of inventory held by third parties;
•  agreed a sample of inventory items to purchase invoices to 

confirm cost and to subsequent sales invoices to confirm that cost 
was not greater than net realisable value; and

•  reviewed the inventory ageing reports for potentially unsaleable 

items and compared this to inventory provisions.

We have no adverse findings to report from our testing of inventory.

HeiQ plcAnnual report and accounts 2020Our audit procedures in relation to these matters were 
designed in the context of our audit opinion as a whole. 
They were not designed to enable us to express an 
opinion on these matters individually and we express 
no such opinion.

Other information
The Directors are responsible for the other information. 
The other information comprises the information 
included in the annual report, other than the financial 
statements and our auditor’s report thereon. Our 
opinion on the financial statements does not cover the 
other information and, except to the extent otherwise 
explicitly stated in our report, we do not express any 
form of assurance conclusion thereon.

In connection with our audit of the financial 
statements, our responsibility is to read the other 
information and, in doing so, consider whether the 
other information is materially inconsistent with the 
financial statements or our knowledge obtained in the 
audit or otherwise appears to be materially misstated. 
If we identify such material inconsistencies or apparent 
material misstatements, we are required to determine 
whether there is a material misstatement of the 
financial statements or a material misstatement of the 
other information. If, based on the work we have 
performed, we conclude that there is a material 
misstatement of this other information, we are required 
to report that fact. 

We have nothing to report in this regard. 

Opinions on other matters prescribed by the 
Companies Act 2006 
In our opinion, the part of the Directors’ remuneration 
report to be audited has been properly prepared in 
accordance with the Companies Act 2006.
In our opinion, based on the work undertaken in the 
course of the audit: 
•  the information given in the Strategic Report and 

the Directors’ Report for the financial year for which 
the financial statements are prepared is consistent 
with the financial statements;

•  the Strategic Report and the Directors’ Report have 
been prepared in accordance with applicable legal 
requirements.

Matters on which we are required to report by 
exception
In the light of the knowledge and understanding of the 
Group and the Parent Company and its environment 
obtained in the course of the audit, we have not 
identified material misstatements in the Strategic 
Report or the Directors’ Report. 

We have nothing to report in respect of the following 
matters in relation to which the Companies Act 2006 
requires us to report to you if, in our opinion:
•  adequate accounting records have not been kept by 
the Parent Company, or returns adequate for our 
audit have not been received from branches not 
visited by us; or

•  the Parent Company financial statements and the 
part of the Directors’ remuneration report to be 
audited are not in agreement with the accounting 
records and returns; or

•  certain disclosures of Directors’ remuneration 

specified by law are not made; or

•  we have not received all the information and 

explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Directors’ responsibilities 
statement set out on page 55, the Directors are 
responsible for the preparation of the financial 
statements and for being satisfied that they give a true 
and fair view, and for such internal control as the 
Directors determine is necessary to enable the 
preparation of financial statements that are free from 
material misstatement, whether due to fraud or error. 

In preparing the financial statements, the Directors are 
responsible for assessing the Group’s and the Parent 
Company’s ability to continue as a going concern, 
disclosing, as applicable, matters related to going 
concern and using the going concern basis of 
accounting unless the Directors either intend to 
liquidate the Group or the Parent Company or to cease 
operations, or have no realistic alternative but to do so.

.059

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Independent Auditor’s Report to the Members of HeiQ plc continued

Audit response to risks identified 
As a result of performing the above, we identified 
valuation of intangibles, recognition of income and 
inventory existence and valuation as key audit matters 
and our response to this risk is set out on the following 
page. 

In addition to the above, our procedures to respond to 
risks identified included the following: 
•  reviewing the financial statement disclosures and 
testing to supporting documentation to assess 
compliance with relevant laws and regulations 
discussed above; 

•  performing analytical procedures to identify any 
unusual or unexpected relationships that may 
indicate risks of material misstatement due to fraud; 

•  reading minutes of meetings of those charged with 
governance and reviewing correspondence with 
HMRC; and 

•  in addressing the risk of fraud through management 
override of controls, testing the appropriateness of 
journal entries and other adjustments; assessing 
whether the judgments made in making accounting 
estimates are indicative of a potential bias; and 
evaluating the business rationale of any significant 
transactions that are unusual or outside the normal 
course of business. 

We gained an understanding of the legal and regulatory 
framework applicable to the Group and the industry in 
which it operates, and considered the risk of acts by 
the Group which were contrary to applicable laws and 
regulations, including fraud. These included but were 
not limited to compliance with Companies Act 2006, 
the FCA Listing Rules, the principles of the QCA Code 
and International Financial Reporting Standards. 

We designed audit procedures to respond to the risk, 
recognising that the risk of not detecting a material 
misstatement due to fraud is higher than the risk of not 
detecting one resulting from error, as fraud may involve 
deliberate concealment by, for example, forgery, 
misrepresentations or through collusion. 

We focused on laws and regulations that could give rise 
to a material misstatement in the Group’s financial 
statements. Our tests included, but were not limited to:
•  agreement of the financial statement disclosures to 

underlying supporting documentation; 

•  enquiries of management; 
•  review of minutes of Board meetings throughout the 

period; and 

•  considering the effectiveness of the control 

environment in monitoring compliance with laws and 
regulations. 

A further description of our responsibilities for the audit 
of the financial statements is located on the Financial 
Reporting Council’s website at: www.frc.org.uk/
auditorsresponsibilities. This description forms part of 
our auditor’s report. 

Auditor’s responsibilities for the audit of the 
financial statements
Our objectives are to obtain reasonable assurance 
about whether the financial statements as a whole are 
free from material misstatement, whether due to fraud 
or error, and to issue an auditor’s report that includes 
our opinion. Reasonable assurance is a high level of 
assurance, but is not a guarantee that an audit 
conducted in accordance with ISAs (UK) will always 
detect a material misstatement when it exists. 
Misstatements can arise from fraud or error and are 
considered material if, individually or in the aggregate, 
they could reasonably be expected to influence the 
economic decisions of users taken on the basis of 
these financial statements.

Extent to which the audit is capable of detecting 
irregularities, including fraud
Irregularities, including fraud, are instances of non-
compliance with laws and regulations. We design 
procedures in line with our responsibilities, outlined 
above, to detect irregularities, including fraud. The risk 
of not detecting a material misstatement due to fraud 
is higher than the risk of not detecting one resulting 
from error, as fraud may involve deliberate 
concealment by, for example, forgery or intentional 
misrepresentations, or through collusion. The extent to 
which our procedures are capable of detecting 
irregularities, including fraud, is detailed below.

However, the primary responsibility for the prevention 
and detection of fraud rests with both those charged 
with governance of the Parent Company and 
management.

In identifying and assessing risks of material 
misstatement in respect of irregularities, including 
fraud and non-compliance with laws and regulations, 
our procedures included the following: 
•  enquiring of the Company Secretary and the Audit 
Committee, including obtaining and reviewing 
supporting documentation, concerning the Group’s 
policies and procedures relating to: 
–  identifying, evaluating and complying with laws 
and regulations and whether they were aware of 
any instances of non-compliance; 

–  detecting and responding to the risks of fraud 

and whether they have knowledge of any actual, 
suspected or alleged fraud; and

–  the internal controls established to mitigate risks 
related to fraud or non-compliance with laws and 
regulations.

•  discussing among the engagement team on how 
and where fraud might occur in the financial 
statements and any potential indicators of fraud. As 
part of this discussion, we identified potential for 
fraud in the valuation of intangible assets, valuation 
and existence of inventory and recognition of 
income; and 

•  obtaining an understanding of the legal and 

regulatory frameworks that the Group operates in, 
focusing on those laws and regulations that had a 
direct effect on the financial statements or that had 
a fundamental effect on the operations of the 
Group. The key laws and regulations we considered 
in this context included the UK Companies Act and 
the Listing Rules.

.060

HeiQ plcAnnual report and accounts 2020Other matters which we are required to address
We were appointed by the Audit Committee on 
December 15, 2020. The period of total uninterrupted 
engagement is less than a year, covering the year 
ended December 31, 2020. 

The non-audit services prohibited by the FRC’s Ethical 
Standard were not provided to the Group or the Parent 
Company and we remain independent of the Group and 
the Parent Company in conducting our audit. 

Our audit opinion is consistent with the additional 
report to the Audit Committee.

Use of our report
This report is made solely to the Company’s members, 
as a body, in accordance with Chapter 3 of Part 16 of 
the Companies Act 2006. Our audit work has been 
undertaken so that we might state to the Company’s 
members those matters we are required to state to 
them in an auditor’s report and for no other purpose.  
To the fullest extent permitted by law, we do not accept 
or assume responsibility to anyone other than the 
Company and the Company’s members as a body, for 
our audit work, for this report, or for the opinions we 
have formed.

Ian Weekes
Senior Statutory Auditor
April 23, 2021

For and on behalf of
Crowe U.K. LLP
55 Ludgate Hill
London
EC4M 7JW

.061

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Consolidated Statement of Comprehensive Income 
For the year ended December 31, 2020

Revenue
Cost of sales

Gross profit
Other operating income
Selling and general administrative expenses
Other operating expenses

Operating profit

Deemed cost of listing
Transaction costs of relisting
Other income
Other costs
Finance income
Finance costs
Share of (losses)/profits of associates

Income before taxation
Taxation

Income after taxation

Earnings per share (cents) – basic

Earnings per share (cents) – diluted

Other comprehensive income:
Exchange differences on translation of foreign operations 

Items that may be reclassified to profit or loss in subsequent periods 
Actuarial losses from defined benefit pension plans

Items that will not be reclassified to profit or loss in subsequent periods 

Total comprehensive income for the year

Income attributable to:
Equity holders of HeiQ
Non-controlling interests

Comprehensive income/(loss) attributable to:
Equity holders of the Company
Non-controlling interests

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

Note

8
9

8
9
9

5
5

22
22
7

10

11

11

 50’401 
 (22’402)

27’999
 4’744 
 (16’117)
 (5’127)

 11’499 

 (1’402)
 (1’871)
 – 
 (69)
 68 
 (1’184)
 (15)

 7’026 
 (2’112)

 4’914 

4.41

4.21

 2’469 

 2’469 
 (731)

 (731)

 6’652 

4’991
 (77)

4’914

6’729
(77)

6’652

27’954
(14’382)

13’572
1’585
(12’048)
(1’687)

1’422

–
–
24
–
8
(428)
3

1’029
(314)

715

0.71

0.71

53

53
(205)

(205)

563

726
(11)

715

574
(11)

563

.062

HeiQ plcAnnual report and accounts 2020Consolidated Statements of Financial Position 
As at December 31, 2020

ASSETS
Intangible assets
Property, plant and equipment
Right-of-use assets
Investments
Deferred tax assets
Other non-current assets

Non-current assets

Inventories
Trade receivables
Other receivables and prepayments
Cash and cash equivalents

Current assets

Total assets

EQUITY AND LIABILITIES
Share capital
Capital reserve
Other reserve
Share-based payment reserve
Merger reserve
Currency translation reserve
Retained deficit

Equity attributable to owners of the parent

Non-controlling interests

Total equity 

Lease liabilities
Deferred tax liability
Long-term borrowings
Other non-current liabilities

Total non-current liabilities

Trade and other payables
Accrued liabilities
Income tax liability
Deferred revenue
Short-term borrowings
Lease liabilities
Other current liabilities

Total current liabilities

Total liabilities

Total liabilities and equity

Note

12
13
14
6,7
10
15

16
17
17

18
18
19
19
5
19
19

14
10
22
21

10

22
14
23

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

 5’264 
 5’467 
 2’564 
 –
 826 
 206 

 4’522 
 3’884 
 2’714 
 44 
380
 73 

 14’327 

 11’617 

 13’328 
 13’437 
 2’609 
 25’695 

 3’202 
9’175
342
 3’603 

 55’069 

 16’322 

 69’396 

 27’939 

 49’559 
 134’537 
 (2’043)
 50 
 (126’912)
 2’937 
 (8’711)

2’696
25’168
(1’312)
–
–
467
(13’702)

 49’417 

13’317

 (20)

23

 49’397 

13’340

 2’304 
 857 
1’400
 3’425

 7’986 

 5’815 
 3’214 
 1’495 
 – 
 173 
 349 
 967 

 12’013 

 19’999 

69’396

2’445
216
–
2’780

5’441

1’830
3’113
101
50
2’478
339
1’247

9’158

14’599

27’939

The Notes on pages 66 to 97 form an integral part of these Consolidated Financial Statements. The Financial 
Statements on pages 62 to 65 were approved and authorized for issue by the Board of Directors on April 23, 
2021 and signed on its behalf by:

Xaver Hangartner
Chief Financial Officer
April 23, 2021

.063

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Consolidated Statement of Changes in Shareholders’ Equity
For the year ended December 31, 2020

Share
capital
US$’000

Note

Capital
reserve
US$’000

Other
reserve
US$’000

Share-
based 
payment 
reserve
US$’000

Merger
reserve
US$’000

Currency 
translation 
reserve
US$’000

Retained 
deficit
US$’000

Non-
controlling 
interests
US$’000

Total
equity
US$’000

19

19

2’664
–

24’921 (1’107)
–

–

–

–

32

–

–

–

–

396

(149)

–

32

247

(205)

(205)

–

–

–

–

2’696

25’168 (1’312)

–

–

–

–

–

–

(731)

(731)

–
–

–

–

–

–

–

–

–

–

–

–

–
–

–

–

–

–

–

–

–

–

–

414 (14’428)
726

–

– 12’464
715

(11)

53

–

–

(152)

53

726

(11)

–

–

–

–

–

–

–

–

–

–

34

34

563

428

(149)

34

313

467 (13’702)

23 13’340

–  4’991 

 (77) 4’914

2’469

–

–

1’738

–

2’469  4’991

 (77)

 6’652 

–

–
–

–

–

–

– (126’912)

–
–

50

–

50

–
–

–

–

–

–

–
–

–

–

–

–

–
–

–

–

–

–

2’542

– 28’039
– (1’260)

–

50

 34 

 34 

 34   26’863 

–

–

–

–

7’276

19’503

49’559

134’537 (2’043)

50 (126’912) 2’937  (8’711)

 (20)  49’397 

39’587

89’866

Issuance of shares
Cost of share issues

19

7’276
–

20’763
(1’260)

Balance on  
January 1, 2019
Income after taxation
Other comprehensive 
(loss)/income

Total comprehensive 
(loss)/income for the 
year

Issuance of shares
Dividends paid from 
capital contributions
Capital contributions 
from non-controlling 
interests

Transactions with 
owners

Balance on  
December 31, 2019

Income after taxation
Other comprehensive 
(loss)/income

Total comprehensive 
(loss)/income for the 
year

Reverse acquisition 
adjustment

Share-based payment 
charges
Capital contributions 
from non-controlling 
interests

Transactions with 
owners

Balance on  
December 31, 2020

.064

HeiQ plcAnnual report and accounts 2020Consolidated Statement of Cash Flows
For the year ended December 31, 2020

Cash flows from operating activities

Income before taxation
Cash flow from operations reconciliation:
Depreciation and amortization
Loss on disposal of property, plant and equipment
Loss on disposal of investments
Finance costs
Finance income
Expected credit loss on trade receivables
Pension expense
Non-cash equity compensation
Share of loss/(profit) of associates
Deemed cost of listing
Foreign exchange differences
Working capital adjustments:
(Increase)/decrease in inventories
(Increase) in trade and other receivables
Increase in trade and other payables

Cash generated from operations
Taxes paid

Net cash generated from operating activities

Cash flows from investing activities
Consideration for acquisitions of businesses (Note 26)
Cash assumed on acquisitions of businesses (Note 26)
Purchase of property, plant and equipment
Proceeds from the disposal of property, plant and equipment
Development of intangible assets
Investment in associated company
Proceeds from the disposal of associated company
Finance income

Net cash from/(used in) investing activities

Cash flows from financing activities
Finance costs
Repayment of leases
Proceeds from borrowings
Repayment of borrowings
Dividends paid from capital contributions

Net cash (used in)/from financing activities

Net increase in cash and cash equivalents

Cash and cash equivalents – beginning of the year
Effects of exchange rate changes on the balance of cash held in foreign currencies

Cash and cash equivalents – end of the year

Note: Non-cash transactions: Certain shares were issued during the year for a non-cash consideration as described in Note 19. 

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

7’026 

1’029

1’254 
46 
22
399 
(68)
377 
176 
1’217 
15 
1’402 
(164)

(8’161)
(5’165)
2’777 

1’153 
(48) 

1’105 

(1’424)
27’111
(932)
10 
(635)
–
7 
68 

24’205

(399)
(354)
2
(2’737)
– 

(3’488) 

21’822

3’603 
270 

25’695

1’267
2
–
428
(8)
–
–
428
(3)
–
(40)

696
(2’044)
1’412

3’167
(178)

2’989

(1’290)
–
(370)
4
(118)
(15)
–
8

(1’781)

(182)
(386)
929
–
(149)

212

1’420

2’163
20

3’603

.065

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements
For the year ended December 31, 2020

1. General information 

HeiQ plc (“the Company’’) and its subsidiaries (together, “the Group’’) is an established global brand in materials 
and textile innovation which operates in high-growth markets, creating some of the most effective, durable and 
high-performance textile effects available worldwide. The principal activity of the Company is that of a holding 
company for the Group, as well as performing all administrative, corporate finance, strategic and governance 
functions of the Group.

The Company was incorporated on May 14, 2014 as Auctus Growth Limited, in England and Wales under the 
Companies Act 2006 with company number 09040064, with an investment strategy to undertake an acquisition 
of a target company or business. The Company was re-registered as a public company on July 24, 2014. 
On December 4, 2020, the Company’s name was changed to HeiQ plc. The Company’s registered office is 
5th Floor, 15 Whitehall, London, SW1A 2DD.

The Company was admitted to listing on the Official List by way of a Standard Listing in accordance with 
Chapter 14 of the Listing Rules and to trading on the London Stock Exchange’s Main Market for listed securities 
on August 22, 2014. 

Following the reverse takeover by the Company of HeiQ Materials AG (“HeiQ”), an established global brand in 
materials and textile innovation, the Company’s enlarged share capital was admitted to the standard segment 
of the Official List and initiation of trading on the London Stock Exchange’s Main Market commenced on 
December 7, 2020 under the ticker ‘HEIQ’. The ISIN of the Ordinary Shares is GB00BN2CJ299 and the SEDOL 
Code is BN2CJ29.

2. Basis of preparation and measurement

a. Basis of preparation
The Consolidated Financial Statements have been prepared in accordance with IFRS, issued by the International 
Accounting Standards Board, including interpretations issued by the International Financial Reporting 
Interpretations Committee, applicable to companies reporting under IFRS, and the Companies Act 2006 
applicable to companies reporting under IFRS.

Unless otherwise stated, the Consolidated Financial Statements are presented in United States Dollars (US$) 
which is the presentational currency of the Group, and all values are rounded to the nearest thousand dollars 
except where otherwise indicated.

The individual entities’ functional currencies are listed below: 

Entity:

HeiQ plc
HeiQ Materials AG
HeiQ ChemTex Inc.
HeiQ Pty Ltd
HeiQ Australia Pty Ltd
HeiQ GrapheneX AG
HeiQ Company Limited
HX Company Limited
HeiQ Medica S.L.
HeiQ Iberia Unipessoal Lda

Functional currency

GBP
CHF
USD
AUD
AUD
CHF
TWD (Taiwan Dollar)
TWD
EUR
EUR

On a single entity level, transactions in foreign currencies are translated into the functional currency at the rate of 
exchange ruling on the date of the transaction. Monetary assets and liabilities denominated in foreign currencies 
are translated at the exchange rate ruling at the reporting date. The resulting gain or loss is reflected in the 
Consolidated Statement of Comprehensive Income within operating income or operating expense if the account 
in the Statement of Financial Position is of an operating nature – e.g., trade and other receivables/payables and 
within either “Finance income” or “Finance costs” if the account is of a non-operating nature – e.g., cash and cash 
equivalents, loans receivable, payable. 

Single entities with a functional currency other than US$ are translated into US$ as part of the consolidation 
where assets and liabilities are translated at closing rate and profit and loss items are translated at an average 
rate for the year. Equity transactions are translated at the historic rate. The residual value flows into the currency 
translation reserve.

The Consolidated Financial Statements have been prepared under the historical cost convention except for 
certain financial and equity instruments that have been measured at fair value.

.066

HeiQ plcAnnual report and accounts 2020The Consolidated Financial Statements have been prepared on the going concern basis, which contemplates the 
continuity of normal business activity and the realization of assets and the settlement of liabilities in the normal 
course of business. The Directors have reviewed the Group’s overall position and outlook and are of the opinion 
that the Group is sufficiently well funded to be able to operate as a going concern for at least the next twelve 
months from the date of signing these financial statements.

The preparation of Financial Statements in conformity with IFRS requires the use of certain critical accounting 
estimates. It also requires management to exercise its judgment in the process of applying the Group’s accounting 
policies. The areas involving a higher degree of judgment and complexity, or areas where assumptions and 
estimates are significant to the Consolidated Financial Statements, are disclosed in Note 3.

Transaction costs of equity transactions relating to the issue and re-admission of the Company’s shares are 
accounted for as a deduction from equity where they relate to the issue of new shares and listing costs are 
charged to the Statement of Comprehensive Income.

b. Basis of consolidation
The Consolidated Financial Statements comprise the financial statements of the Company and its subsidiaries 
listed in Note 6 “Subsidiaries” to the Consolidated Financial Statements.

The basis of consolidation of the acquisition of HeiQ Materials AG by the Company in December 2020 is described 
in the basis of preparation above in Note 2(a). 

Business combinations other than reverse acquisitions as described in Note 5 are accounted for under the 
acquisition method.

A subsidiary is defined as an entity over which the Company has control. The Company controls an entity when the 
Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to 
affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which 
control is transferred to the Group. They are deconsolidated from the date that control ceases.

Intra-group transactions, balances and unrealized gains on transactions are eliminated; unrealized losses are also 
eliminated unless the cost cannot be recovered. Where necessary, adjustments are made to the financial 
statements of subsidiaries to ensure consistency of accounting policies with those of the Group.

The total comprehensive income of non-wholly owned subsidiaries is attributed to owners of the parent and to the 
non-controlling interests in proportion to their relative ownership interests. 

c. Investment in associates
The Group has applied IFRS 11 “Joint Arrangements” to its investment in associates. Under IFRS 11 “Joint 
Arrangements”, investments in joint arrangements are classified as either joint operations or joint ventures 
depending on the contractual rights and obligations of each investor. The Directors have assessed the nature of 
the Company’s joint arrangements and determined them to be that of an associated company, accounted for 
using the equity method.

Under the equity method of accounting, interests in associated companies are initially recognized at cost and 
adjusted thereafter to recognize the Group’s share of the post-acquisition profits or losses and movements in 
other comprehensive income. When the Group’s share of losses in an associated company equals or exceeds its 
interests in the associated company, the Group does not recognize further losses, unless it has incurred 
obligations or made payments on behalf of the associated company.

d. New standards, interpretations and amendments effective for the current period
Adopted
•  Amendments to IFRS 3: Definition of a Business
•  Amendments to IFRS 9, IAS 39 and IFRS 7: Interest Rate Benchmark Reform
•  Amendments to IFRS 16: COVID-19-Related Rent Concessions
•  Amendments to IAS 1 and IAS 8: Disclosure Initiative – Definition of Materiality

The Group has considered the above new standards, interpretations and amendments and has concluded that 
they are either not relevant to the Group or they do not have a significant impact on the Group’s consolidated 
financial statements.

New standards, interpretations and amendments not yet effective for the current period
There are a number of standards, amendments to standards, and interpretations which have been issued by the 
IASB that are effective in future accounting periods that the Group has decided not to adopt early. The most 
significant of these are as follows: 
•  Amendments to IAS 37 Onerous Contracts – Cost of Fulfilling a Contract
•  Amendments to IAS 16 Property, Plant and Equipment: Proceeds before Intended Use
•  Amendments to IFRS 3 References to Conceptual Framework

Management is currently assessing the impact of these new standards on the Group. 

.067

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020 
Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

3. Significant accounting policies

The preparation of the Consolidated Financial Statements in compliance with IFRS requires the Directors to 
exercise judgment in applying the Company’s accounting policies. The areas involving a higher degree of  
judgment or complexity, or areas where assumptions and estimates are significant to the Consolidated Financial 
Statements are disclosed in Note 4 “Significant accounting judgments, estimates and assumptions” to the 
Consolidated Financial Statements.

a. Foreign currency transactions and translation
The Consolidated Financial Statements are presented in US Dollars (US$), which is the Group’s principal 
functional currency.

The results and financial position of all Group entities that have a functional currency different from the 
presentation currency are translated into the presentation currency as follows:
•  assets and liabilities are translated at the closing rate at the date of the Statement of Financial Position;
•  income and expenses are translated at average exchange rates (unless this average is not a reasonable 

approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income 
and expenses are translated at the dates of the transactions); and

•  all resulting exchange differences are recognized in other comprehensive income.

On consolidation, the Group recognizes in other comprehensive income the exchange differences arising from the 
translation of the net investment in foreign entities, and of monetary items receivable from foreign subsidiaries 
for which settlement is neither planned nor likely to occur in the foreseeable future.

b. Property, plant and equipment
Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, if any. 
The cost of an item of property, plant and equipment initially recognized includes its purchase price and any cost 
that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of 
operating in the manner intended by the Group. 

Property, plant and equipment are generally depreciated on a straight-line basis over their estimated useful lives:

Furniture and fixtures  
Motor vehicles 
Machinery and equipment    
Computers and software  

5–7 years 
5 years
5–15 years
5 years 

Property, plant and equipment held under leases are depreciated over the shorter of the lease term and 
estimated useful life.

c. Research and development expenditure
Research expenditure is recognized as an expense when it is incurred.

Development expenditure is recognized as an expense except those costs incurred on development projects are 
capitalized as long-term assets to the extent that such expenditure is expected to generate future economic 
benefits. Development expenditure is capitalized if, and only if, an entity can demonstrate all of the following:
•  its ability to measure reliably the expenditure attributable to the asset under development;
•  the product or process is technically and commercially feasible;
•  its future economic benefits are probable;
•  its ability to use or sell the developed asset; and
•  the availability of adequate technical, financial and other resources to complete the asset under development.

Capitalized development expenditure is measured at cost less accumulated amortization and impairment losses, 
if any. Certain internal salary costs are included where the above criteria are met. These internal costs are 
capitalized when they are incurred in respect of products developed for sale. Development expenditure initially 
recognized as an expense is not recognized as assets in subsequent periods. 

Capitalized development expenditure in respect of such products is amortized on a straight-line method over a 
period of five to ten years when the products or services are ready for sale or use. In the event that it is no longer 
probable that the expected future economic benefits will be recovered, the development expenditure is written 
down to its recoverable amount.

d. Intangible assets
All intangible assets, except goodwill, are stated at cost less accumulated amortization and any accumulated 
impairment losses.

.068

HeiQ plcAnnual report and accounts 2020 
 
 
  
The estimated useful lives are as follows:
Patents and trademarks 
Internally developed assets  

5–10 years
5–10 years

Goodwill
Goodwill represents the amount by which the fair value of the cost of a business combination exceeds the 
fair value of the net assets acquired. Goodwill is not amortized and is stated at cost less any accumulated 
impairment losses.

The recoverable amount of goodwill is tested for impairment annually or when events or changes in circumstance 
indicate that it might be impaired. Impairment charges are deducted from the carrying value and recognized 
immediately in the income statement. For the purpose of impairment testing, goodwill is allocated to each of the 
Group’s cash-generating units expected to benefit from the synergies of the combination. If the recoverable 
amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated 
first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit 
pro-rata on the basis of the carrying amount of each asset in the unit. An impairment loss recognized for goodwill 
is not reversed in a subsequent period. 

Acquisition-related intangible assets
Net assets acquired as part of a business combination includes an assessment of the fair value of separately 
identifiable acquisition-related intangible assets, in addition to other assets, liabilities and contingent liabilities 
purchased. These acquisition-related intangible assets are amortized on a straight-line basis over their useful 
lives which are individually assessed.

The estimated useful lives are as follows:
Patents and trademarks 
Brand names 

10 years
10 years

e. Impairment of financial assets
The expected credit loss model defined in IFRS 9 “Financial Instruments” requires the Group to account for 
expected credit losses and changes in those expected credit losses at each reporting date to reflect changes in 
credit risk since initial recognition of the financial assets. The credit event does not have to occur before credit 
losses are recognized. IFRS 9 “Financial Instruments” allows for a simplified approach for measuring the loss 
allowance at an amount equal to lifetime expected credit losses for trade receivables and contract assets.

The Group has one type of financial asset subject to the expected credit loss model: trade receivables.

The expected loss rates are based on the Group’s historical credit losses experienced over the three-year period 
prior to the period end. The historical loss rates are then adjusted for current and forward-looking information on 
macroeconomic factors affecting the Group’s customers. 

f. Impairment of non-financial assets
At each reporting date, the Directors assess whether indications exist that an asset may be impaired. If 
indications do exist, or when annual impairment testing for an asset is required, the Directors estimate the 
asset’s recoverable amount. An asset’s recoverable amount is the higher of an asset’s or cash-generating unit’s 
fair value less costs to sell and its value-in-use, and is determined for an individual asset, unless the asset does 
not generate cash inflows that are largely independent of those from other assets or groups of assets. Where the 
carrying amount of an asset or cash-generating unit exceeds its recoverable amount, the Directors consider the 
asset impaired and write the subject asset down to its recoverable amount. In assessing value-in-use, the 
Directors discount the estimated future cash flows to their present value using a pre-tax discount rate that reflects 
current market assessments of the time value of money and the risks specific to the asset. In determining fair 
value less costs to sell, the Directors consider recent market transactions, if available. If no such transactions can 
be identified, the Directors utilize an appropriate valuation model.

When applicable, the Group recognizes impairment losses of continuing operations in the Statements of 
Comprehensive Income in those expense categories consistent with the function of the impaired asset.

g. Right-of-use assets
A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, 
which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or 
before the commencement date net of any lease incentives received, any initial direct costs incurred, and an estimate 
of costs expected to be incurred for dismantling and removing the underlying asset, and restoring the site or asset. 

.069

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020 
 
 
 
Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

3. Significant accounting policies continued

Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the 
estimated useful life of the asset, whichever is the shorter. Right-of-use assets are subject to impairment or 
adjusted for any re-measurement of lease liabilities. 

The Group has elected not to recognize a right-of-use asset and corresponding lease liability for short-term leases 
with terms of 12 months or less and leases of low-value assets. Lease payments on these assets are expensed to 
profit or loss as incurred.

h. Leases
The determination of whether an arrangement is, or contains, a lease is based on the substance of the 
arrangement at inception date; whether fulfillment of the arrangement is dependent on the use of a specific asset 
or assets or the arrangement conveys a right to use the asset.

Identifying leases 
The Group accounts for a contract, or a portion of a contract, as a lease when it conveys the right to use an asset 
for a period of time in exchange for consideration. Leases are those contracts that satisfy the following criteria: 
•  there is an identified asset; 
•  the Group obtains substantially all the economic benefits from use of the asset; and 
•  the Group has the right to direct use of the asset. 

The Group considers whether the supplier has substantive substitution rights. If the supplier does have those 
rights, the contract is not identified as giving rise to a lease.

In determining whether the Group obtains substantially all the economic benefits that arise from use of the asset, 
the Group considers only the economic benefits that arise from use of the asset, not those incidentals to legal 
ownership or other potential benefits. 

In determining whether the Group has the right to direct use of the asset, the Directors consider whether the 
Group directs how and for what purpose the asset is used throughout the period of use. If there are no significant 
decisions to be made because they are pre-determined due to the nature of the asset, the Directors consider 
whether the Group was involved in the design of the asset in a way that predetermines how and for what purpose 
the asset will be used throughout the period of use. If the contract or portion of a contract does not satisfy these 
criteria, the Group applies other applicable IFRSs rather than IFRS 16 “Leases”.

Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease 
term, with the discount rate determined by reference to the rate inherent in the lease unless (as is typically the 
case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of 
the lease is used, which the Directors have assessed to be between 1.75% and 5%, depending on the nature of 
the asset and location.

Variable lease payments are only included in the measurement of the lease liability if they depend on an index or 
rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain 
unchanged throughout the lease term. Other variable lease payments are expensed in the period to which 
they relate.

On initial recognition, the carrying value of the lease liability also includes: 
•  amounts expected to be payable under any residual value guarantee; 
•  the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to assess that 

option; and

•  any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of 

termination option being exercised. 

Right-of-use assets are initially measured at the amount of the lease liability, reduced for any lease incentives 
received, and increased for: 
•  lease payments made at or before commencement of the lease; 
•  initial direct costs incurred; and 
•  the amount of any provision recognized where the Group is contractually required to dismantle, remove or 

restore the leased asset.

Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on 
the balance outstanding and are reduced for lease payments made. Right-of-use assets are amortized on a 
straight-line basis over the remaining term of the lease or over the remaining economic life of the asset if, rarely, 
this is judged to be shorter than the lease term. 

.070

HeiQ plcAnnual report and accounts 2020When the Group revises its estimate of the term of any lease (because, for example, it re-assesses the probability 
of a lessee extension or termination option being exercised), it adjusts the carrying amount of the lease liability to 
reflect the payments to make over the revised term, which are discounted at the same discount rate that applied 
on lease commencement. The carrying value of lease liabilities is similarly revised when the variable element of 
future lease payments dependent on a rate or index is revised. In both cases an equivalent adjustment is made to 
the carrying value of the right-of-use asset, with the revised carrying amount being amortized over the remaining 
(revised) lease term.

i. Taxation
Deferred taxation
Deferred tax is provided in full, using the liability method, on temporary differences arising between the tax bases 
of assets and liabilities and their carrying amounts in the Consolidated Financial Statements. Deferred tax is 
determined using tax rates (and laws) that have been enacted or substantially enacted by the reporting date and 
expected to apply when the related deferred tax is realized, or the deferred liability is settled.

Deferred tax assets are recognized to the extent that it is probable that the future taxable profit will be available 
against which the temporary differences can be utilized.

Income taxation
Current income tax assets and liabilities are measured at the amount to be recovered from, or paid to, the 
taxation authorities. The tax rates and tax laws used to compute the amount are those that are enacted or 
substantively enacted at the reporting date in the jurisdictions where the Group operates and generates 
taxable income. 

j. Revenue from contracts with customers and other income
The Group’s revenue represents the fair value of the consideration received or receivable for the sale of functional 
ingredients (including chemicals), materials or finished goods directly to retail or wholesale customers and the 
rendering of services, net of value added tax and other similar sales-based taxes, rebates and discounts after 
eliminating intercompany sales.

For fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the value of 
services rendered by the Group exceed the payment received, an amount recoverable on contracts asset is 
recognized. Conversely, if the payments exceed the value of services rendered, a liability is recognized. If the 
contract is time-and-materials based and includes an hourly fee, revenue is recognized over time in the amount 
to which the Group has the right to invoice.

Take or pay arrangements
Certain customers have agreed, under a “take or pay” contract, to purchase a specified minimum quantity of a 
range of particular products over a specified period of time. However, the customer has to pay for the full quantity 
stated in the contract, irrespective of whether the customer takes delivery of the minimum quantity to which they 
are entitled. Upon payment of the full amount, the contract allows customers to defer its unexercised rights and to 
consume the remaining units to a later date, although there is no compulsion to do so. If the Group expects to 
benefit from such future exercise by the customer, it recognizes the expected amount as revenue in proportion to 
the pattern of rights exercised by the customer (by comparing the goods delivered to date with those expected to 
be delivered overall).

The Directors have therefore considered likely future customer behavior and thus estimated the proportion of 
revenues to be recognized under such contracts.

Framework agreements
For services revenue from framework agreements, the stage of completion is determined based on the proportion 
of contract costs incurred compared to total estimated contract costs. The outcome of a development project can 
be determined with reasonable certainty when a project budget is agreed which sets out milestones and costs for 
all project deliverables. Staff and contractors record their actual time and external costs spent on each project 
which is regularly reviewed against budget.

In making their estimation as to the amounts recoverable on contracts, the Directors consider estimates of 
anticipated revenues and costs from each contract and monitor the need for any provisions for losses arising from 
adjustments to underlying assumptions if this indicates it is appropriate. 

.071

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

3. Significant accounting policies continued

Contract work in progress is stated at costs incurred, less those amounts transferred to profit or loss, after 
deducting foreseeable losses and payments on account not matched with revenue. Amounts recoverable on 
contracts are included in current assets and represent revenue recognized in excess of payments on account.

The revenue recognized and deferred from such agreements was as follows:

Revenue from framework agreements

Amounts invoiced
Amounts recognized

Amount recognized in revenue

Deferred revenue

Amount brought forward
Recognized as income

Amount carried forward to be recognized in future periods

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

–
50

50

–
300

300

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

50
(50)

–

350
(300)

50

k. Share-based payments
The Group accounts for share-based payments under IFRS 2 “Share-based Payment”. All of the Group’s share-
based awards are equity settled. 

Equity-settled share-based payments to employees are measured at the fair value of the equity instruments at 
the grant date. Equity-settled share-based payments to non-employees are measured at the fair value of services 
received, or if this cannot be measured, at the fair value of the equity instruments granted at the date that the 
Group obtains the goods or counterparty renders the service. The fair value of such shares issued has been 
estimated by reference to the cash consideration received for shares issued or material third-party transactions 
at or close to the dates for such non-cash issues.

The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-
line basis over the vesting period, based on the Directors’ estimate of equity instruments that will eventually vest, 
with a corresponding increase in equity. Where the conditions are non-vesting, the expense and equity reserve 
arising from share-based payment transactions is recognized in full immediately on grant.

At the end of each reporting period, the Directors revise their estimate of the number of equity instruments 
expected to vest. The impact of the revision of the original estimates, if any, is recognized in profit or loss such 
that the cumulative expense reflects the revised estimate, with a corresponding adjustment to other reserves.

l. Employee benefits
Short-term benefits
Short-term employee benefit obligations are measured on an undiscounted basis and are expensed as the related 
service is provided. A liability is recognized for the amount expected to be paid under short-term cash bonus or 
profit-sharing plans if the Group has a present legal or constructive obligation to pay this amount as a result of 
past service provided by the employee and the obligation can be estimated reliably.

Long-term benefits
Defined benefit plans
The Group operates a defined benefit pension plan in Switzerland, which requires contributions to be made to a 
separately administered fund. The cost of providing benefits under the defined benefit plan is determined using 
the projected unit credit method.

Re-measurements, comprising of actuarial gains and losses, the effect of the asset ceiling, excluding amounts 
included in net interest on the net defined benefit liability and the return on plan assets (excluding amounts 
included in net interest on the net defined benefit liability), are recognized immediately in the statement of 
financial position with a corresponding debit or credit to retained earnings through other comprehensive income 
in the period in which they occur. Re-measurements are not reclassified to profit or loss in subsequent periods.

.072

HeiQ plcAnnual report and accounts 2020Past-service costs are recognized in profit or loss on the earlier of:
•  the date of the plan amendment or curtailment; and
•  the date that the Group recognizes related restructuring costs.

Net interest is calculated by applying the discount rate to the net defined benefit liability or asset. The Group 
recognizes the following changes in the net defined benefit obligation under “cost of sales”, “administration 
expenses” and “selling and distribution expenses” in the Consolidated Statement of Profit or Loss (by function):
•  service costs comprising current service costs, past-service costs, gains and losses on curtailments and 

non-routine settlements; and
•  net interest expense or income.

Defined contribution plans
The income statement expense for the defined contribution pension plans operated represents the contributions 
payable for the year.

m. Finance income and expenses
Finance expenses comprise interest payable, lease expenses recognized in profit or loss using the effective 
interest method, unwinding of the discount on provisions, and net foreign exchange losses that are recognized 
in the income statement. 

Finance income comprises interest receivable on cash deposits and net foreign exchange gains.

Interest income and interest payable are recognized in profit or loss as it accrues, using the effective 
interest method.

Foreign currency gains and losses are reported on a net basis.

n. Cash and cash equivalents
For the purpose of presentation in the Consolidated Statement of Cash Flows, cash and cash equivalents include 
cash on hand, deposits held at call with financial institutions, other short-term highly liquid investments with 
original maturities of three months or less that are readily convertible to known amounts of cash and which are 
subject to an insignificant risk of changes in value, and bank overdrafts. 

o. Trade and other receivables
Trade receivables are recognized initially at fair value and subsequently measured at amortized cost using the 
effective interest method, less provision for impairment.

p. Inventories
Inventories are stated at the lower of cost and net realizable value. Cost is based on the weighted average 
principle and includes expenditure incurred in acquiring the inventories and other costs in bringing them to their 
existing location and condition. 

q. Provisions
A provision is recognized when the Group has a present obligation, legal or constructive, as a result of a past 
event and it is probable that an outflow of resources embodying economic benefits will be required to settle the 
obligation, and a reliable estimate can be made. Provisions are reviewed at each reporting date and adjusted to 
reflect the current best estimate. If it is no longer probable that an outflow of economic resources will be required 
to settle the obligation, the provision is reversed. Where the effect of the time value of money is material, 
provisions are discounted using a current pre-tax rate that reflects, where appropriate, the risks specific to the 
liability. When discounting is used, the increase in the provision due to the passage of time is recognized as an 
interest expense.

r. Contingent liabilities
Contingent liabilities are possible obligations whose existence depends on the outcome of uncertain future events 
or present obligations where the outflow of resources is uncertain or cannot be measured reliably. Contingent 
liabilities are not recognized in the Consolidated Financial Statements but are disclosed unless they are remote.

s. Segmental reporting
The Directors consider that the Group has one reportable segment, that of textile innovation focused on scientific 
research, specialty materials manufacturing and consumer ingredient branding. Accordingly, all revenues, 
operating results, assets and liabilities are allocated to this activity.

The Group also analyses and measures its performance into geographic regions, specifically Europe, North & 
South America and Asia.

.073

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

4. Significant accounting judgments, estimates and assumptions

The Directors have made the following judgments which may have a significant effect on the amounts recognized 
in the Consolidated Financial Statements:

a. Basis of consolidation
The Directors consider that the share-for-share exchange between Auctus Growth Plc and HeiQ Materials AG to  
be a reverse acquisition as HeiQ Materials AG is considered to be the acquirer. Further details of the basis of 
consolidation and how the Directors developed the most appropriate accounting policy are outlined in the basis of 
consolidation within accounting policy Note 2(b). The difference between the consideration shares transferred in 
the combination (“Consideration Shares”) and the fair value of the net assets acquired has been charged to the 
Consolidated Statement of Income as a deemed cost of listing.

b. Revenue from take or pay arrangements
Certain customers have agreed, under a “take or pay” contract, to purchase a specified minimum quantity of a 
range of particular products over a specified period of time. However, the customer has to pay for the full quantity 
stated in the contract, irrespective of whether the customer takes delivery of the minimum quantity to which they 
are entitled. Upon payment of the full amount, the contract allows the customer to defer its unexercised rights 
and to consume the remaining units to a later date, although there is no compulsion to do so. If the Group expects 
to benefit from such future exercise by the customer, it recognizes the expected amount as revenue in proportion 
to the pattern of rights exercised by the customer (by comparing the goods delivered to date with those expected 
to be delivered overall).

The Directors have therefore considered likely future customer behavior and thus estimated the proportion of 
revenues to be recognized under such contracts. Any changes to such estimates would not have a material impact 
on the amount of revenue recognized in each year. 

c. Impairment of non-financial assets
IFRS requires the Directors to undertake an annual test for impairment of indefinite lived assets and, for finite 
lived assets, to test for impairment if events or changes in circumstances indicate that the carrying amount of an 
asset may not be recoverable.

Impairment testing is an area involving judgment in determining estimates, requiring assessment as to whether 
the carrying value of assets can be supported by the net present value of future cash flows derived from such 
assets using cash flow projections which have been discounted at an appropriate rate. In calculating the net 
present value of the future cash flows, certain assumptions are required to be made in respect of highly uncertain 
matters, including management’s expectations of:
•  growth in EBITDA, calculated as adjusted operating profit before depreciation and amortization;
•  the level of capital expenditure to support long-term growth; and
•  the selection of discount rates to reflect the risks involved.

The Directors prepare and approve cash flow projections which are used in the fair value calculations.
Changing the assumptions selected by the Directors, in particular the discount rate and growth rate assumptions 
used in the cash flow projections, could significantly affect their impairment evaluation and hence the  
Group’s results.

Goodwill of £3.4 million relating to the acquisition of the Chem-Tex Assets in 2017 was allocated to the Chem-Tex 
business and represents a group of cash-generating units and tested for impairment as of the reporting date. The 
carrying value of the Chem-Tex Assets was tested for impairment on the basis of value-in-use, including a gross 
margin of 47.5%, capital expenditure of US$400’000 and a discount rate of 16% based on the rate that would be 
used by a market participant. The impairment test indicated that no impairment loss is required. 

The sensitivity of impairment tests to changes to underlying assumptions is summarized below. Impairment would 
result from the following changes to assumptions: 
•  An increase in the discount rate to 23%
•  A gross margin of 41% or below
•  Capital expenditure of US$1’100’000 per annum or higher.

d. Defined benefit plans (pension benefits)
The costs of the Group’s defined benefit pension plan and other post-employment medical benefits and the 
present value of the pension obligation are determined using actuarial valuations. An actuarial valuation involves 
making various assumptions that may differ from actual developments in the future. These include the 
determination of the discount rate, future salary increases, mortality rates and future pension increases. Due to 
the complexities involved in the valuation and its long-term nature, a defined benefit obligation is highly sensitive 
to changes in these assumptions. All assumptions are reviewed at each reporting date.

Further details about pension obligations are provided in Note 20 “Pensions and other post-employment benefit plans”.

.074

HeiQ plcAnnual report and accounts 20205. Business combinations

Reverse acquisition
On December 7, 2020, HeiQ plc became the legal parent of HeiQ Materials AG by way of reverse acquisition. 
The cost of the acquisition is deemed to have been incurred by HeiQ Materials AG, the legal subsidiary, in the 
form of equity instruments issued to the owners of the legal parent. This acquisition has been accounted for as 
a reverse acquisition.

This transaction is deemed outside the scope of IFRS 3 and not considered a business combination because the 
Directors have made a judgment that, prior to the transaction, Auctus Growth Plc was not a business under the 
definition of IFRS 3 Appendix A and the application guidance in IFRS 3.B7- B12 due to Auctus Growth Plc being a 
shell company that had no processes or capability for outputs (IFRS 3.B7).

On this basis, the Directors have developed an accounting policy for this transaction, applying the principles set 
out in IAS 8.10-12, in that the policy adopted: 
•  is relevant to the users of the financial statements;
•  is more representative of the financial position, performance and cash flows of the Group;
•  reflects the economic substance of the transaction, not merely the legal form; and
•  is free from bias, prudent and complete in all material aspects. 

The accounting policy adopted by the Directors applies the principles of IFRS 3 in identifying the accounting acquirer 
and the presentation of the Consolidated Financial Statements of the legal parent (HeiQ plc) as a continuation of the 
accounting acquirer’s Financial Statements (HeiQ Materials AG). This policy reflects the commercial substance of this 
transaction as the original shareholders of the subsidiary undertakings were the most significant shareholders post 
transaction, owning 84.8% of the enlarged issued share capital of the Company.

Accordingly, the following accounting treatment and terminology was applied in respect of the reverse acquisition:
•  the assets and liabilities of the legal subsidiary, HeiQ Materials AG, are recognized and measured in the Group 

Financial Statements at the pre-combination carrying amounts, without reinstatement to fair value;

•  the retained earnings and other equity balances recognized in the Group Financial Statements reflect the 

retained earnings and other equity balances of HeiQ Materials AG and its subsidiaries immediately before the 
business combination, and the results of the year from January 1, 2020 to the date of the business 
combination are those of HeiQ Materials AG. However, the equity structure appearing in the Consolidated 
Financial Statements reflects the equity structure of the legal parent (Auctus Growth Plc), including the equity 
instruments issued under the share-for-share exchange to effect the business combination; the cost of the 
combination has been determined from the perspective of HeiQ Materials AG. 

The fair value of the shares in HeiQ Materials AG has been determined from the admission price of the HeiQ plc 
shares on Re-admission to trading on the London Stock Exchange’s Main Market of £1.12 per share. The value 
of the consideration shares was £119’571’088 (equivalent to US$156’889’584). The fair value of the notional 
number of equity instruments that the legal subsidiary would have had to have issued to the legal parent to give 
the owners of the legal parent the same percentage ownership in the combined entity was 15.2% of the market 
value of the shares after issues, being £21’428’000 (US$28’124’000). The difference between the notional 
consideration paid by HeiQ plc for HeiQ Materials AG and the HeiQ plc net assets acquired of £20’360’000 
(US$26’722’000) has been charged to the Consolidated Statement of Comprehensive Income as a deemed 
cost of listing amounting to £1’068’000 (equivalent to US$1’402’000) with a corresponding entry to the 
merger reserve. 

The transaction costs associated with the reverse acquisition and readmission totaled $1’871’000 and have been 
charged to profit and loss. 

Details of net assets acquired and the deemed cost of listing are as follows:

Consideration effectively transferred

Net assets acquired:

Cash and cash equivalents 
Trade and other receivables
Trade and other payables

Net assets acquired

Deemed cost of listing

US$’000

28’124

27’105
163
(546)

26’722

1’402

.075

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

5. Business combinations continued

The amounts transferred to the merger reserve were as follows:

HeiQ equity capital pre-combination
Deemed cost of acquisition
Consideration shares issued on acquisition
Retained losses of Company at combination

Merger reserve as at December 31, 2020

US$’000

29’095
1’402
(156’894)
(515)

(126’912)

Acquisition of MasFabEs
On December 15, 2020, the Group completed the acquisition of a 50.01% interest in a leading Spanish mask 
manufacturer MasFabEs S.L. for a consideration of €132’751 (equivalent to US$156’570). The company was 
renamed HeiQ Medica S.L. and will manufacture medical devices with the Group’s cutting-edge textile 
technologies.

The following table summarizes the consideration paid for the goodwill, the fair value of assets acquired, liabilities 
assumed and non-controlling interests at the acquisition date:

Fair value of consideration 

Net assets acquired:
Property, plant and equipment 
Inventories
Cash
Net working capital
Deferred tax asset
Borrowings

Total identifiable net assets acquired at fair value

Non-controlling interests

Goodwill recognized on acquisition

US$’000

157

1’195
1’152
6
(886)
112
(1’512)

67

(33)

123

.076

HeiQ plcAnnual report and accounts 20206. Subsidiaries

Details of the Company’s subsidiaries as at December 31, 2020 are as follows:

Company

HeiQ Materials AG

Country of 
registration or 
incorporation

Switzerland

HeiQ ChemTex Inc.

United States

HeiQ Pty Ltd1

Australia

HeiQ GrapheneX AG

Switzerland

HeiQ Company Limited

HX Company Limited

HeiQ Medica S.L.

Taiwan

Taiwan

Spain

Registered office

Principal activity

Percentage of 
Ordinary Shares 
held

Rütistrasse 12, 8952 Schlieren
Zurich

2725 Armentrout Dr
Concord, NC 28025

Development,
 production and 
sale of chemicals

Development,
 production and 
sale of chemicals

Level 20/181 William Street
Melbourne, VIC 3000

Research and 
development

100%

100%

100% 

Rütistrasse 12, 8952 Schlieren  
Zurich

No. 14 & 16, Ln. 50, Wufu 1st Rd.
Luzhu District, Taoyuan City 33850

Inactive

100%

Distribution

100%

No. 14 & 16, Ln. 50, Wufu 1st Rd.
 Luzhu District, Taoyuan City 33850

Trading and 
production

Plaza de la Estación s/n, 29560 
Pizarra

Manufacture of 
medical devices

66.7%

50%

100%

HeiQ Iberia Unipessoal 
Lda

Portugal

Rua Engº Frederico Ulrich, nº 2650,
 4470-605 Maia

Sales agency 
company

With the exception of HeiQ Materials AG, all subsidiaries are held indirectly.

1. The HeiQ Group held a 50% interest up until May 2017, when it acquired the remaining 50%. HeiQ Pty Ltd comprised HeiQ Pty Ltd and its wholly owned subsidiary, 
HeiQ Australia Pty Ltd, until HeiQ Australia Pty Ltd filed for voluntary deregistration on July 17, 2020 as part of a consolidation of the local businesses into a single 
entity. Subsequently, the business name “HeiQ Australia” was registered on July 20, 2020 by HeiQ Pty Ltd to be used for trading purposes and on October 4, 2020, 
trading as a single entity commenced. The official registered address for HeiQ Pty Ltd (and the business name HeiQ Australia) is as above. 

HeiQ operates a sales representative office in the People’s Republic of China registered as HeiQ Materials Company Limited at Room 2011, Xuhui Commercial 
Mansion, No. 168 Yude Road, Shanghai, China.

7. Associated companies

Details of the Group’s investments in associated companies are as follows: 

Company

HeiQ-RAS GmbH

Country of 
registration or 
incorporation

Germany

Registered office

Principal activity

Percentage of 
Ordinary Shares 
held by HeiQ 

An der Irler Höhe 3a, 93055 
Regensburg

Regulatory services

50%

HeiQ-RAS GmbH
Microbe Investigations AG

Carrying value

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

–
–

–

15
29

44

HeiQ-RAS GmbH (“HeiQ Germany”)
In June 2019, the Group incorporated HeiQ Germany with a paid-in capital of €25’000 and, upon incorporation, 
agreed to sell a 50% interest to RAS AG, Germany for consideration of €12’500, equivalent to approximately 
US$15’000. 

.077

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020 
Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

7. Associated companies continued

The investment has been accounted for using the equity method of accounting whereby the investment is initially 
recognized at cost and the carrying value is increased or decreased to recognize the Group’s share of the profit or 
loss of the associate after the date of acquisition. 

As at December 31, 2020, the carrying value of the investment is summarized as follows:

Balance brought forward
Consideration paid
Group’s share of post-acquisition losses

Carrying value

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

15
–
(15)

–

–
15
–

15

Summarized financial information 
Set out below is summarized financial information for HeiQ Germany which is accounted for using the equity 
method. The information reflects the amounts presented in the financial information of HeiQ Germany, adjusted 
for differences in accounting policies between the Group and the associated company where appropriate, and not 
the Group’s share of those amounts.

Summarized statement of comprehensive income

Revenue
Loss from continuing operations
Tax

Loss after tax

Total comprehensive income for the year

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

–
(42)
–

(42)

(42)

–
–
–

–

–

Microbe Investigations AG
On June 7, 2012, HeiQ subscribed for a 49% interest in Microbe Investigations AG for a total consideration of  
CHF 24’500 (US$25’634).

The investment was accounted for using the equity method of accounting, as summarized below: 

Balance brought forward
Group’s share of post-acquisition results
Proceeds received on disposal
Loss on disposal

Carrying value

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

29
–
(7)
(22)

–

23
6
–
–

29

On October 23, 2020, the Group disposed of its interest in Microbe Investigations AG for a consideration of CHF 
6’000 (approximately US$7’000). 

.078

HeiQ plcAnnual report and accounts 20208. Revenue and other operating income

The Group’s activities are materials innovation which focuses on scientific research, manufacturing and consumer 
ingredient branding. The primary source of revenue is the production and sale of functional ingredients, materials 
and finished goods. Other sources of revenues include research and development services as well as laboratory 
work. Revenues were mainly generated in the regions of Europe, North & South America and Asia. 

The following table reconciles HeiQ Group’s revenue for the periods presented:

Revenue split by product type

Functional ingredients sales
Functional materials sales
Finished goods sales
Other third-party revenues

Total revenue

Revenue split by region

North & South America
Asia
Europe
Others

Total revenue

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

 42’023 
 764
7’444
 170 

50’401

27’526
42
–
386

27’954

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

 19’813 
 19’887 
 10’429 
 272 

50’401

17’218
7’098
3’513
125

27’954

During the year ended December 31, 2020, no customers individually totaled more than 10% of total revenues 
(2019: two customers totaling more than 10% at 12% and 11% respectively).

Other operating income

Foreign exchange gains
Other

Total other operating income

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

3’986
758

4’744

1’401
184

1’585

.079

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

9. Expenses by nature

Cost of goods sold

Material expenses
Personnel expenses
Depreciation of property, plant and equipment 
Other costs of goods

Total cost of goods sold

Selling and general administration expense

Personnel expenses
Commissions
Audit expense
Depreciation of property, plant and equipment
Amortization
Depreciation of right-of-use assets
Other

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

 17’586
 1’279
 382
3’155

22’402

11’016
 1’285
 395
1’686

14’382

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

9’091
 1’133 
 108 
 394 
 110 
 368 
 4’913 

6’783
1’117
(9)
317
149
404
3’287

Total selling and general administration expense 

16’117

12’048

Personnel expenses

Wages and salaries
Social security and other payroll taxes
Pension costs
Share-based payments

Total personnel expenses

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

 8’290 
 415 
 448 
 1’217 

10’370 

7’496
283
89
201

8’069

The average monthly number of employees was as follows:

97

86

Other operating expenses

Foreign exchange losses
Other

Total other operating expenses

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

5’124
3

5’127

1’687
–

1’687

.080

HeiQ plcAnnual report and accounts 2020 
10. Taxation

For the year ending December 31, 2020, the Group had a tax expense of US$2’112’000 (2019: US$314’000). 
The effective tax rate was 28.8% (2019: 30.5%). The effective tax rate was primarily impacted by non-deductible 
expenditure. 

The components of the provision for taxation on income included in the Statement of Profit or Loss and Other 
Comprehensive Income are summarized below:

Current income tax expense

Swiss corporate income taxes
United States state and federal taxes
Taiwan corporate income taxes

Total current income tax expense

Deferred income tax expense
Switzerland
Portugal
Taiwan

Total deferred income tax expense

Total income tax expense

Tax liability

Opening balance – (Prepaid taxes)
Income tax expense for the year
Taxes paid
Foreign currency movements

Closing balance

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

304
1’112
161

1’577

588
(28)
(25)

535

2’112

46
147
35

228

86
–
–

86

314

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

(42)
1’577
(48)
8

1’495

(92)
228
(178)
–

(42)

The differences between the statutory income tax rate and the effective tax rates are summarized as follows:

Expected tax at statutory Swiss income tax rate of 20%

Increase/(decrease) in tax resulting from:

Effect of different tax rates in foreign jurisdictions 
Tax credits
Net recognized tax losses
Non-deductible expenditure
Other – net

Total income tax expense

Expected tax at statutory Swiss income tax rate of 20%

Increase/(decrease) in tax resulting from:

Effect of different tax rates in foreign jurisdictions 
Net unrecognized tax losses
Capital allowances less depreciation
Other – net

Total income tax expense

Year ended
December 31, 
2020

20.0%

2.4%
(0.8%)
(4.5%)
7.7%
4.0%

US$’000

1’469

175
(60)
(329)
567
290

2’112

28.8%

Year ended
December 31, 
2019

US$’000

206

(19)
100
(6)
33

314

20.0%

(1.8%)
9.7%
(0.6%)
3.2%

30.5%

.081

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

10. Taxation continued

The Group had net deferred tax liabilities of US$31’000 at December 31, 2020 (2019: Net deferred tax assets of 
US$164’000). The deferred tax assets relate to taxable temporary differences.

The components of the net deferred income tax assets included in non-current assets are as follows:

Deferred tax assets
Pension fund obligations
Tax losses recognized
Deferred revenue

Total deferred tax assets

Deferred tax liabilities
Capital allowances and depreciation

Deferred tax liabilities

Net deferred tax assets (liabilities)

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

655
171
–

826

(857)

(857)

(31)

370
–
10

380

(216)

(216)

164

As at December 31, 2020, the Group had approximately US$171’000 of tax losses available to be carried forward 
against future profits (2019: US$2.2 million). Approximately US$1.5 million of the losses brought forward expired 
in 2020.

In applying judgment in recognizing deferred tax assets, management has critically assessed all available 
information, including future business profit projections and the track record of meeting forecasts. Management 
expects the deferred tax asset to be substantially recovered in 2021.

11. Earnings per share

The calculation of earnings per share is based on the following earnings and number of shares:

Profit after tax attributable to owners of the Company 
Basic earnings per share (cents)
Diluted earnings per share (cents)
Basic weighted average number of shares in issue
Diluted weighted average number of shares in issue

Year ended
December 31,
2020
US$’000

4’991
4.41
4.21
113’143’731
118’666’601

Year ended
December 31,
2019
US$’000

726
0.71
0.71
102’959’511
102’959’511

Basic earnings per share is calculated by dividing the profit/loss after tax attributable to the equity holders of the 
Company by the weighted average number of shares in issue during the year.

Diluted earnings per share is calculated by dividing the profit/loss attributable to the equity holders of the 
Company by the weighted average number of Ordinary Shares outstanding during the year plus the weighted 
average number of Ordinary Shares that would be issued on conversion of all the dilutive potential Ordinary 
Shares into Ordinary Shares. 

In calculating the weighted average number of Ordinary Shares outstanding (the denominator of the earnings per 
share calculation) during the period in which the reverse occurs:
(a) the number of Ordinary Shares outstanding from the beginning of that period to the acquisition date shall be 
computed on the basis of the weighted average number of Ordinary Shares of the legal acquiree (accounting 
acquirer) outstanding during the period multiplied by the exchange ratio established in the merger agreement; and
(b) the number of Ordinary Shares outstanding from the acquisition date to the end of that period shall be the actual 

number of Ordinary Shares of the legal acquirer (the accounting acquiree) outstanding during that period.

The basic earnings per share for each comparative period before the acquisition date presented in the 
Consolidated Financial Statements following a reverse acquisition shall be calculated by dividing;
(a) the profit or loss of the legal acquiree attributable to Ordinary Shareholders in each of those periods; by 
(b) the legal acquiree’s historical weighted average number of Ordinary Shares outstanding multiplied by the 

exchange ratio established in the acquisition agreement.

.082

HeiQ plcAnnual report and accounts 202012. Intangible assets

Cost

As at January 1, 2019
Additions arising from internal development
Currency translation differences

As at December 31, 2019
Additions through business combinations 
Additions arising from internal development
Currency translation differences

As at December 31, 2020

Amortization
As at January 1, 2019
Amortization for the year
Currency translation differences

As at December 31, 2019
Amortization for the year
Currency translation differences

As at December 31, 2020

Net book value
As at December 31, 2020

As at December 31, 2019

Goodwill
US$’000

Trademarks 
and patents
US$’000

Internally 
developed 
assets
US$’000

Brands
US$’000

Total
US$’000

3’393
–
–

3’393
123
–
–

3’516

–
–
–

–
–
–

–

3’516

3’393

378
39
–

417
–
33
41

491

170
78
1

249
70
31

350

141

168

1’030
79
19

1’128
–
602
121

1’851

336
41
7

384
11
37

432

1’419

744

295
–
–

295
–
–
–

295

48
30
–

78
29
–

107

188

217

5’096
118
19

5’233
123
635
162

6’153

554
149
8

711
110
68

889

5’264

4’522

Goodwill, brands and certain trademarks were recognized in earlier years arising from the acquisition of certain 
assets (the “Chem-Tex Assets’’) through a newly established subsidiary, HeiQ USA, in April 2017. 

Additional goodwill was recognized on the acquisition of MasFabEs S.L. in December 2020 as described in  
Note 5 above.

Goodwill acquired in a business combination is allocated, at acquisition, to the cash generating unit (‘CGU’) that is 
expected to benefit from that business combination. Management considers that the goodwill is attributable to 
the textile innovation CGU, because that is where the benefits are expected to arise from expansion opportunities 
and synergies of the business. The Directors consider that the Group has one reportable segment, that of textile 
innovation focused on scientific research, specialty materials manufacturing and consumer ingredient branding. 

The Group tests goodwill annually for impairment or more frequently if there are indications that these assets 
might be impaired. The recoverable amounts of the CGU are determined from fair value less costs to sale. The 
value of the goodwill comes from the future potential of the assets rather than using the assets as they are 
(i.e., there is assumed expansionary capex which supports growth in revenues and the value of the business 
and therefore goodwill).

The key assumptions for the fair value less costs to sale approach are those regarding sales prices, margins and 
a discount rate. 

The Group monitors its pre-tax Weighted Average Cost of Capital and those of its competitors using market data. 
In considering the discount rate applying to the CGU, the Directors have considered the relative size and risks of 
its CGU. 

The impairment review uses a discount rate adjusted for post-tax cash flows. The Group prepares cash flow 
forecasts derived from the most recent financial plan approved by the Board and extrapolates revenues, net 
margins and cash flows for the following five years based on forecast growth rates of the CGU. Cash flows beyond 
this period are also considered in assessing the need for any impairment provisions. A discount rate of 16% and 
expenditure of US$2’000’000 to maintain the assets in their current use over the five years has been assumed. 
The terminal growth rate used for the fair value calculation thereafter is 1%. The directors consider these 
assumptions are consistent with that which a market participant would use in determining fair value.

.083

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

12. Intangible assets continued

The Company tested goodwill for impairment and determined that the recoverable amount relating to the 
acquisition of the Chem-Tex Assets in excess of its carrying amount and therefore no impairment is 
considered necessary. 

In calculating the net present value of the future cash flows, certain key input assumptions were used, including:
•  Long-term revenue growth of 1% per annum
•  A gross margin of 47.5%
•  Capital expenditure of US$400’000 per annum
•  A discount rate of 16%

Goodwill in respect of MasFabEs S.L. was not tested as the business was acquired in December 2020 and the net 
assets recognized at their estimated fair value at this time. 

Internally developed assets and other intangibles
Internally generated assets represent expenditure incurred on development projects. 

The Group tests internally developed assets and other intangibles for impairment only if there are indications that 
these assets might be impaired. The Company has not identified any impairment indicators and accordingly, has 
concluded that no impairment is necessary.

13. Property, plant and equipment

Machinery 
and 
equipment
US$’000

Motor 
vehicles
US$’000

Computers 
and 
software
US$’000

Furniture
 and 
fixtures
US$’000

4’811
348
(7)
37

5’189

1’224
629
 (628)
365

6’779

1’393
504
(1)
21

1’917

42
538
 (607)
112

2’002

4’777

3’272

332
10
–
1

343

–
191
 (46)
4

492

109
71
–
–

180

–
84
 (24)
2

242

250

163

641
12
–
12

665

1
77
 (2)
69

100
–
–
–

100

12
35
 (18)
3

Total
US$’000

5’884
370
(7)
50

6’297

1’237
932
 (694)
441

810

132

8’213

150
127
–
8

285

–
142
–
37

464

346

380

21
10
–
–

31

–
12
 (7)
2

38

93

69

1’673
712
(1)
29

2’413

42
776
 (638)
153

2’746

5’467

3’884

Cost

As at January 1, 2019
Additions 
Disposals
Currency translation differences

As at December 31, 2019

Acquisition on business combination
Additions 
Disposals
Currency translation differences

As at December 31, 2020

Depreciation
As at January 1, 2019
Charge for the year
Disposals
Currency translation differences

As at December 31, 2019

Acquisition on business combination
Charge for the year
Eliminated on disposal
Currency translation differences

As at December 31, 2020

Net book value
As at December 31, 2020

As at December 31, 2019

.084

HeiQ plcAnnual report and accounts 202014. Right-of-use assets

Cost

As at January 1, 2019
Additions 

As at December 31, 2019
Additions 
Disposals due to expiry of lease
Currency translation differences

As at December 31, 2020

Depreciation
As at January 1, 2019
Depreciation for the year

As at December 31, 2019
Depreciation for the year
Disposals due to expiry of lease
Currency translation differences

As at December 31, 2020

Net book value
As at December 31, 2020

As at December 31, 2019

Land and 
buildings
US$’000

Motor 
vehicles
US$’000

Office 
equipment
US$’000

3’748
9

3’757
76
 (306)
174

3’701

698
379

1’077
345
 (306)
66

1’182

2’519

2’680

111
–

111
-
 (43)
8

76

61
19

80
16
 (43)
7

60

16

31

22
–

22
32
 (14)
1

41

13
6

19
7
 (14)
0

12

29

3

Total
US$’000

3’881
9

3’890
108
 (363)
183

3’818

772
404

1’176
368
 (363)
73

1’254

2’564

2’714

Future minimum lease payments associated with these leases were as follows:

Not later than one year
Later than one year and not later than five years
Later than five years

Total minimum lease payments
Less: Future finance charges

Present value of minimum lease payments

Current liability
Non-current liability

Present value of minimum lease payments

15. Other non-current assets

Deposits
Amounts due from third parties

Other non-current assets

As at
December 31,
2020
 US$’000

As at
December 31,
2019
US$’000

385
1’346
1’162

2’893
(240)

2’653

349
2’304

2’653

390
1’265
1’413

3’068
(284)

2’784

339
2’445

2’784

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

55
151

206

57
16

73

.085

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

16. Inventories

Raw materials
Semi-finished goods
Finished goods

Total inventories

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

7’951
2’692
2’685

13’328

1’045
956
1’201

3’202

17. Trade and other receivables

The majority of trade receivables are current, and the Directors believe these receivables are collectible. The 
Directors consistently assess the collectability of these receivables. As at December 31, 2020, the Directors 
considered a portion of these receivables uncollectible and recorded a provision in the amount of US$551’000 
(2019: US$174’000).

Trade receivables

Not past due
<30 days
31–60 days
61–90 days
91–120 days
>120 days

Total trade receivables

Provision for expected credit loss

Total trade receivables

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

 3’975 
 1’304 
 763 
 115 
 482 
 7’349 

13’988

(551)

13’437

 6’113 
 860 
 191 
 9 
–
 2’176 

9’349

(174)

9’175

The Group uses a simplified approach to recognize lifetime expected losses on trade and other receivables. 
Expected losses consider payment performance history, external information available regarding credit ratings as 
well as future expected credit losses.

The provision for expected loss rates is based on the Group’s historical credit losses experienced over the 
three-year period prior to the period end. Most significantly, in the case of take-or-pay contracts, the rate of 
provision is 5% for amounts more than one year past due, 20% for amounts more than two years past due and 
25% for amounts more than three years past due. The historical loss rates are then adjusted for current and 
forward-looking information on macroeconomic factors affecting the Group’s customers. The Directors have 
identified the gross domestic product, unemployment rate and inflation rate as the key macroeconomic factors 
in the countries in which the Group operates.

Other receivables and prepayments

Other receivables – from tax authorities
Prepayments and other receivables

Total other receivables and prepayments

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

1’372
1’237

2’609

262
80

342

.086

HeiQ plcAnnual report and accounts 202018. Share capital and share options

Movements in the Company’s share capital were as follows:

Balance as of January 1, 2019 and December 31, 
2019
Consolidation of shares
Placing of shares
Subscription for shares
Issue of shares to acquire HeiQ Materials AG
Shares issued in lieu of fees
Costs of share issues

Number of
shares
No.

Share
 capital
US$’000

Share
premium
US$’000

Totals
US$’000

Note

2’668’999
(i)
(1’779’346)
(ii)
11’789’142
6’068’000
(iii)
(iv) 106’759’900
385’209
(v)
–
(vi)

350
–
4’641
2’389
42’027
152
–

1’305
–
12’684
6’529
114’865
414
(1’260)

1’655
–
17’325
8’918
156’892
566
(1’260)

Balance as at December 31, 2020

125’891’904

49’559

134’537

184’096

The par value of all shares is £0.30. All shares in issue were allotted, called up and fully paid.

i.  On December 4, 2020, the Company’s share capital was reorganized such that every three existing Ordinary 

Shares of £0.10 each were consolidated into one new Ordinary Share of £0.30 each.

ii.  On the same date, the Company completed a conditional placing of 11’789’142 new Ordinary Shares in the 
capital of the Company at £1.12 per Ordinary Share, raising £13’203’839 (equivalent to US$17’325’158).

iii. A conditional subscription to raise gross proceeds of £6’796’160 (US$8’917’448), through the issue of 

6’068’000 new Ordinary Shares at £1.12 per share was also completed on the same date. 

iv.  On December 4’ 2020, the Company announced that it had agreed to acquire the entire issued and to 

be issued share capital of HeiQ Materials AG, the consideration for which was £119’571’088 (equivalent 
to US$156’892’850), satisfied by the issue and allotment to the HeiQ Shareholders of 106’759’900 
Consideration Shares at a deemed issue price of £1.12 per Ordinary Share. The Acquisition constituted 
a reverse takeover under the Listing Rules as it resulted in a fundamental change in the business and 
management of the Company. 

v.  On the same date, the Company issued a further 385’209 new Ordinary Shares at £1.12 per Ordinary Share to 
satisfy the payment of certain fees amounting to £431’434 (US$566’098) in connection with the acquisition.
vi. Costs directly associated with the raising of equity funds totaling £960’500 (US$1’260’275) were expensed 

against share premium.

For the purposes of the financial statements, each of the share transactions have been translated to US Dollars  
at £1:US$1.312.

Share Option Scheme
The Company has adopted the HeiQ plc Option Scheme.

Under the Option Scheme, awards may be made only to employees and Executive Directors. The Board will 
administer the Option Scheme with all decisions relating to awards made to Executive Directors taken by the 
Remuneration Committee.

Awards under the plan will be market value options, but participants resident in jurisdictions where local 
securities laws or other regulations are considered problematic may be awarded cash-based equivalents. Any 
awards made are not pensionable.

All awards made will be subject to one or more performance conditions at the discretion of the Board. Ordinary 
Shares received on exercise of any options awarded under the Option Scheme may be required to be held for a 
period of time before they can be disposed of (other than disposals to satisfy any tax payable on exercise).

The total number of Ordinary Shares which can be issued under the Option Scheme (together with any other 
employees’ share scheme operated by the Company) may not exceed 10% of the Company’s Ordinary Share 
capital from time to time.

A total of 6’260’000 awards were made under the Option Scheme pursuant to Re-admission on December 7, 2020.

The key performance indicators attaching to these awards relate to targets for sales growth (65% of the award) 
and operating margin (35% of the award) over a period of three years.

.087

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

18. Share capital and share options continued

An option-holder has no voting or dividend rights in the Company before the exercise of a share option.

The weighted average share price of options granted at grant date was £1.12 and the estimated fair value of each 
share option granted was £0.269. This estimated fair value was calculated by applying a Black-Scholes option 
pricing model. A 0.25% risk-free interest rate and an expected volatility of the Company’s share price has been 
used in these calculations. The weighted average exercise price of options granted during the year was £1.23.

The expense and equity reserve arising from these share-based payment transactions recognized in the year 
ended December 31, 2020 was US$50’000 (year ended December 31, 2019: nil).

Other share-based transactions
During the year ended December 31, 2020, HeiQ Materials AG issued 18’000 shares (2019: 9’000 shares) to 
employees in respect of contractual obligations for a total consideration of US$1’167’000 (2019: US$428’000).

19. Reserves

The share-based payment reserve arises from the requirement to value share options in existence at the year end 
at fair value. Further details of share options are included in Note 18.

The currency translation reserve represents cumulative foreign exchange differences arising from the translation 
of the financial statements of foreign subsidiaries and is not distributable by way of dividends.

The share premium account represents the amount received on the issue of Ordinary Shares by the Company in 
excess of their nominal value and is non-distributable.

The other reserve comprises the cumulative re-measurement of defined benefit obligations and plan assets to fair 
value and which are recognized as a component of other comprehensive income. Such actuarial gains and losses 
from defined benefit pension plans are not reclassified to profit or loss in subsequent periods.

The retained deficit comprises all other net gains and losses and transactions with owners not recognized 
elsewhere.

The merger reserve was created in accordance with IFRS3 ‘Business Combinations’. The merger reserve arises 
due to the elimination of the Company’s investment in HeiQ Materials AG. Since the shareholders of HeiQ 
Materials AG became the majority shareholders of the enlarged Group, the acquisition is accounted for as though 
there is a continuation of the legal subsidiary’s financial statements. In reverse acquisition accounting, the 
business combination’s costs are deemed to have been incurred by the legal subsidiary.

20. Pensions and other post-employment benefit plans

The Group operates a defined benefit pension plan in Switzerland, which requires contributions to be made to a 
separately administered fund. The cost of providing benefits under the defined benefit plan is determined using 
the projected unit credit method.

Correspondingly, the value of the defined benefit obligation at valuation date is equal to the present value of the 
accrued pro-rated service considering expected salary at eligibility date and the future pension increase.

The pension scheme is with Swisscanto pension fund (“Swisscanto Sammelstiftung”).

Pension plan description
The pension plans grant disability and death benefits which are defined as a percentage of the salary insured. 
Upon reaching retirement age, the savings capital will be converted with a fixed conversion rate into an  
old age pension. In the event that an employee leaves employment prior to reaching pensionable age, the 
cumulative balance of the savings account is withdrawn from the pension plan and invested into the pension 
plan of the employee’s new employer.

.088

HeiQ plcAnnual report and accounts 2020Regulatory framework
Pension plan legal structure
HeiQ Materials AG is affiliated to a collective foundation. The collective foundation operates one defined benefit 
pension plan for HeiQ Materials AG. Under Swiss law, all employees are required to be a member of the pension 
plan. There are minimum benefits requested by law (for old age, disability, death and termination). The pension 
plans cover more than legally requested. Each affiliated company has a pension plan committee. The committee 
is represented by 50% of employer representatives and the remaining 50% are employee representatives.

Responsibilities of the board of trustees (and/or the employer on the board of trustees)
The highest corporate body of the collective foundation is the board of trustees. The board of trustees is elected 
out of the affiliated companies and is also represented by 50% of employee and employer representatives (on the 
level of the collective foundation). This board handles the general management of the pension scheme, ensures 
compliance with the statutory requirements, defines the strategic objectives and policies of the pension scheme 
and identifies the resources for their implementation. This board decides also on the asset allocation and is 
responsible to the authorities for the correct administration of the collective foundation.

Special situation
The pension scheme has no minimum funding requirement (when the pension fund is in a surplus position), 
although the pension scheme has a minimum contribution requirement as specified below. Under local 
requirements, where a pension fund is operated in a surplus position, limited restrictions apply in term of the 
trustee’s ability to apply benefits to the members of the locally determined “free reserves”. In instances where the 
pension fund enters into an underfunded status as per statutory valuation (which follows different valuation 
principles than IFRS and is not to be compared with the funding status per IFRS mentioned above), the active 
members, along with the employer, are required to make additional contributions until such time the pension fund 
is in a fully funded position.

Funding arrangements that affect future contributions
Swiss law provides for minimum pension obligations on retirement. Swiss law also prescribes minimum annual 
funding requirements. An employer may provide or contribute a higher amount than as specified under Swiss law 
– such amounts are specified under the terms and conditions of each of the Swiss employee’s individual terms 
and conditions of employment.

In addition, employers are able to make one-off contributions or prepayments to these funds. Although these 
contributions cannot be withdrawn, they are available to the company to offset its future employer cash 
contributions to the plan. Although a surplus can exist in the fund, Swiss law requires minimum annual funding 
requirements to continue.

For the active members of the pension plan, annual contributions are required by both the employer and 
employee. The employer contributions must be at least equal to the employee contributions, but may be higher, 
separately mentioned in the constitution of the pension plan.

Minimum annual contribution obligations are determined with reference to an employee’s age and current salary; 
however, as indicated above these can be increased under the employee’s terms and conditions of employment.

In the event of the winding up of HeiQ Materials AG, or the pension fund, HeiQ Materials AG has no right to any 
refund of any surplus in the pension fund. Any surplus balance is allocated to the members (active and 
pensioners).

General risk
The Group faces the risk that its equity ratio can be affected by a poor performance of the assets of the pension 
fund or change of assumptions. Therefore, sensitivities of the main assumptions have been calculated and 
disclosed (see below).

The following tables summarize the components of net benefit expense recognized in the Statement of 
Comprehensive Income and the funded status and amounts recognized in the Statement of Financial Position 
for the plan:

.089

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

20. Pensions and other post-employment benefit plans continued

Net benefit obligations
The components of the net defined benefits obligations included in non-current liabilities are as follows:

Fair value of plan assets
Defined benefit obligation

Funded status (net liability)

Duration (years)
Expected benefits payable in following year

Development of obligations and assets

Present value of funded obligations, beginning of year
Employer service cost
Employee contributions
Past service cost
Interest cost
Benefits (paid)/refunded
Actuarial (loss)/gain on benefit obligation
Currency (loss)/gain

Present value of funded obligations, end of year
Defined benefit obligation participants
Defined benefit obligation pensioners

Defined benefit obligation, end of year

Fair value of plan assets, beginning of year
Expected return on plan assets
Employer’s contributions
Employees’ contributions
Benefits (paid)/refunded
Admin expense
Actuarial gain/(loss) on plan assets
Currency gain

Fair value of plan assets, end of year

Movements in net liability recognized in statement of financial position:

Net liability, beginning of year
Expense recognized in profit and loss
Employer’s contributions (following year expected contributions)
Prepaid/(accrued) pension cost:
– operating income/(expense)
– finance expense
Total gains recognized within other comprehensive income
Currency loss

Net liability, end of year

Actual return on plan assets
Expected employer’s cash contributions for following year

.090

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

 6’311 
 (9’587)

 (3’276)

 18.9 
 (269)

4’454
(6’374)

(1’920)

19.0
(194)

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

 (6’374)
 (391)
 (237)
 – 
 (21)
 (1’044)
 (809)
 (711)

 (9’587)
 (8’942)
 (645)

 (9’587)

 4’454 
 14 
 237 
 237 
 1’044
 (15)
 (141)
 481

6’311

(6’178)
(356)
(213)
301
(53)
784
(544)
(115)

(6’374)
(5’775)
(599)

(6’374)

4’420
38
213
213
(784)
(14)
289
79

4’454

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

 (1’920)
 (413)
 237 
 176 
 (169)
 (7)
 (950)
 (230)

 (3’276)

–2.37%
295

(1’758)
(85)
213
(129)
144
(15)
(256)
(34)

(1’920)

7.50%
212

HeiQ plcAnnual report and accounts 2020Asset allocation

Cash
Bonds
Equities
Property (incl. mortgages)
Other

Total

Amounts recognized in other comprehensive income 

Actuarial (losses)/gains arising from plan experience
Actuarial gains/(losses) arising from financial assumptions

Re-measurement of defined benefit obligations

Re-measurement of assets

Deferred tax asset recognized
Other

Total recognized in OCI

As at
December 31,
2020

As at
December 31,
2019

0.5%
24.5%
34.5%
24.2%
16.3%

0.6%
24.5%
34.6%
18.8%
21.5%

100.0%

100.0%

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

(553)
(256)

(809)

(141)

286
(96)

(760)

177
(722)

(544)

289

51
–

(204)

Principal actuarial assumptions (beginning of year)
The principal assumptions used in determining pension and post-employment benefit obligations for the plan are 
shown below:

Discount rate
Interest credit rate
Expected net return on plan assets
Average future salary increases
Future pension increases
Mortality tables used
Average retirement age
Expected life expectation at regular retirement age (male/female)

Sensitivities
A quantitative sensitivity analysis for significant assumptions is as follows:

Sensitivities

Impact on defined benefit obligation

Discount rate + 0.25%
Discount rate – 0.25%
Salary increase + 0.25%
Salary decrease – 0.25%
Pension increase + 0.25%
Pension decrease – 0.25% (not lower than 0%)

As at
December 31,
2020

0.30%
1.00%
0.30%
1.50%
0.00%
BVG 2015 GT
65/64
22.83/25.85

As at
December 31,
2019

0.90%
1.00%
0.90%
1.50%
0.00%
BVG 2015 GT
65/64
22.61/25.64

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

 (401)
 432 
 61 
 (59)
 216 
–

(293)
315
49
(48)
156
–

A negative value corresponds to a reduction of the defined benefit obligation, a positive value to an increase of 
the defined benefit obligation.

The sensitivity analyses above have been determined based on a method that extrapolates the impact on the 
defined benefit obligation as a result of reasonable changes in key assumptions occurring at the end of the 
reporting period. The sensitivity analyses are based on a change in a significant assumption, keeping all other 
assumptions constant. The sensitivity analyses may not be representative of an actual change in the defined 
benefit obligation as it is unlikely that changes in assumptions would occur in isolation from one another.

.091

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

21. Other non-current liabilities 

Defined benefit obligation IAS 19 (Note 20)
Deferred consideration in relation to the acquisition of the Chem-Tex Assets (see below)
Other non-current liabilities

Other non-current liabilities

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

3’276
149
–

3’425

1’920
856
4

2’780

Deferred consideration pertains to the acquisition of assets from Chem-Tex Inc. in 2017 and is payable other than 
in a short timeframe. The fair value of the deferred consideration has been discounted using an imputed interest 
rate of 6% (being the Group’s estimated cost of debt) to take into account the time value of money.

The deferred consideration and related financing expense are summarized below:

Consideration:
Balance brought forward
Amortization of fair value discount
Consideration settled in cash
Foreign exchange differences

Deferred consideration carried forward

Current liability
Non-current liability

Total

As at 
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

2’103
245
(1’267)
35

1’116

967
149

1’116

3’102
245
(1’290)
46

2’103

1’247
856

2’103

The maturity profile of other non-current liabilities is shown in paragraph (g) “Liquidity risk” of Note 25 “Financial 
risk management” to the Consolidated Financial Statements.

22. Borrowings

As at December 31, 2020, the Group’s borrowings consist primarily of:
•  a bank loan taken out in October 2020 which incurs interest at 2.25% and which is secured on property owned 
by a company which is controlled by a minority shareholder of HeiQ Medica. It is repayable in equal monthly 
instalments of €8’000 (US$9’500) over eight years up to September 2028. As at December 31, 2020, 
€777’000 (US$951’000) is outstanding – the short-term portion being €93’000 (US$114’000) and the 
long-term portion being €684’000 (US$838’000);

•  a loan of €459’000 (US$562’000) payable to a company controlled by a minority shareholder of HeiQ Medica. 

The loan is repayable by December 31, 2022 and does not incur any interest; and

•  a short-term bank loan of €45’000 (US$55’000) which was repaid in January 2021 and did not incur any 

interest.

In 2019, the Group’s borrowings consisted of a short-term revolving credit facility which incurred interest at Libor 
plus a margin of 0.8%. This loan was repaid during 2020.

.092

HeiQ plcAnnual report and accounts 2020The following table provides a reconciliation of the Group’s future maturities of its total borrowings for each year 
presented:

Not later than one year
Later than one year but less than five years
After more than five years

Total borrowings

The following table represents the Group’s finance costs for each year presented:

Amortization of deferred finance costs – acquisition costs
Lease finance expense
Interest on borrowings
Bank fees
Loss on foreign currency transactions

Total finance costs

23. Other current liabilities

Deferred consideration in relation to the acquisition of the Chem-Tex Assets (Note 21)

Other current liabilities

24. Fair value and financial instruments

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

173
1’043
357

1’573

2’478
–
–

2’478

Year ended
December 31,
2020
US$’000

Year ended
December 31,
2019
US$’000

245
52
108
46
733

1’184

245
58
88
33
4

428

As at
December 31,
2020
US$’000

As at
December 31,
2019
US$’000

967

967

1’247

1’247

a. Fair value
The fair value of an asset or liability is the price that would be received to sell that asset or paid to transfer that 
liability in an orderly transaction occurring in the principal market (or most advantageous market in the absence of 
a principal market) for such asset or liability. In estimating fair value, the Directors utilize valuation techniques 
that are consistent with the market approach, the income approach and/or the cost approach. Such valuation 
techniques are consistently applied. Inputs to valuation techniques include the assumptions that market 
participants would use in pricing an asset or liability. IFRS 13 “Fair Value Measurement” establishes a fair value 
hierarchy for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets 
or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is defined as follows: 

Level 1: Inputs are unadjusted, quoted prices in active markets for identical assets at the measurement date. 

Level 2: Inputs (other than quoted prices included in Level 1) can include the following: 
•  observable prices in active markets for similar assets; 
•  prices for identical assets in markets that are not active; 
•  directly observable market inputs for substantially the full term of the asset; and 
•  market inputs that are not directly observable but are derived from or corroborated by observable market data. 

Level 3: Unobservable inputs which reflect the Directors’ best estimates of what market participants would use in 
pricing the asset at the measurement date. 

All financial instruments measured at fair value use Level 2 valuation techniques for the each of the years ended 
December 31, 2019 and December 31, 2020.

.093

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

24. Fair value and financial instruments continued

Level 2 fair value measurements are those including inputs other than quoted prices included within Level 1 that 
are observable for the asset or liability directly or indirectly. 

There were no transfers between fair value levels during the year ended December 31, 2020 (2019: none).

b. Financial instruments
For trade receivables, the Group applies the simplified approach permitted by IFRS 9 “Financial Instruments”, 
which requires expected lifetime losses to be recognized from initial recognition of the receivables.

Financial liabilities are initially measured at fair value and subsequently measured at amortized cost.

The Group is not a financial institution. The Group does not apply hedge accounting and its customers are 
considered creditworthy and pay consistently within agreed payments terms.

A classification of the Group’s financial instruments is included in the table below:

Cash and cash equivalents held at amortized cost
Trade receivables and accrued income held at amortized cost
Financial assets at amortized cost
Financial liabilities at amortized cost
Borrowings and leases

Total

25. Financial risk management

As at 
December 31,
2020
US$’000

As at 
December 31,
2019
US$’000

25’695
13’437
2’815
(14’820)
(4’225)

22’902

3’603
9’175
415
(9’070)
(5’262)

(1’139)

For the purposes of capital management, capital includes issued capital and all other equity reserves attributable 
to the equity holders of the Company. The primary objective of the Directors’ capital management is to ensure that 
the Group maintains a strong credit rating and healthy capital ratios in order to support its business and maximize 
shareholder value.

To maintain or adjust the capital structure, the Directors may adjust the dividend payment to shareholders, return 
capital to shareholders or issue new shares. No changes were made in the objectives, policies or processes 
during the year.

The Directors manage the Group’s capital structure and adjust it in light of changes in economic conditions and 
the requirements of the financial covenants. The Group includes in its net debt, interest-bearing loans and 
borrowings, trade and other payables, less cash and short-term deposits.

The Group’s principal financial liabilities comprise borrowings and trade and other payables, which it uses 
primarily to finance and financially guarantee its operations.

The Group’s principal financial assets include cash and cash equivalents and trade and other receivables derived 
from its operations.

a. Market risk 
Market risk is the risk that changes in market prices, such as foreign exchange rates and interest rates, will affect 
the Group’s income or the value of its holdings of financial instruments. The objective of market risk management 
is to manage and control market risk exposures within acceptable parameters, while optimizing the returns.

b. Interest rate risk 
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because 
of changes in market interest rates. As the Group’s borrowings are either on fixed interest terms or interest-free, 
the Group is not subject to interest rate risk.

c. Credit risk
Credit risk is the risk that a customer or counterparty to a financial instrument will not meet its obligations under 
a contract and arises primarily from the Group’s cash in banks and trade receivables.

.094

HeiQ plcAnnual report and accounts 2020d. Foreign currency risk
Foreign currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate due to changes 
in foreign exchange rates. The Group’s exposure to the risk of changes in foreign exchange rates relates primarily 
to its financing activities (when financial liabilities and cash are denominated other than in a company’s functional 
currency).

Most of the Group’s transactions are carried out in US Dollars (US$). Foreign currency risk is monitored closely on 
an ongoing basis to ensure that the net exposure is at an acceptable level.

The Group maintains a natural hedge whenever possible, by matching the cash inflows (revenue stream) and cash 
outflows used for purposes such as capital and operational expenditure in the respective currencies. The Group’s 
net exposure to foreign exchange risk was as follows:

Functional currency

As at December 31, 2020

CNY
US$’000

EUR
US$’000

GBP
US$’000

Financial assets denominated in US$
Financial liabilities denominated in US$

Net foreign currency exposure

248
 (102)

146

2’145
 (268)

1’877

As at December 31, 2019

Financial assets denominated in US$
Financial liabilities denominated in US$

CNY
US$’000

 2’030 
–

EUR
US$’000

 2’253 
 (200)

Net foreign currency exposure

 2’030 

 2’053 

US$
US$’000

17’190
 (129)

717
 (475)

242

17’061

Functional currency

GBP
US$’000

 8 
 (96)

 (88)

US$
US$’000

 7’093 
 (7)

 7’086 

Others
US$’000

5
 23 

28

Total
US$’000

20’305
 (951)

19’354

Others
US$’000

Total
US$’000

 2 
21

 11’386 
 (282)

 23

 11’104 

Foreign currency sensitivity analysis:
The following tables demonstrate the sensitivity to a reasonably possible change in foreign currency exchange 
rates, with all other variables held constant. 

The impact on the Group’s profit before tax is due to changes in the fair value of monetary assets and liabilities. 
The Group’s exposure to foreign currency changes for all other currencies is not material.

A 10% movement in each of the Chinese Yuan (CNY), Euro (EUR), British Pound (GBP) and US Dollar (US$) would 
increase/(decrease) net assets by the amounts shown below. This analysis assumes that all other variables, in 
particular interest rates, remain constant.

As at December 31, 2020

Effect on net assets:
Strengthened by 10%
Weakened by 10%

As at December 31, 2019

Effect on net assets:
Strengthened by 10%
Weakened by 10%

CNY
US$’000

EUR
US$’000

GBP
US$’000

US$
US$’000

Others
US$’000

 15 
 (15)

 188 
 (188)

 24 
 (24)

 1’706 
 (1’706)

 3
 (3) 

CNY
US$’000

EUR
US$’000

GBP
US$’000

US$
US$’000

Others
US$’000

203
(203)

205
(205)

(9)
9

709
(709)

2
(2)

e. Cash and cash equivalents
The credit risk from its cash and cash equivalents is limited because the counterparties are banks with high credit 
ratings and have not experienced any losses in such accounts.

.095

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Consolidated Financial Statements continued
For the year ended December 31, 2020

25. Financial risk management continued

f. Trade receivables
Trade receivables are due from customers and collectability is dependent on the financial condition of each 
individual company as well as the general economic conditions of the industry. The Directors review the financial 
condition of customers prior to extending credit and generally does not require collateral in support of the Group’s 
trade receivables. The majority of trade receivables are current and the Directors believe these receivables are 
collectible. As at December 31, 2020, the Group had two customers that individually accounted for more than 
10% of total receivables, totaling 38% of total trade receivables (2019: two customers that individually accounted 
for more than 10% of total receivables, totaling 65%).

g. Liquidity risk
Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they are due. The 
Directors manage this risk by:
•  maintaining adequate cash reserves through the use of the Group’s cash from operations and bank 

borrowings; and

•  continuously monitoring projected and actual cash flows to ensure the Group maintains an appropriate amount 

of liquidity.

The table below summarizes the maturity profile of the Group’s financial liabilities, based on contractual 
undiscounted payments:

Year ended December 31, 2020

Trade and other payables
Borrowings
Leases (gross cash flows)
Other liabilities
Retirement obligations

As at December 31, 2020

Year ended December 31, 2019

Trade and other payables
Borrowings
Leases (gross cash flows)
Other liabilities
Retirement obligations

As at December 31, 2019

Less than
1 year
US$’000

 5’815 
 1’573 
 385 
 4’283 
–

2 to 5
years
US$’000

–
–
 1’346 
 5’675 
–

> 5
years
US$’000

–
–
 1’162 
–
3’276

Total
US$’000

5’815
1’573
2’893
9’958
3’276

 12’056 

 7’021 

 4’438 

 23’515 

Less than
1 year
US$’000

1’930
2’478
390
4’360
–

9’158

2 to 5
years
US$’000

–
–
1’265
2’780
–

4’045

> 5
years
US$’000

–
–
1’413
–
1’920

Total
US$’000

1’930
2’478
3’068
7’140
1’920

3’333

16’536

26. Notes to the statements of cash flows

Net debt reconciliation:

Year ended December 31, 2020

Cash and cash equivalents
Leases
Borrowings

Totals

Opening 
balances
US$’000

New 
agreements
US$’000

 3’603 
 (2’784)
 (2’478)

 (1’659)

 – 
 (222)
 (61)

 (283)

Assumed on 
acquisition 
of 
subsidiaries
US$’000

Cash 
movements
US$’000

Foreign 
exchange 
differences
US$’000

 – 
 – 
 (1’512)

 21’822 
 354 
 2’735 

 270 
 – 
 (257)

Closing 
balances
US$’000

 25’695 
 (2’652)
 (1’573)

 (1’512)

 24’911 

 13 

 21’470 

.096

HeiQ plcAnnual report and accounts 2020Year ended December 31, 2019

Cash and cash equivalents
Leases
Borrowings

Totals

Reconciliation of cash on business combinations:

Cash assumed on reverse acquisition of HeiQ plc 
Cash assumed on acquisition of HeiQ Medica

Cash assumed on acquisitions of businesses 

Consideration payment for acquisition of Chem-Tex
Consideration payment for acquisition of HeiQ Medica

Consideration payment for acquisitions of businesses

27. Contingencies and provisions

Opening 
balances
US$’000

New 
agreements
US$’000

Cash 
movements
US$’000

2’163
(3’162)
(1’522)

(2’521)

–
(8)
–

(8)

1’420
386
(929)

877

Foreign 
exchange 
differences
US$’000

20
–
(27)

(7)

Closing 
balances
US$’000

3’603
(2’784)
(2’478)

(1’659)

27’105
6

27’111

(1’267)
(157)

(1’424)

The Directors are not aware of any contingencies or other provisions which might impact on the Group’s 
operations or financial position. 

28. Related party transactions

Two companies controlled by a director of HeiQ USA are the landlord for two buildings in the United States which 
are leased to HeiQ USA. These leases have been capitalized as right-of-use assets in accordance with IFRS 16 
“Leases”. The total amount paid during the year ended December 31, 2020 was US$160’000 (2019: US$160’000).

A company controlled by a director of HeiQ Materials AG supplied materials and services totaling US$145’000 in 
the year ended December 31, 2020 (2019: US$48’000).

As at December 31, 2020, the Group has a balance receivable from its associated company, HeiQ-RAS GmbH, 
of US$17’000 (2019: US$nil).

A bank loan of €800’000 (US$950’000) is secured on property owned by a company which is controlled by 
a minority shareholder of HeiQ Medica. 

A loan of €459’000 (US$562’000) is payable to a company controlled by minority shareholders of HeiQ Medica. 
See note 22 for further details.

Details of the remuneration of the directors are contained in the Remuneration Committee Report on pages  
50 to 53.

29. Material subsequent events

On March 9, 2021, HeiQ Iberia Unipessoal Lda acquired 51% of the share capital and voting rights of Chrisal NV, 
a company incorporated in Belgium, to be renamed HeiQ Chrisal. Chrisal NV is a biotechnology company and a 
leader in innovative ingredients and consumer products that incorporate the benefits of probiotics and synbiotics. 
It has three technology platforms, all with the purpose of creating healthy and sustainable microbial ecosystems. 
The application of its proprietary technology includes cosmetics, personal care, textiles, wound dressings, water 
purification, air treatment and cleaning products. The company has its office, manufacturing site and bottling 
facility in Lommel, Belgium.

The purchase consideration was payable partly in cash (€5’000’000) and partly by the issue of 1’101’928 
new ordinary shares for €2’500’000.

The acquisition is part of the Group’s strategy of becoming a global leader in materials innovation and allows 
access to the broader market of microbial surface management and a bio-based green complementary 
technology platform to its successful antimicrobials.

30. Ultimate controlling party

As at December 31, 2020, the Company did not have any single identifiable controlling party.

.097

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Company Statement of Financial Position  
(registered company number: 09040064)
As at December 31, 2020

ASSETS
Non-current assets
Investments
Amounts due from subsidiaries

Current assets
Trade and other receivables
Cash and bank balances

TOTAL ASSETS

LIABILITIES
Current liabilities
Trade and other payables

NET ASSETS

EQUITY
Share capital
Share premium account
Share-based payment reserve
Accumulated losses

TOTAL EQUITY

As at
December 31, 
2020
£’000

As at
December 31, 
2019
£’000

Note

4
5

7
6

8

9
9
10

119’571
18’000

137’571

191
1’554

1’745

139’316

(483)

(483)

138’833

37’767
102’536
38
(1’508)

138’833

–
–

–

15
859

874

874

(18)

(18)

856

267
994
–
(405)

856

The Company has taken advantage of Section 408 of the Companies Act 2006 and has not included a Profit and 
Loss account in these separate financial statements. The loss attributable to members of the Company for the 
year ended December 31, 2020 is £1’103’000 (year ended December 31, 2019: loss of £57’000).

The notes on pages 101 to 106 form an integral part of these Financial Statements. The Financial Statements on 
pages 98 to 100 were authorized for issue by the board of Directors on April 23, 2021 and were signed on its 
behalf by:

Xaver Hangartner
Director

.098

HeiQ plcAnnual report and accounts 2020Company Statement of Changes in Equity
For the year ended December 31, 2020

For the year ended December 31, 2019:
Balance as at January 1, 2019
Loss for the year

Balance as at December 31, 2019

For the year ended December 31, 2020:
Loss for the year
Issue of shares
Cost of issuing shares
Share-based payment charges
Transactions with owners

Balance as at December 31, 2020

Share 
premium 
account 
£’000

Share-based 
payment 
reserve 
£’000

Accumulated
losses
£’000

Share 
capital 
£’000

267
–

267

994
–

994

–
37’500
–
–
37’500

–
102’502
(960)
–
101’542

37’767

102’536

–
–

–

–
–
–
38
38

38

The Notes on pages 101 to 106 are an integral part of these financial statements.

Total 
£’000

913
(57)

856

(348)
(57)

(405)

(1’103)
–
–
–
–

(1’103)
140’002
(960)
38
139’080

(1’508) 138’833

.099

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Company Statement of Cash Flows
For the year ended December 31, 2020

Cash flows from operating activities

Loss before taxation
Cash flow from operations reconciliation:
Finance income
Share-based payment charges
Transaction costs settled in shares
Working capital adjustments:
(Increase) in trade and other receivables
Increase in trade and other payables

Cash used in operations
Taxes paid

Net cash used in operating activities

Cash flows from investing activities
Finance income
Amounts advanced to subsidiaries

Net cash used in investing activities

Cash flows from financing activities
Proceeds from equity issuance
Costs of share issues

Net cash from financing activities

Net increase/(decrease) in cash and cash equivalents

Cash and cash equivalents – beginning of the year

Cash and cash equivalents – end of the year

Year ended
December 31,
2020
£’000

Year ended
December 31,
2019
£’000

(1’103)

(57)

(21)
38
431

(180)
469

(366)
–

(366)

21
(18’000)

(17’979)

20’000
(960)

19’040

695

859

1’554

–
–
–

(4)
–

(61)
–

(61)

–
–

–

–
–

–

(61)

920

859

.100

HeiQ plcAnnual report and accounts 2020Notes to the Company Financial Statements 
For the year ended December 31, 2020

1. General information

The Company was incorporated on May 14, 2014 as Auctus Growth Limited, in England and Wales under the 
Companies Act 2006 with company number 09040064, with an investment strategy to undertake an acquisition 
of a target company or business. The Company was re-registered as a public company on July 24, 2014. 
On December 4, 2020, the Company’s name was changed to HeiQ plc. The Company’s registered office is 
5th Floor, 15 Whitehall, London, SW1A 2DD.

The Company was admitted to listing on the Official List by way of a Standard Listing in accordance with Chapter 
14 of the Listing Rules and to trading on the London Stock Exchange’s Main Market for listed securities on 
August 22, 2014. 

Following the reverse takeover by the Company of HeiQ Materials AG (“HeiQ”), an established global brand in 
materials and textile innovation, the Company’s enlarged share capital was admitted to the standard segment 
of the Official List and initiation of trading on the London Stock Exchange’s Main Market commenced on 
December 7, 2020 under the ticker ‘HEIQ’. The ISIN of the Ordinary Shares is GB00BN2CJ299 and the SEDOL 
Code is BN2CJ29.

The principal activity of the Company is that of a holding company for the Group, as well as performing all 
administrative, corporate finance, strategic and governance functions of the Group. 

The Company’s financial statements are prepared in Pounds Sterling, which is the presentational currency for 
the financial statements.

2. Summary of significant accounting policies

(a) Basis of preparation
These financial statements have been prepared in accordance with IFRS, issued by the International Accounting 
Standards Board, including interpretations issued by the International Financial Reporting Interpretations 
Committee, applicable to companies reporting under IFRS, and the Companies Act 2006 applicable to companies 
reporting under IFRS.

These financial statements are prepared under the historical cost convention. Historical cost is generally based on 
the fair value of the consideration given in exchange of assets. The principal accounting policies are set out below.

The Company produces consolidated accounts which include the results of the Company.

The financial statements have been prepared on a going concern basis which contemplates the continuity of 
normal business activities and the realization of assets and the settlement of liabilities in the ordinary course  
of business. 

The Directors have assessed the Company’s ability to continue in operational existence for the foreseeable future 
in accordance with the Financial Reporting Council’s Guidance on the going concern basis of accounting and 
reporting on solvency and liquidity risks issued in April 2016.

The Company has prepared forecasts and projections which reflect the expected trading performance of the 
Company and the Group on the basis of best estimates of management using current knowledge and 
expectations of trading performance. 

As at December 31, 2020, the Company had £1’554’000 (2019: £859’000) in cash, which is considered 
sufficient for its present needs. 

Based on the above, the Directors consider there are reasonable grounds to believe that the Company will be able 
to pay its debts as and when they become due and payable, as well as to fund the Company’s future operating 
expenses. The going concern basis preparation is therefore considered to be appropriate in preparing these 
financial statements.

(b) Investments
Investments are carried at cost less, where appropriate, any provision for impairment.

.101

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020 
 
Financial statements
Notes to the Company Financial Statements continued
For the year ended December 31, 2020

2. Summary of significant accounting policies continued

(c) Loans to subsidiaries 
Loans to subsidiaries are measured at the present value of the future cash payments discounted at a market rate 
of interest for a similar debt instrument unless such amounts are repayable on demand. The present value of 
loans that are repayable on demand is equal to the undiscounted cash amount payable reflecting the Company’s 
right to demand immediate repayment.

(d) Foreign currencies
Transactions in foreign currencies are recorded using the rate of exchange ruling at the date of the transaction. 
Monetary assets and liabilities denominated in foreign currencies are translated using the contracted rate or the 
rate of exchange ruling at the statement of financial position date and the gains or losses on translation are 
included in the profit and loss account.

(e) Cash and cash equivalents
Cash and cash equivalents comprise cash in hand, bank balances, deposits with financial institutions and 
short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject 
to an insignificant risk of changes in value.

(f) Trade and other receivables
Trade and other receivables are recognized initially at fair value and subsequently measured at amortized cost 
using the effective interest method, less provision for impairment.

(g) Income taxes
The charge for taxation is based on the profit/loss for the year and takes into account taxation deferred because 
of timing differences between the treatment of certain items for taxation and accounting purposes.

Deferred tax is provided on timing differences which arise from the inclusion of income and expenses in tax 
assessments in periods different from those in which they are recognized in the financial statements. The 
following timing differences are not provided for: differences between accumulated depreciation and tax 
allowances for the cost of a fixed asset if and when all conditions for retaining the tax allowances have been met; 
and differences relating to investments in subsidiaries, to the extent that it is not probable that they will reverse in 
the foreseeable future and the reporting entity is able to control the reversal of the timing difference. Deferred tax 
is not recognized on permanent differences arising because certain types of income or expense are non-taxable 
or are disallowable for tax or because certain tax charges or allowances are greater or smaller than the 
corresponding income or expense.

(h) Share-based payment arrangements 
Equity-settled share-based payments to employees are measured at the fair value of the equity instruments at 
the grant date. Equity-settled share-based payments to non-employees are measured at the fair value of services 
received, or if this cannot be measured, at the fair value of the equity instruments granted at the date that the 
Company obtains the goods or counterparty renders the service. Details regarding the determination of the fair 
value of equity-settled share-based transactions are set out in Note 18 to the Consolidated Financial Statements.

The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-
line basis over the vesting period, based on the Group’s estimate of equity instruments that will eventually vest, 
with a corresponding increase in equity. Where the conditions are non-vesting, the expense and equity reserve 
arising from share-based payment transactions is recognized in full immediately on grant.

At the end of each reporting period, the Group revises its estimate of the number of equity instruments expected 
to vest. The impact of the revision of the original estimates, if any, is recognized in profit or loss such that the 
cumulative expense reflects the revised estimate, with a corresponding adjustment to other reserves.

(i) Trade and other payables
Trade and other payables are initially recognized at fair value and thereafter stated at amortized cost using 
the effective interest method unless the effect of discounting would be immaterial, in which case they are stated 
at cost. 

(j) Share capital
Proceeds from issuance of Ordinary Shares are classified as equity. Incremental costs directly attributable to the 
issuance of new Ordinary Shares or options are shown in equity as a deduction from the proceeds.

.102

HeiQ plcAnnual report and accounts 2020(k) Financial instruments
Financial instruments are recognized in the statements of financial position when the Company has become 
a party to the contractual provisions of the instruments.

Financial instruments are classified as liabilities or equity in accordance with the substance of the contractual 
arrangement. Interest, dividends, gains and losses relating to a financial instrument classified as a liability are 
reported as an expense or income. Distributions to holders of financial instruments classified as equity are 
charged directly to equity.

Financial instruments are offset when the Company has a legally enforceable right to offset and intends to settle 
either on a net basis or to realize the asset and settle the liability simultaneously.

A financial instrument is recognized initially at its fair value plus, in the case of a financial instrument not at fair 
value through profit or loss, transaction costs that are directly attributable to the acquisition or issue of the 
financial instrument.

Financial instruments recognized in the statements of financial position are disclosed in the individual policy 
statement associated with each item.

(i) Financial liabilities
Financial liabilities are recognized when, and only when, the Company becomes a party to the contractual 
provisions of the financial instrument.

All financial liabilities are recognized initially at fair value plus directly attributable transaction costs and 
subsequently measured at amortized cost using the effective interest method other than those categorized  
as fair value through profit or loss.

Fair value through profit or loss category comprises financial liabilities that are either held for trading or are 
designated to eliminate or significantly reduce a measurement or recognition inconsistency that would otherwise 
arise. Derivatives are also classified as held for trading unless they are designated as hedges. There were no 
financial liabilities classified under this category.

A financial liability is derecognized when the obligation under the liability is discharged, cancelled or expires. When 
an existing financial liability is replaced by another from the same party on substantially different terms, or the 
terms of an existing liability are substantially modified, such an exchange or modification is treated as a 
derecognition of the original liability and the recognition of a new liability, and the difference in the respective 
carrying amounts is recognized in the profit or loss. 

(ii) Equity instruments
Ordinary Shares are classified as equity. Dividends on Ordinary Shares are recognized as liabilities when approved 
for appropriation.

(iii) Other financial instruments
Other financial instruments not meeting the definition of basic financial instruments are recognized initially at fair 
value. Subsequent to initial recognition, other financial instruments are measured at fair value with changes 
recognized in profit or loss except investments in equity instruments that are not publicly traded and whose  
fair value cannot otherwise be measured reliably shall be measured at cost less impairment.

.103

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Company Financial Statements continued
For the year ended December 31, 2020

3. Critical accounting judgments and key sources of estimation uncertainty

In the application of the Company’s accounting policies, which are described in Note 2, management is required 
to make judgments, estimates and assumptions about the carrying values of assets and liabilities that are not 
readily apparent from other sources. The estimates and underlying assumptions are based on historical 
experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates 
are recognized in the period in which the estimate is revised if the revision affects only that period or in the period 
of the revision and future periods if the revision affects both current and future periods.

The key sources of judgment that have a significant effect on the amounts recognized in the financial statements 
are described below.

Impairment of investments and amounts due from subsidiaries
As described in Note 2 to the financial statements, investments are stated at the lower of cost less provision for 
impairment. The present value of loans to subsidiaries that are repayable on demand is equal to the undiscounted 
cash amount payable reflecting the Company’s right to demand immediate repayment.

At each reporting date investments and loans made to subsidiaries are reviewed to determine whether there is 
any indication that those assets have suffered an impairment loss. If there is an indication of possible 
impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount.  
If the estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable 
amount, and an impairment loss is recognized immediately in profit or loss. The Directors have carried out an 
impairment test on the value of the loans due from subsidiaries and have concluded that no impairment provision 
is necessary.

The investments in and loans to subsidiaries are supported by the intangible assets in the subsidiaries, tangible 
fixed assets, cash and receivables. 

The Company tests investments in and loans receivable from subsidiaries for impairment only if there are 
indications that these assets might be impaired. The Company considers that there are no such indications of 
impairment and impairment testing has not been performed. Accordingly, the Company considers that the value 
of investments in and loans to subsidiaries are not impaired.

4. Investments

Investments in subsidiary undertakings

Balance brought forward 
Additions

Balance at end of year 

As at
December 31,
2020
£’000

As at
 December 31,
2019
£’000

–
119’571

119’571

–
–

–

Details of the Company’s subsidiaries as at December 31, 2020 are set out in Note 6 to the Consolidated 
Financial Statements.

5. Amounts due from subsidiaries

Balance brought forward at beginning of year 
Amounts advanced

Balance at end of year 

As at
December 31,
2020
£’000

As at
 December 31,
2019
£’000

–
18’000

18’000

–
–

–

The amounts owing from subsidiaries are unsecured, interest-free and are to be settled in cash. The present value 
of amounts that are repayable on demand is equal to the undiscounted cash amount payable, reflecting the 
Company’s right to demand immediate repayment.

.104

HeiQ plcAnnual report and accounts 20206. Cash and cash equivalents

Bank balances 

Cash and cash equivalents

7. Trade and other receivables

Prepayments
VAT receivable
Other receivables

Trade and other receivables

8. Trade and other payables

Trade payables
Accruals
Taxes and social security
Other payables

Trade and other payables

As at
December 31,
2020
£’000

As at
December 31,
2019
£’000

1’554

1’554

859

859

As at
December 31,
2020
£’000

As at
 December 31,
2019
£’000

88
67
36

191

11
–
4

15

As at
December 31,
2020
£’000

As at
December 31,
2019
£’000

226
230
7
20

483

–
18
–
–

18

The Directors consider that the carrying amounts of amounts falling due within one year approximate to their 
fair values.

9. Share capital and share options

Share capital
Details of the Company’s allotted, called-up and fully paid share capital are set out in Note 18 to the Consolidated 
Financial Statements.

Movements in the Company’s share capital were as follows:

Balance as of January 1, 2019 and December 31, 2019
Consolidation of shares
Placing of shares
Subscription for shares
Issue of shares to acquire HeiQ Materials AG
Shares issued in lieu of fees
Costs of share issues

Balance as at December 31, 2020

Number of
shares
No.

2’668’999
(1’779’346)
11’789’142
6’068’000
106’759’900
385’209
–

125’891’904

Share
 capital
£’000

267
–
3’537
1’820
32’028
115
–

37’767

Share
premium
£’000

994
–
9’667
4’976
87’543
316
(960)

Totals
£’000

1’261
–
13’204
6’796
119’571
431
(960)

102’536

140’303

The par value of all shares is £0.30. All shares in issue were allotted, called up and fully paid. The Ordinary Shares 
of the Company carry one vote per share and an equal right to any dividends declared.

Share options
Details of the Company’s share option scheme and options issued during the year are set out in Note 18 to the 
Consolidated Financial Statements.

.105

Strategic reportCorporate governanceFinancial statementsHeiQ plcAnnual report and accounts 2020Financial statements
Notes to the Company Financial Statements continued
For the year ended December 31, 2020

10. Reserves

The share premium account represents the amount received on the issue of Ordinary Shares by the Company in 
excess of their nominal value and is non-distributable. 

The share-based payment reserve arises from the requirement to value share options in existence at the year end 
at fair value (see Note 18 to the Consolidated Financial Statements).

11. Share-based payments

Details of the Company’s share options and related expense are contained in Note 18 to the Consolidated 
Financial Statements.

12. Segment information

Operating segments are identified on the basis of internal reports about components of the Company that are 
regularly reviewed by the Board. Until its acquisition of HeiQ Materials AG on December 7, 2020, the Company 
was an investing company and did not trade. On completion of the acquisition of HeiQ Materials AG and its 
subsidiaries, the Company became the holding company of the Group. 

The Company has one segment, namely that of a parent company to its subsidiaries. Accordingly, no segmental 
analysis has been provided in these financial statements.

13. Employees

The number of employees including Directors was as follows:

Directors

Total

14. Related party transactions

Year ended
December 31,
2020
No.

Year ended
December 31,
2019
No.

5

5

3

3

The only key management personnel of the Company are the Directors. Details of their remuneration are 
contained in the Remuneration Committee report on pages 50 to 53.

Details of amounts due between the Company and its subsidiaries are shown in Note 5 above. 

15. Subsequent events

Disclosures in relation to events subsequent to December 31, 2020 are shown in Note 29 to the Consolidated 
Financial Statements.

16. Ultimate controlling party

As at December 31, 2020, no one entity owns greater than 50% of the issued share capital. Therefore, the 
Company does not have an ultimate controlling party.

.106

HeiQ plcAnnual report and accounts 2020Company information

Directors
Carlo Centonze, Chief Executive Officer
Xaver Hangartner, Chief Financial Officer
Esther Dale-Kolb, non-executive Chairwoman
Karen Brade, non-executive Director
Benjamin Bergo, non-executive Director

Company Secretary
Ross Ainger

Company number
09040064

Registered address
5th Floor, 15 Whitehall
London  
SW1A 2DD

Independent auditors
Crowe U.K. LLP
55 Ludgate Hill
London  
EC4M 7JW

Financial advisor and joint broker
Arlington Group Asset Management Limited
15 Whitehall
London
SW1A 2DD

Joint broker
Cenkos Securities plc
6 7 8 Tokenhouse Yard
London
EC2R 7AS

Registrars
Computershare Investor Services PLC
The Pavilions
Bridgwater Road
Bristol
BS13 8AE

UNITED KINGDOM (Ultimate parent)
HeiQ plc
1st floor 47/48 Piccadilly
London  
W1J 0DT

SWITZERLAND (Operational headquarters)
HeiQ Materials AG
Ruetistrasse 12
8952 Schlieren (Zurich)

AUSTRALIA
HeiQ PTY
c/ Deakin ManuFutures
75 Pidgons Rd
Waurn Ponds VIC 3216

BELGIUM
HeiQ Chrisal NV
Priester Daensstraat 9
3920 Lommel

GREATER CHINA
Representative Office
Room 2501
Xuhui Commercial Mansion
No. 168 Yude Road
Shanghai

HeiQ Company Ltd / HX Company Ltd
No. 14 & 16, Ln. 50, Wufu 1st Rd.
Luzhu District
Taoyuan City 33850
Taiwan

JAPAN
Representative Office
NIU Bldg 2F
2-1-17 Nihonbashi
Chuo-ku
Tokyo, 103-0027 

PORTUGAL
HeiQ Iberia Unipessoal Lda
Tecmaia
Rua Engº Frederico Ulrich, nº 2650
4470-605 Maia

SPAIN
HeiQ Medica SL
Plaza de la Estación s/n
29560 Pizarra (Málaga)

USA
HeiQ ChemTex Inc. 
180 Gee Rd NE
Calhoun GA 30701

2725 Armentrout Drive
Concord NC 28025

www.heiq.com

H

e

i

Q

p

l

c

A

n

n

u

a

l

r

e

p

o

r

t

a

n

d

a

c

c

o

u

n

t

s

2

0

2

0